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ABSTRACT
G lyS py
A S o ftw a r e  S uite  for  A s s ig n in g  G lycan  T o p o l o g ie s  fr o m  
S e q u e n tia l  M ass  S pec tr a l  Data
by
Anthony Lapadula 
University of New Hampshire, September 2007
GlySpy is a suite o f algorithms used to determine the structure of glycans. Glycans, which 
are orderly aggregations of monosaccharides such as glucose, mannose, and fucose, are often 
attached to  proteins and lipids, and provide a wide range of biological functions. Previous 
biomolecule-sequencing algorithms have operated on linear polymers such as proteins or DNA 
but, because glycans form complicated branching structures, new approaches are required. 
GlySpy uses data derived from sequential mass spectrometry (MSn), in which a precursor 
molecule is fragmented to form products, each of which may then be fragmented further, 
gradually disassembling the glycan. GlySpy resolves the structures o f the original glycans by 
examining these disassembly pathways.
xxiv
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The four main components o f GlySpy are: (1) OSCAR (the Oligosaccharide Subtree Constraint 
Algorithm), which accepts analyst-selected MS” disassembly pathways and produces a set of 
plausible glycan structures; (2) IsoDetect, which reports the MS" disassembly pathways that are 
inconsistent w ith a set o f expected structures, and which therefore may indicate the presence o f 
alternative isomeric structures; (3) IsoSolve, which attempts to  assign the branching structures 
o f multiple isomeric glycans found in a complex mixture; and (4) Intelligent Data Acquisition 
(IDA), which provides automated guidance to the mass spectrometer operator, selecting glycan 
fragments for further MS" disassembly.
This dissertation provides a primer fo r the underlying interdisciplinary topics— 
carbohydrates, glycans, MS", and so on—and also presents a survey of the relevant literature 
with a focus on currently-available tools. Each of GlySp/s four algorithms is described in detail, 
along with results from their application to biologically-derived glycan samples. A summary 
enumerates GlySpy's contributions, which include de novo glycan structural analysis, favorable 
performance characteristics, interpretation of higher-order MSn data, and the automation of 
both data acquisition and analysis.
xxv
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 1:
INTRODUCTION
Glycans (Rademacher 70; Van den Steen 85; Various 86; Varki 88) are oligosaccharides that 
are conjugated to fats (lipids) and over half of human proteins (Apweiler 4), and play important 
roles in a wide variety of biological processes (Dwek 22; Gabius 28; Gabius 29; Ioffe and Stanley 
42; Lowe and Marth 59; Stanley and Ioffe 78; Van den Steen 85; Varki 87; Varki 88). Glycans are 
"so ubiquitous ... that cells appear to other cells and to  the immune system as sugarcoated" 
(Maeder 60). Unlike linear DNA and proteins, glycans can form complicated branching 
structures, where one monosaccharide residue may be linked to several others. These linkages 
also have variables such as linkage position and anomericity, resulting in astonishing numbers of 
theoretically possible structures (Laine 51). Because glycans cannot be amplified as DNA can, 
glycan sequencing technologies must operate on minute quantities o f oligosaccharides, often 
eliminating Nuclear Magnetic Resonance (NMR) as a feasible analysis method. Structural 
analysis may be augmented with enzymes that cleave glycans in well-defined ways, but these 
methods are restricted by the limited number of available exo- and endoglycosidases (Kiister 50) 
and by the fact that many such enzymes are not completely specific.
These issues and others have made glycobiology, the study o f carbohydrates in biological 
processes, the focus of increasing interest and a fertile ground for bioinformatics efforts
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Marchal 61; von der Lieth 90). No single sequencing strategy has yet emerged, but the extreme 
sensitivity o f mass spectrometry (MS) and sequential mass spectrometry (MSn) combined with 
bioinformatics tools will provide significant progress toward high-throughput glycan sequencing.
Glycans are significant in a number o f biological and biomedical research areas. For 
instance, glycans are biomarkers for various cancers (Alper 2; Dziadek and Kunz 24; Ono and 
Hakomori 67; Turner 84) and the principal component o f new and promising vaccines for diverse 
cancers (Lo-Man 58), viruses (Dwek 23), and bacteria (Ada and Isaacs 1; Gaucher 30; Muhlecker 
64). They drive parasite-host (Hokke and Deedler 39; Khoo and Dell 47; Nyame 66) and 
microbe-host (Hooper and Gordon 40) interactions, as well as egg fertilization (Hedrick and 
Nishihara 38; Mozingo and Hedrick 63; Tseng 83) and protein folding (Parodi 68). They are 
crucial to drug development efforts (Dove 21; Koeller and Wong 48; Walsh 92) and are involved 
in allergic (Huby 41) and inflammatory responses (Kannagi 46). Defective glycan metabolism 
manifests as Congenital Disorders o f Glycosylation, Gaucher, Fabry, Tay-Sachs, and Sandhoff 
diseases, among others (Butters 14; Dwek 23; Jaeken and Matthijs 43; Jeyakumar 44; Platt 69; 
Vosseller 91). Research in these and related areas is hindered by the lack o f effective glycan 
sequencing tools and methods (Stephan 79).
The UNH Glycomics Center, formerly the Center for Structural Biology, has pioneered 
techniques to establish the topology (branching and linkage) of glycans using MS" (Ashline 5; 
Ashline 7; Hanneman and Reinhold 33; Hanneman 34; Hanneman and Reinhold 35; Lapadula 54; 
Reinhold 71; Reinhold 72; Reinhold 73; Sheeley and Reinhold 75; Singh and Reinhold 76; Singh 
77; Zhang and Reinhold 95; Zhang 96; Zhang 97), and other methods have been developed 
internationally (Cancilla 16; Harvey 36; Harvey 37; Konig and Leary 49; Viseux 89; Weiskopf 93; 
Xie 94).
2
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For several years, the author has been developing GlySpy (Lapadula 52; Lapadula 53; 
Lapadula 54) at the UNH Glycomics Center to  automate much of the glycan structural analysis 
currently performed manually. GlySpy uses data derived from sequential mass spectrometry 
(MSn), in which a precursor molecule is fragmented to form products, each o f which may then 
be fragmented further, gradually disassembling the glycan. GlySpy resolves the structures o f the 
original glycans by examining these disassembly pathways.
GlySpy consists of four major, interrelated components:
1) OSCAR (the Oligosaccharide Subtree Constraint Algorithm), which accepts analyst- 
selected MS" disassembly pathways and produces a set o f plausible glycan 
structures;
2) IsoDetect, which reports the MS" disassembly pathways that are inconsistent w ith a 
set of expected structures, and which therefore may indicate the presence of 
alternative isomeric structures;
3) IsoSolve, which attempts to assign the branching structures o f multiple isomeric 
glycans found in a complex mixture; and
4) Intelligent Data Acquisition (IDA), which provides automated guidance to the mass 
spectrometer operator, selecting glycan fragments for further MS" disassembly.
These tools range in capability from OSCAR, which requires precisely-selected input from a 
skilled analyst, through IsoDetect, which performs in a more autonomous fashion, to IsoSolve 
and IDA, which execute w ith virtually no human guidance. Each tool has its own strengths and 
limitations, as discussed throughout this document. The algorithms are presented in detail, 
along w ith results acquired from biologically-derived glycan samples, as opposed to simpler 
synthetic test cases preferred by some existing tools. Relevant MS" spectra are given in
3
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APPENDIX A: SELECTED EXPERIMENTAL SPECTRA. OSCAR uses over 50 inference rules to 
efficiently eliminate candidate glycan structures from consideration. A selection o f these is 
found in APPENDIX B: SAMPLE OSCAR INFERENCE RULES. These rules, nearly unanimously, 
operate on the abstract tree structure inherent in glycan topology and are not heavily 
dependent on chemical knowledge.
To begin, this dissertation provides a primer for the underlying interdisciplinary topics 
(carbohydrates, glycans, sequential mass spectrometry, and so on) before moving on to a large- 
scale view of GlySpy's components, and then to a survey of the relevant literature w ith a focus 
on currently-available tools. Next each algorithm is presented along with results and discussion. 
Finally a summary of the work is given, with an emphasis on GlySpy's contributions to the fields 
o f glycomics and computer science. These contributions include de novo glycan structural 
analysis, favorable performance characteristics, interpretation of higher-order MS" data, and the 
automation of both data acquisition and analysis.
We know of no other practical approaches to inferring tree structure that depend upon 
examining subtree fragments derived from sequential disassembly o f the original tree. Careful 
software engineering was required to avoid falling prey to the combinatorial aspects of this 
problem. Adapted techniques include aspects of blackboard systems, constraint-based systems, 
and guided search algorithms, and are applied to the challenging interdisciplinary topic of glycan 
structural analysis.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 2:
BACKGROUND
A complete description of carbohydrates and glycans is beyond the scope of this 
dissertation. What follows is largely derived from (Brooks 10; Brown 11; Campbell and Farrell 
15).
2.1. Carbohydrates and Glvcans
The term carbohydrate comes from the chemical formula satisfied by the earliest-known 
substances of this class: (CH20 )n, that is, one carbon for each water, or carbo-hydrate. 
Carbohydrates are the most abundant organic substances produced by living organisms, storing 
energy and forming structural components such as cellulose. They are formed from 
monosaccharide building blocks including glucose, mannose, galactose, fucose, GlcNAc, GalNAc, 
and Neu5Ac (Figure 1). When incorporated into a larger carbohydrate, the monosaccharides are 
known as residues.
When a carbohydrate is attached to  a protein or a lipid, it is often called a glycan, and the 
combined structure is called a glycoprotein or a glycolipid. The residue attached to the protein 
or lipid is identified as the reducing-end residue, and will be drawn as the right-most residue in 
this document. The reducing-end sugar can be thought of as the root o f a tree, w ith terminal 
residues constituting the tree's leaves.
5
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Figure 1: The monosaccharides glucose, mannose, galactose, fucose,
GlcNAc, GalNAc and Neu5Ac.
The work described in this document utilizes glycans derived from a variety of sources, with
special focus on these samples as purchased from Sigma-Aldrich Co., St. Louis, MO:
1) Chicken ovalbumin, the main protein in egg white (product A5503)
2) IgG, human serum immunoglobulin G (product 14506)
3) Purified type III bovine brain gangliosides, a glycosphingolipid (product G2375)
4) Fetuin, a fetal calf blood protein (product F2379)
2.2. Glvcan Release. Reduction and Permethvlation
The UNH Glycomics Center routinely derivatizes (chemically modifies) glycans before MS" 
analysis. The exact chemical protocols used are beyond the scope o f this document, but
6
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descend from a long line of techniques, most recently (Ciucanu and Kerek 17), and are described 
more fully in (Ashline 5). A brief overview o f these techniques may be useful.
Glycans are first released from their conjoiners and purified. This yields a complex mixture 
o f oligosaccharides, and direct links back to their sources are lost. Frequently, the exposed 
hemiacetal bond is reduced w ith sodium borohydride to form an alditol, breaking the carbon 
ring o f the reducing-end (root) sugar and giving it a modified mass that serves as a reference 
anchor during MSn analysis. Last, the glycans are permethylated. Here, methylation replaces all 
acidic protons, in effect converting all hydroxyl groups (OH) to methoxyl groups (OCH3, 
abbreviated OMe). Permethylation allows for the detection of cleavages between residues, as 
will be discussed in Section 2.6.3.
Figure 2 shows the results o f derivatization on the monosaccharides introduced above. We 
establish class names to represent monomers with identical masses: H fo r hexose (glucose, 
mannose, and galactose); F fo r deoxyhexose (fucose); N for HexNAc (GlcNAc and GalNAc); and S 
for sialic acid (Neu5Ac). GlySpy supports three reduced residues derived from H, F, and N; these 
are designated h, f, and n, respectively. Reduced fucose residues (f) are quite rare and are not 
considered further in this report; both h and n are included in Figure 2.


































Exact Mass: 307.20 Da
Neuraminic Acid 
(Sialic Acid) 
Exact Mass: 407.22 Da 
Figure 2: The permethylated monosaccharide classes H, N, F, and S, 
and the permethylated, reduced classes h and n.
Linkage positions are numbered; anomeric carbons are highlighted.
Figure 3 shows a simplified representation o f the monosaccharides from Figure 2. Notice 
that reduced residues are distinguished by the case o f their label, not by a difference in shape. 
This representation is a simplification of (Nomenclature Committee of the Consortium for 
Functional Glycomics 65).
Figure 3: Simplified representation of the monosaccharide classes of Figure 2.
8
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2.3. Interresidue Linkage and Anomericitv
Monosaccharides combine to form disaccharides, trisaccharides, and so on, by forming 
glycosidic bonds in one of two possible stereochemical anomeric orientations, axial (alpha or a) 
or equatorial (beta or P). The interresidue bonds extend from the anomeric carbon (carbon 2 
for sialic acid, carbon 1 otherwise) o f the non-reducing-end sugar to  an available position 
(carbons 4, 7, 8 or 9 fo r sialic acid; otherwise a subset of carbons 2, 3, 4, or 6) of the reducing- 
end sugar. The linkage positions fo r the supported residues are shown in Figure 2, w ith the 
anomeric carbons highlighted. Other monosaccharide residues, fo r example fructose, have 
different linkage positions, but these are outside the scope of this document.
Figure 4 shows a hypothetical trisaccharide with individual residues labeled with 
superscripts. Residue F° is terminal (a leaf), H1 in internal, and n2 is at the reducing end (the 
root). Using the linkage positions shown, we would designate this structure as F l-4H l-4n; that 
is, an F residue 1-4 linked to  an H, which is 1-4 linked to n. As GlySpy does not attempt to 
compute stereochemistry, anomericity is omitted from many figures.
>=°
Figure 4: A hypothetical trisaccharide
2.4. /V-Glvcans and O-Glvcans
A/-linked glycans, or simply A/-glycans, are always attached to proteins at the nitrogen atom 
(hence, "N") of the amide group o f an asparagine amino acid residue. Importantly, they nearly 
always contain a trimannosyl core consisting of five residues linked in an unwavering formation: 
two mannoses a l-3  and a l-6  connected to a single mannose, which is p l-4  connected to  an
9
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internal GlcNAc, which is |31-4 connected to the reducing end GlcNAc. See Figure 5. Larger N- 
glycans attach additional residues to this core.
Figure 5: The five residues of the conserved /V-linked core.
O-linked glycans, or O-glycans, are attached to the oxygen atom (hence, "O") o f a serine or 
threonine amino acid. They commonly consist of from one up to perhaps a dozen residues and 
are often classified according to  a series of common core structures. Core 1-Core 8, as shown on 
page 93 of (Brooks 10).
2.5. Terminology: Chemistry vs. Computer Science
The interdisciplinary nature of this work may cause confusion because o f the differing 
terminology used in the fields o f chemistry and computer science. To reduce this confusion, we 
define some useful synonyms. Table 1, which refers to Figure 5, defines some equivalent terms 
which will be used interchangeably in this document.
Table 1: Equivalent terminology from chemistry and computer science.
Glycan Tree
The glycan's residues are H°, H1, H2, N3, n4 The tree's nodes are H°, H1, H2, N3, n4
n4 is the reducing-end residue n4 is the root of the tree
H1 is a non-reducing-end terminal residue H1 is a leaf
H1 forms a glycosidic bond w ith H2 H1 is a child o f H2 (or H2 is the parent o f H1)
H2 has tw o substituents, H° and H1 H2 has two children, H° and H1
10
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2.6. Mass Spectrometry
2.6.1. MS and MSn
Mass spectrometry (MS) and sequential mass spectrometry (MSn) are well-established 
methods for oligosaccharide analysis. There are many types of mass spectrometers, but, very 
simply put, these instruments measure the mass-to-charge ratio (denoted m/z) o f ionized 
(electrically charged) sample molecules. The result is a spectrum plotting m/z against relative 




Figure 6: A portion of an MS profile spectrum showing 
abundance and mass, with the ion m /z  1187 indicated.
The full range of ionization and detection technologies available is beyond the scope of this 
document. Sequential mass spectrometry (MSn), using an ion trap (IT-MS), allows the operator 
to  select peaks ("precursor ions") from a spectrum, fragment them, and record the resulting 
"product ions" in another spectrum. Fragmenting a peak from the initial MS spectrum yields an 
MS2 spectrum; fragmenting a peak from that yields an MS3 spectrum; and so on.
Figure 7 shows a typical multi-step disassembly of ion m/z 1187.6. As we will see, this 
piecewise disassembly provides valuable clues at each step; OSCAR uses these clues to deduce 
the topology o f the unfragmented glycan. In the figure, each oval represents the spectrum 
generated from fragmenting the labeled precursor ion. The MS3 spectrum shown here was 
generated by selecting 1187.6 from the MS profile spectrum, fragmenting it, selecting 894.4
11
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from that spectrum, and fragmenting it. From this spectrum, both 649.2 and 676.3 can be 




Spectrum 73750- 649894.4 852
431
649.2 676.3 400 600 800
431.1
Figure 7: Two overlapping MS" fragmentation pathways:
m /z  1187.6 894.4 -» 649.2 431.1 and m /z  1187.6 -> 894.4 676.3.
At right is the spectrum generated during disassembly of ion m /z  894.4.
2.6.2. Da vs. m/z
The hypothetical trisaccharide o f Figure 4 has a monoisotopic mass of 685.39 Da. That is, 
this is the total mass in daltons if the compound were composed entirely of the most abundant 
isotopes of its constituent atoms. A dalton is defined to be 1/12 the mass of a carbon-12 atom.
However, this trisaccharide is uncharged and thus undetectable by a mass spectrometer. To 
solve this problem, we establish conditions that cause adduction of a metal cation, usually 
sodium (Na+), to the compound. The mass of the sodium ion is 22.99 Da and its charge is +1. 
Therefore the observed m/z o f the trisaccharide is computed as:
m/z = (685.39 + 22.99) /  (+1) = 708.38
If two sodium ions had been adducted, the observed m/z would have been:
(685.39 + 22.99 + 22.99) /  (+2) = 365.68
12
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In this document, measurements given in Da are masses with no adducted ion, whereas m/z 
always refers to an observed ion, sodiated unless otherwise specified.
2.6.3. Inferring Topology from MSn Data
To assign the topology of a glycan, an analyst w ill examine fragments generated by MS" 
disassembly. Figure 8 shows a simple hypothetical example. When the ion m/z 708.4 (Figure 
8A) is fragmented, assume that high-intensity fragment ions m/z 211.1, 227.1, and 316.2 are 
observed (Figure 8B). The most likely interpretations of these values are as follows:
•  m/z 211.1: A terminal fucose with a 1,2-ene (a double bond between carbons 1 and
2) cleavage at the reducing-end carbon. We abbreviate this composition (residues 
plus cleavages) as F-(ene)'. (The trailing prime indicates that one of the scars must 
occur on the reducing end. Composition notation w ill be covered more fully in 
Section 3.4.)
•  m/z 227.1: An internal hexose with both a 1,2-ene cleavage and an open hydroxyl 
(OH) cleavage. Composition: H-(ene)(oh)'.
•  m/z 316.2: A reduced HexNAc residue with a single open hydroxyl cleavage: n-(oh).
This interpretation is the most plausible because the glycosidic bonds joining monomers are 
the most labile and where fragmentation occurs. Thus, most abundant ions will be the result of 
glycosidic cleavages. Cross-ring cleavages, multiple simultaneous cleavages, and other 
interpretations are possible as well, but these typically yield only low-intensity peaks.




























Figure 8: Fragments potentially generated by disassembly
of the hypothetical trisaccharide FHn.
Because the glycans are permethylated, the fragments generated during MS" preserve hints 
o f their original connectivity. Specifically, the number o f (ene) and (oh) scars in each 
composition indicate the number o f cleavages applied to  the fragment, although the original 
linkage and identity of the cleaved residues are not directly recorded. In this case, the observed 
composition n-(oh) reveals only that the n residue had a single residue connected directly to  it, 
but not the identity of the residue. Similarly, the H-(ene)(oh)' fragment tells us that the H 
residue had previously been directly connected to two residues, and F-(ene)' indicates that the F 
residue had only a single attached residue. Combining these observations, plus the fact that a 
reduced n can occur only at the reducing end of a glycan, the analyst easily infers the linear FHn 
topology o f Figure 8A.
Figure 8C shows one cross-ring fragment that might be observed: part of the H's ring is still 
attached to the terminal F. The mass of this cross-ring fragment reveals that F° is linked to 
either position 4 or 6 of H1. (The linkage could just have easily been 1-6 instead of the shown 1- 
4; the mass of the fragment would have been identical.) Multiple cross-ring cleavages are
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sometimes required to  confirm a linkage assignment; often, a precise determination cannot be 
made.
2.6.4. Cross-Ring Fragments
Cross-ring fragments are identified by the bonds cleaved to  generate the fragment and 
whether or not the fragment contains the anomeric carbon o f the cleaved residue (Domon and 
Costello 20). Figure 9 shows the bond numbering for a hexose residue; all residues supported 




Figure 9: Bond numbering used to identify cross-ring cleavages of a hexose. 







Figure 10: Complementary 3,5 A and 3,5X cross-ring fragments.
Figure 10 shows the two fragments that would result from cleaving bonds three and five of 
the reducing-end hexose. The fragment w ithout the anomeric carbon (labeled "1") is denoted 
the 3,5A fragment; the complementary fragment is denoted 3,5X. We can now see that the cross­
ring fragment o f Figure 8C could more precisely be described as having composition F-3,5A[HNn], 
where the [HNn] denotes the residue classes that might have generated the cross-ring fragment. 
H, N, and n all share the same atomic structure at the relevant parts o f the residues, and hence
15
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any o f these might have generated the fragment. Notice that F-3,5A[F] is not a valid composition, 
as a reducing-end F residue could not produce the fragment exactly as shown—F has no OMe at 
carbon six.
2.7. Structural Isomers
The same monosaccharide building blocks can be linked to form a variety o f structures 
called structural isomers1. For example. Figure 11 shows two isomeric glycans w ith  the same 
composition, but G M la is branched while G M lb  is linear. One goal of this research is to 
successfully analyze mixtures of structural isomers.
676.3m /z  1273.6
898.4
GM1b 847.4 1069.4 MeQ-MeO-MeO-
MeO-
MeO-




Figure 11: The isomeric glycoconjugates from the bovine brain gangliosides G M la  and G M lb . 
These glycans contain the same residues, but have different structures.
1 The terms isomer and isobar are often used interchangeably, creating much confusion in the field. 
In this work, we adopt the terminology of (62). There, structural isomer (shortened to isomer) indicates 
identical atomic compositions arranged in a different structure. We extend this definition slightly to  mean 
the same monosaccharide residues arranged in a different configuration, as in Figure 11. The term  isobar 
will indicate different composition o f atoms occurring at a nominal (unit) mass resolution; that is, 
structures or fragments with nearly identical masses but different chemical compositions.
16
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CHAPTER 3:
GLYSPY
3.1. Overview and Goals
GlySpy is an integrated toolkit for manual, semi-automated, and automated glycan analysis. 




•  Intelligent Data Acquisition (IDA)
OSCAR and IsoDetect are used today in the Glycomics Center and have contributed to 
published and forthcoming reports. As such, these algorithms are relatively mature. IsoSolve 
and IDA are more experimental in nature and should be viewed as stepping stones toward fully 
automated glycan analysis. They perform quite well in situations for which they were designed 
but do not yet obviate the need for a human analyst. This dissertation offers assessments of all 
four algorithms, including cases where they perform poorly. Future work items will be identified 
to improve performance and accuracy.
Even today, however, these tools improve analysts' capabilities and efficiency, and may 
assist in the discovery o f biological insights in a variety o f areas. In the long term, beyond the
17
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scope of this dissertation, it is hoped that these tools will form the basis o f a high-throughput 
glycomics analysis platform, which will automate both data collection and structural analysis. As 
such, the tools should be understood as moving along the continuum from fully-manual toward 
fully-automated glycomics analysis.
3.2. Implementation and Performance
GlySpy was implemented as a single Microsoft Windows command-line interface tool, 
GlySpyCLI.exe, and consists o f over 50,000 lines o f C++.
Execution times, when given, were measured as the best of five consecutive executions o f 
the given test. Each test was executed at an elevated priority level (process level 
ABOVE_NORMAL_PRIORITY_CLASS, thread level THREAD_PRIORITY_ABOVE_NORMAL). This 
protocol minimized the tim ing variations created by a multi-tasking operating system, disk 
caches, and so on. The tests were performed on a Dell E1705 laptop with an Intel T7200 
Centrino Core2 Duo CPU running at 2.0 GHz. The system had 2 GB of system memory and ran 
Microsoft Windows Vista Home Premium.
3.3. Algorithm Integration and Interaction
Figure 12 shows an extremely high-level view of GlySpy, with emphasis on the input and 
output of its four algorithms. We see that, typically, a prepared glycan sample is infused by an 
Advion TriVersa NanoMate into an LTQ mass spectrometer. In manual operation, the analyst 
collects data and chooses the input to provide to  OSCAR, IsoDetect or IsoSolve. In automated 
mode, the Intelligent Data Acquisition module collects spectra, which can then be passed to 
IsoSolve for topology analysis.
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Figure 12: A high-level system diagram showing the 
input and output of GlySpy's four main algorithms.
Because the four GlySpy algorithms are all part of the same executable, they can
communicate extremely efficiently. For example, although not shown in Figure 12, IsoDetect,
IsoSolve and IDA all invoke OSCAR to perform their higher-level tasks. These interactions are
covered as we describe each algorithm.
3.4. Composition Notation
Residue compositions are given as residue counts paired with scars. For example, H4N2n 
represents a composition of four hexoses, two HexNAcs, and one reduced HexNAc.
As mentioned briefly in Section 2.6.3 and Figure 8, scars are denoted by (oh) and (ene)
modifiers, each o f which may be modified by a count. A trailing prime (') indicates that exactly
one o f the scars must occur on the reducing end; if no trailing prime is present, all o f the scars
are located on the non-reducing end. A few examples:
19
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•  H-(oh) represents a single hexose with one (oh) scar on the non-reducing end.
•  HN-(oh)2 represents a Hex-HexNAc dimer, which jointly contains two (oh) scars, 
neither o f which is on the reducing end.
•  H3-(ene)(oh)' represents a hexose trim er w ith both an (ene) and an (oh) scar, one of
which must be a reducing-end scar, and the other a non-reducing-end scar.
Note that compositions, w ith the exception o f the prime indicator, do not directly imply 
structure. For example, HN-(oh)2 makes no claim as to the location of the two non-reducing-end 
scars. They may both be on the H, or both on the N, or split w ith each residue having a single 
scar. However, the lack o f a prime indicates that the reducing end of this dimer is unscarred.
Also, note that subscripts denote the number o f monomers in an ion composition (e.g., H2 
means two hexoses) and superscripts identify particular residues (H2 means the hexose with 
index 2).
3.5. Composition Database
GlySpy maps masses to possible compositions via a glycan fragment database, which is built 
by a stand-alone program also written by the author. This program, called MakeDB, creates the 
database file in under 13 seconds. The database file is 52,546,296 bytes in size, and contains 
6,701 entries for unfragmented glycans and 2,182,614 entries for glycan fragments. To maintain 
this reasonable size, some limitations are placed upon the glycans and fragments contained in 
the database:
•  Each monomer type is limited by a maximum count, as determined by a review of
reported structures: H = 10, F = 4, N = 10, S = 4, h = 1, f  = 1, n = 1.
•  Each composition may have at most one reduced residue (h, f, or n).
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•  Unfragmented glycans are limited to 15 residues and a sodiated mass o f 4000 Da.
•  A maximum of five scars may be present on any fragment, w ith all combinations of 
up to five (oh) scars and three (ene) scars represented.
•  A total of 73 different cross-ring cleavages are supported2.
The glycans and glycan fragments accepted by GlySpy are obviously limited to  those that 
meet the above restrictions. In practice, though, these restrictions are generous and do not 
seem to  be limiting. In extreme cases, an expanded version of the database could easily be 
generated.
3.6. Shared Options and Parameters
Because GlySpy is a single executable, its various commands share many user-selectable 
options. Commands that begin with a dash, e.g., -ErrTol, are global options that can be given on 
the GlySpy command line or on any line o f input. Other options such as NoCrossRing are specific 
to a set of commands.
3.6.1. Shared Global Options
3.6.1.1 The-ErrTol Global Option
The -ErrTol switch gives an error tolerance in Da. When an experimental mass is used to 
retrieve possible compositions, all compositions in the mass range [mass - ErrTol, mass + ErrTol]
2 Many of these 73 cross-ring cleavages are closely related to one another. For example, the 3,5A 
fragment shown in Figure 8C on page 15 is still methylated at carbon 6 (labeled MeO). GlySpy's database 
also supports two alternate versions of this cross-ring fragment, one with an (oh) scar and one with an 
(ene) scar at this position. All cross-ring fragments that contain multiple linkage positions generate 
multiple scarred cross-ring fragment variants such as these.
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are considered. The default is 0.5 Da, and so an experimental mass of 500 Da would match all
compositions w ith masses in the range [499.5, 500.5].
3.6.1.2 The -NLinked Global Option
When the -NLinked global option is given, GlySpy will only consider structures that embed 
the AMinked core motif H3Nn (Figure 5). The structures will have all interresidue linkages 
assigned as well. This option may be given when the analyst is investigating the linkage o f an N- 
glycan and wishes to assign residues to  the 3- or 6-branch o f the /V-linked core.
3.6.1.3 The -NLinkedBranching Global Option
The -NLinkedBranching option is similar to -NLinked with the exception that the
interresidue linkages are not specified. This option is used when the analyst is investigating 
branching topology only, and is not concerned w ith linkage assignments.
3.6.1.4 The -ReducingEndResidue Global Option
The -ReducingEndResidue option specifies which residues are eligible to be the reducing- 
end sugar of suggested structures. The supported option values are shown in Table 2. The 
default is -ReducingEndResidue any. Many examples in this work use 
-ReducingEndResidue reduced.
Table 2: Legal values for the -ReducingEndResidue option.
any Any o f HFSNhfn
unreduced Any o f HFSN
ueduced Any of hfn
Subset Of HFSNhf n Selected residues, fo r example:
-ReducingEndResidue hn
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3.6.2. The NoCrossRing Shared Command Option
Many specific commands share a common NoCrossRing option. This option forces the 
command to interpret a given disassembly pathway as containing glycosidic cleavages only. This 
is useful when the analyst explicitly wishes to exclude the possibility of cross-ring cleavages, 
even though fragments in the pathway may have cross-ring masses that fall w ithin the error 
tolerance window. The NoCrossRing command leads to much faster execution times and 
increased structure specificity, and is used extensively in this work.
3.6.3. The Pathway Shared Command Parameter
Many commands accept an m/z  disassembly pathway as an argument. For example, 
LabelPathway 1636. 8_914 .4_710.3_506.2_316.2 displays possible compositions for 
each ion in the pathway m/z 1636.8 914.4 -> 710.3 -> 506.2 -> 316.2.
Each ion in the pathway may be annotated w ith a charge state, given as xn. If no charge 
state is given +1 is assumed. For example, LabelPathway 1141. 6x2_1012. 0x2_1537.0 
displays compositions for each ion in the pathway, with the first two m/z values assigned a 
charge state of +2 and the last ion assigned +1.
3.7. Structure Notation (Linear Code)
It is often convenient to represent a glycan structure using text instead of a diagram. 
GlySpy's representation is based upon (Nomenclature Committee of the Consortium for 
Functional Glycomics 65). In this linear code, reading from left-to-right moves from the non- 
reducing-end of the glycan to the reducing end, and so the final monomer listed is the reducing- 
end residue. Parentheses are used to  designate branching.
23
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# Hypothetical Topology Linear Code
H(H)HNn
FH(SH)HNn
Table 3: Increasingly complex glycan topologies and their corresponding linear codes.
Table 3 shows a series of hypothetical glycan topologies along w ith the linear code for each. 
As residues are added, the topology's complexity increases. In this example, n is always the 
reducing end residue (or, correspondingly, the root of the tree). Topology 1 shows that linear 
glycans require no parentheses in their linear code, because, of course, they are not branched. 
Topology 2 show how a simple branch is represented in the linear code: One of the branches is 
parenthesized, but the other is not. (In our notation, the choice o f which branch to parenthesize 
is arbitrary; other similar notations specify complex rules to generate canonical 
representations.) Topology 3 shows that branches can themselves contain linear components,
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and so FH and (SH) represent the two non-reducing-end linear sequences. Topology 4 shows 
how additional branching is represented. Here the right-most H residue has three branches, 
represented as FH, (SH), and (N) in the linear code. Similarly, we see a reducing-end fucose- 
substituted n, represented (F)n.
The simple five residue W-linked core (topology 2 in Table 3, and which is described in 
greater detail in Figure 5 on page 10) is represented H(H)HNn. Optional interresidue linkages 
may be given as well, yielding H6(H3)H4N4n. A more verbose form is available, where the 
anomeric carbon that originates the glycosidic bond is also listed: Hl-6(Hl-3)Hl-4Nl-4n. 
Finally, alpha/beta anomericity may also be included: Hal-6 (Hal-3) Hbl-4Nbl4n. For N- 
linked structures, the user must indicate each core residue by applying a prime: 
H' (H') H' N' n'. If the reducing end of the glycan contains a scar, -  (oh) or -  (ene) may be 
appended.
As further examples, consider GM la and G M lb from Figure 11 on page 16. GMla is written 
as HN ( s )hh— (oh) for branching alone, and as H3N4 (S3)H4H-(oh) when linkage is given. 
Similarly, the linear G M lb is written as either shnhh- (oh) or S3H3N4H4H- (oh).
Note that linkage designators are neither subscripted nor superscripted, avoiding possible 
confusion w ith monomer quantities or indices, respectively.
The linear code used in this document will omit optional components not relevant to the 
particular algorithm being discussed. For example, none of GlySpy's algorithms consider 
anomericity, and so a /b  will always be eliminated.
3.8. Known Limitations
All GlySpy algorithms are limited by the compositions found in the underlying fragment
database. Glycans with other compositions w ill not be accepted.
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OSCAR supports multiply-charged ions, but the analyst is responsible fo r assigning correct 
charge states. The remaining algorithms (IsoDetect, IsoSolve, and IDA) accept only singly- 
charged ions. Due to limitations o f the Thermo LTQ ion trap, this will restrict these three 
algorithms to  processing glycans with observed masses under 2000 Da. Future work is 
envisioned to more fully support multiply-charged ions.
OSCAR supports analysis o f cross-ring cleavages, where the appropriate ions have been 
selected by the analyst, and computes interresidue linkages. The remaining algorithms focus 
solely on glycosidic cleavages and therefore compute only branching topologies.
All algorithms are capable o f processing both N- and O-linked glycans. However, the glycans 
must be fully permethylated; acetylated or phosphorylated glycans are not supported.
3.9. Reported Glvcan Structures
Glycans examined in this document come from the well-characterized sources o f bovine 
brain gangliosides, fetuin, IgG, and ovalbumin. In many cases, we compare the structures 
revealed by GlySpy with those reported in the literature. For convenience, we list the reported 
structures in Table 4. Reported IgG structures are taken from Table II o f (Butler 13), ovalbumin 
from (Harvey 37), and G M la /G M lb  from (Svennerholm 80).
26
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Branching Topology
Source m /z  Com position (M u ltip le  if Isomers)
Bovine Brain 
Gangliosides 1273.65 H3NS-(oh)’
GM la: HN(S)HH-(oh) 
G M lb: SHNHH-(oh)
Fetuin 3618.8 H6N4S3n SHNISHNJH^SHNH'jH'N’n'
1606.83 H3FN2n NH'IH'lH’N’fFjn*
1636.84 H4N2n HNH’lH 'jH 'N’n'





Ovalbumin 1677.87 H3N3n NH’INJiH'JH’N'n'
1922.99 H3N4n
N(N)H,(N)(H,)H,N'n’
.. ... . ,n,
Table 4: Structures reported in the literature for the glycans examined in this work. 
These are collected here to allow for comparison to GlySpy's results.
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CHAPTER 4: 
COMPARISONS TO RELATED WORK
To my knowledge, no computational tools have been developed to  support an MS" glycan 
sequencing strategy. Many tools use MS2 (also known as MS/MS or tandem MS), where a single 
fragmentation spectrum is collected, and others use simply the MS mass to infer composition or 
even structure. Here existing tools are reviewed to provide some sense of the current state of 
the art. Because GlySpy's capabilities are built on OSCAR, we begin w ith high-level comparisons 
between this algorithm and currently available tools.
OSCAR is distinct from other currently available glycan sequencing software. For example, 
unlike the computer programs StrOligo (Ethier 25; Ethier 26), GlycoMod (Cooper 18) and 
Cartoonist (Goldberg 32), OSCAR does not encode any biologically-based structural restrictions. 
In other words, OSCAR does not apply constraints inferred from reported glycans or presumed 
biosynthetic pathways.3 As such, OSCAR is able to assign novel glycan topologies. This 
architecture also enables straightforward future coverage of additional monosaccharides.
3 "Biosynthetic pathways" refers to the sequence of steps that take initial reactants to final products, 
including the enzymes active at each step. W e write that these pathways are merely "presumed" as much 
here remains to be discovered. For example, the pathways by which cancerous cells synthesize distinctive 
glycans are little understood.
28
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Another important distinction is that GlycoMod and Cartoonist use only a composition mass, 
and StrOligo, GLYCH (Tang 81) and GlycosidlQ (Joshi 45) are limited to MS/MS spectral data. In 
contrast, OSCAR uses higher-order MS" and interprets each product ion in the context o f its 
precursor, and so the location o f each fragment within the full glycan is assigned w ith greater 
confidence. This hierarchical precursor-product relationship is a fundamental advantage of 
higher-order MS" analysis.
Importantly, OSCAR is a de novo algorithm, meaning it proceeds from first principles. It does 
not attempt to match an unknown glycan sample against a database of known glycans, as KCaM 
(Aoki 3) does against the KEGG and CarbBank databases or as GlycosidlQ does against the 
GlycoSuiteDB database (Cooper 19). OSCAR also does not attempt to match known structural 
motifs, as do GlycoMod and Tseng et al.'s catalog-library method (Tseng 82; Xie 94). OSCAR 
examines only MS" ions in order to propose structures, and so it is free to  propose novel 
topologies.
Next we examine a representative sampling o f currently available tools in greater detail.
4.1. GlycoSuiteDB
Several attempts have been made to  construct database repositories o f glycan structures. 
Perhaps the best known of these is GlycoSuiteDB (Cooper 19), a commercial system available 
from Proteome Systems Limited (Sydney, Australia) at http://www.glvcosuite.com. 
GlycoSuiteDB is an annotated and curated database that, as of Release 8.0, contains 9436 
entries from 864 references and 245 species. Of the 3238 unique glycan structures, 1851 are 
completely characterized.
GlycoSuiteDB can be searched in a variety of ways, including composition, structure, 
biological source, and more. See Figure 13. Selecting "disease" and "composition" brings you to
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the form shown in Figure 14. Here the user selects the disease(s) o f interest along w ith ranges 
of monosaccharide residues (e.g., 0-5 Hex and 1-3 HexNAc), and is presented with a list o f 
matching records.
The value o f databases is that they are searched easily and flexibly. GlycoSuiteDB adds the 
important aspect o f being professionally curated. However, no database can address the issue 
of new, unreported structures, and this is why GlySpy focuses on the area o f de novo analysis.
\ Fte Vjew Favorites Jw** tteip m
*-.Address https://tmat.proteomesystems.com/glyco/giycosuite/giycodb -  0 ° °
C lycoS u ite





R elease 8 .0 , August. 2 0 0 5
GtycoSuite comprises GlycoSuiteDB, the 
leading curated and annotated glycan 
database, and new bioinformatic tools 
which interface mass spec tro metric data 
with the database.
Release 8.8 contains 9436 entries, sourced 
from 864 references. Click here for more 
details.
<
B u ild  q u e ry  fo rm
To conduct a query p lease  se lect fro m  th e  o p tions  below. For e xam p le  
queries click here
FH s t ru c tu re  D d is e a s e  Q m ass
□  c o m p o s it io n  0  a tta c h e d  p ro te in  D  ta x o n o m y
0  b io lo g ic a l s o u rc e  0  re fe re n c e  Q  l in k a g e
0  a cce ss io n
3  19 Internet
Figure 13: The GlycoSuiteDB query form.
30
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
GlycoSuiteDB Q u ery  - M icrosoft In te rn e t Explorer
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1*1
EXAM PLES TOOLS D O C U M EN TATIO N  LIC EN SIN G  STATUS L IN K S  ABO UT
Query
index results by taxonomy
/  h e lp /
Select a pre-defined disease state:
d a n c e r , O v a r ia n  ( C y s t ic )
Carbohydrate-Deficient Glycoprotein Syndrome, Type II 
Carcinoid Tumor, with multiple liver metastasis 
Carcinoma
or enter disease-related keyword(s):
S elect exac tly  th is  ke yw ord  O
/ h e l p /
Enter a composition, or a composition range,
I I H«*
[ [ HexNAc 
j 1dHex
I I Pent








O  Match this exact composition (empty 
boxes imply ’O')
and/or number of monosaccharide residues
■3 4ft Internet
Figure 14: GlycoSuiteDB query by disease and composition.
4.2. GlycosidlQ
GlycosidlQ (Joshi 45), also available at http://www.glycosuite.com. is a commercial MS2 
glycan fingerprinting tool built upon the GlycoSuiteDB database. Its operation is split into three 
parts: fragmentation, matching and scoring.
First, each glycan structure in GlycoSuiteDB is presented to an in silico fragmentation 
algorithm. This algorithm creates all fragments possible given one or two glycosidic cleavages or 
one glycosidic cleavage plus one cross-ring cleavage. The resulting fragment mass list is saved 
and associated w ith the parent structure.
Next GlycosidlQ uses each mass on an experimental MS2 spectrum as a search key into the 
database of fragment mass lists. Each structure has an associated count that records the
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number o f times it was matched by an experimental mass. The set of structures w ith a non-zero 
hit count are then passed to the next phase, scoring.
Here, each candidate structure is evaluated against the experimental spectrum, with 
penalties imposed for each feature o f the structure that is unsupported by the experimental 
data. A second scoring scheme is used, where the high intensity peaks are given greater weight 
than low intensity peaks. A combined score is used to  rank the candidates for presentation to 
the user.
The authors note that it was not possible to generate all theoretical fragments due to 
"computational storage and querying limitations." As such, they manually identified "specific 
fragments that were common to many spectra ... and manually added to the theoretical 
fragment database."
The results returned by GlycosidlQ are of course limited by the contents o f GlycoSuiteDB. 
The authors claim that, when challenged with structures missing from the database, the tool 
returns structures that are very similar to  the desired glycan. It is, however, unclear how the 
user would determine if the highest-ranked candidate is tru ly correct, or merely a close analog.
4.3. GIvcanMass
GlycanMass, a tool hosted at http://www.expasv.org/tools/glvcomod/glvcanmass.html by 
the Swiss Institute of Bioinformatics, calculates the mass of a glycan given its monosaccharide 
composition and derivatization (underivatized, permethylated, or peracetylated). For example, 
selecting a permethylated glycan w ith composition Hex3HexNAc2 (see Figure 15) returns a 
monoisotopic mass of 1148.5939. GlycanMass does not offer support fo r reduced glycans or for 
charge adducts such as Na+.
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3  GlycanMass M icroso ft In te rn e t Explorer
£dfc Vtew Fflyorites loob fjelp
http://www.expasy.org/tools/glyco(nod/^ ycarvriass.hti<nl
■: F m  
I B *
G lycanM ass
GlycanMass is a tool which allows to calculate the mass of an oligosaccharide 
structure [Mass values / Disclaimer],
Note: You can use GlycoMod to predict the possible oligosaccharide structures that 
occur on proteins from their experimentally determined masses.
Please specify the monosaccharide composition of your oligosaccharide:
Pentose (e.g. xylose): |___
s°3h [22
PO3H: ^
Hexose (e.g. Man, Gal): [3_
HexNAc (e.g. GlcNAc. GalNAc): [2] 
Deoxyhexose (e g fucose):
NeuAc (e.g. sialic acid): [ [
NeuGc: [
KDN:
HexA (e.g. glucuronic acid):
Monosaccharide residues are:
O  underivatised ®  permethylated O  peracetylated.
All mass values are
O  average or ©  monoisotopic.
[ Reset ] all fields, i Catniiate | g|yCan mass
1
Figure 15: The GlycanMass web tool.
4.4. GlycoMod
GlycoMod (Cooper 18), available at http://www.expasy.org/tools/glvcomod/. accepts an 
experimental mass, adduct, type o f glycan (/V-linked or O-linked), derivatization (underivatized, 
permethylated, or peracetylated), and a range for each monosaccharide type. It then produces 
a report listing the possible compositions for the given mass, along with a link to the matching 
GlycoSuiteDB database record. Figure 16 shows a portion o f the input to search for a sodiated, 
permethylated, reduced /V-glycan with mass 1187.7 Da. Figure 17 shows the unsurprising 
output that identifies this glycan as having the composition o f the /V-linked core.
GlycoMod accepts a list of experimental masses, but, importantly, these masses are all
unfragmented MS1 masses. That is, each listed ion represents a different intact glycan; the tool
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merely repeats the mass-to-composition analysis fo r each. In contrast, OSCAR accepts multiple 
MS" fragmentation pathways to assign topology, using the relationships between precursor and 
product ions to infer structural constraints.
m m m
1: F ie  6d» ; Sew Favorites loots Hi* i n
|; AStlJress jjst http://www.expasy.org/tools/grycCTnodr v 5 3  Gc I
Enter a list of experimental masses: 4
1 1 6 7 .6
All mass values are
O  average or ©  monoisotopic, i
Or upload a file, containing one mass per line, from your computer
Mass tolerance: +/- |o £ 1 j PattonJ l
! Il Browse... 1 i
Ion mode and adducts:
positive negative : neutral
O  [M+H]+ ©  [M-HJ-
®  Na+ or O  K+ | O  acetate or O  trifluoroacetic acid O  [M]
i O  other:; j mass:! i i O  other:! i mass:! 1
®  N-linked oligosaccharides i O  O-linked oligosaccharides
Form of N-lmked oliqosacchande: 0R  i Form of O-linked oligosaccharide:
| R educed o ligosaccharides |$|j itG lycopeptides  (on lythose containing S o rT  will be  used)
- t l/Vl VJ
g ? ®  Internet
Figure 16: A section of the input page for GlycoMod.
: File Edit View Favorites Tools Ftefc 
j j Address http://www.expasy.org/cgi-bin/glycornod.pl
m
t I  H  60
1—  ...................  " "  ..........................................................  - 1
User m ass : 1187.7 
A dduc t (Na+) :  22.989768
Derivative m ass (Reduced reducing end): 62.0732
glycoform mass Amass (Dalton) structure type Links
1102.552 0.085 (Hex)3 (HexNAc)2 . GlycoSuiteDB I f
j  1 structure found. I
I...................................................................  . ............................  ...I I
i n  : 4  Internet I
Figure 17: Sample GlycoMod output.
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4.5. StrOliao
StrOligo (Ethier 25; Ethier 26) is a set of subroutines applied in series to MS2 spectra to 
analyze PMP-derivatized /V-glycans. First, isotopic peak envelopes are identified and reduced to 
a single monoisotopic peak. StrOligo accomplishes this by fitting the experimental envelopes to 
simulated envelopes generated from presumed compositions at the given mass. When 
successful, the isotopic peaks are merged w ith the monoisotopic peak, enhancing the 
monoisotopic peak and simplifying the spectrum.
From the remaining peaks, StrOligo examines all pairs o f peaks to identify possible single 
and double residue losses, and this information is encoded into a relationship tree. See Figure 
18, taken from (Ethier 25). Although the authors recognize that this tree may contain inaccurate 
relationships, they maintain that the true relationships in the tree will dominate. It is unclear 
what the tool would do if challenged w ith a spectrum containing multiple structural isomers.
At this point, the nodes in the relationship tree represent masses, not compositions. 
Accordingly, StrOligo then computes the likely starting compositions for the full glycan (which 
"generally results in 50 to  100 compositions") and ranks them according to  their agreement with 
the relationship tree. The resulting compositions are then presented to the user, who may 
select one or more to proceed to the structural analysis phase.
Here StrOligo uses presumed mammalian biosynthetic constraints to greatly reduce the 
number o f structures considered. For example, the only substitution allowed on the reducing- 
end GlcNAc is a fucose. All structures compatible with both the user-selected composition and 
the biosynthetic rules are generated, and each structure is then ranked according to its
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agreement w ith the relationship tree. The list of structures is presented to  the user in ranked 
order.
StrOligo ignores cross-ring cleavages and makes no attempt to assign interresidue linkage. 
Also, because the glycans are unmethylated, the algorithm cannot draw sharp conclusions about 
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Figure 18: A sample relationship tree as computed by StrOligo.
The text box shows some of the possible compositions for ion m /z  1590.6.
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The algorithm's use o f biosynthetic pathways may exclude many actual structures, as our 
understanding o f the pathways will surely increase with time. Additionally, the fact that disease 
states often present unconventional glycosylation profiles suggests that the use o f presumed 
biosynthetic pathways may hinder the search for biomarkers. The mammalian biosynthetic 
restrictions also reduce the applicability of the tool to  other organisms. For example, the C. 
elegans glycan m/z 1928 from (Lapadula 54) includes a Hex-Fuc substitution on the reducing- 
end GlcNAc, a m otif that is disallowed by StrOligo. The authors seem aware of this limitation 
and state that "efforts are currently being made to include other biosynthetic rules." In a 
follow-up paper (Ethier 26), the authors report that some biosynthetic constraints had to be 
removed to process glycans from IgG, beta interferon, and fetuin. The de novo approach used 
by OSCAR does not suffer from these limitations, but the algorithm must correspondingly work 
harder to avoid being overrun by a multitude o f possible structures.
4.6. GLYCH: GLYcan CHaracterization
GLYCH (Tang 81) performs de novo interpretations of high energy CID MS2 spectra of 
permethylated glycans. The algorithm relies on cross-ring cleavages to  make appropriate 
assignments.
GLYCH defines the Prefix Residue Mass (PRM) mi as the total mass for the residues of the 
subtree rooted at residue i. See Figure 19, which is taken from (Tang 81). It also defines the 
Prefix Residue Feature (PRF) for residue i as (mi, r„ bj), where mi is the PRM, r, is the residue 
type, and bj is the linkage position from residue i's parent. Therefore any glycan w ith n residues 
can be described by the series o f PRFs (nrii, rlr b i ) ... (mn, rn, bn).
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Figure 19: (a) A sample oligosaccharide containing 12 residues, 
(b) Subtrees rooted by residues r3, r9, r10, and ru.
Each theoretically-possible PRF is assigned a score equal to the number of peaks consistent 
with it. Then a pathway PRF3 through PRFn is sought that maximizes the sum of the selected 
PRFs' scores; this sum is assigned to  the structure defined by that pathway.
A post-processing step is applied, where each proposed structure is fragmented in silico, and 
the resulting theoretical spectrum is compared w ith the experimental. The number o f common 
peaks is used to rank the structures, and the results are presented to the user.
GLYCFI removes low intensity peaks before processing the spectrum. It is unclear why this is 
done (other than improved performance), as these peaks might be the very ones to  lend crucial 
support to the correct glycan structure. Cross-ring cleavages, after all, are usually much lower in 
intensity than glycosidic cleavages.
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Also, the authors leave unanswered the question of what GLYCH does when support for 
PRFk is missing because the corresponding low-intensity peak was removed. Now the glycan is 
actually defined by two sequences: PRF^-PRF^ and PRFk+1..PRFn. Can the algorithm typically 
overcome this gap?
The authors report that GLYCH's scoring algorithm seems to prefer linear structures to 
branching, and that as the complexity o f the glycan increased, so did the number of optimal 
solutions. The reasons for these behaviors are left unexplained, but the observations cast some 
doubt on the applicability of this method to the de novo assignment of larger, branching 
structures. In fact, GLYCH supports only binary branching, and so the common bisecting HexNAc 
motif is unsupported. It is also unclear what GLYCH would do if presented w ith an MS2 
spectrum of an isomeric mixture.
Even though the glycans analyzed were permethylated, it does not appear that GLYCH takes 
especially good advantage of the cleavage indications left behind on fragments. Perhaps this is 
because these cleavages provide more information when they appear in an MS" disassembly 
pathway. For comparison, OSCAR relies heavily on these clues.
4.7. The Cataloq-Librarv Method
Tseng's Catalog-Library approach (Tseng 82; Tseng 83) is not a tool, but could readily be 
automated. As such, it merits discussion here. This method observes that a given substructure, 
even when embedded in different structures, will fragment to provide a reliable mass spectral 
fingerprint motif.
To this end, the authors constructed a catalog of five different motifs, gathered from MS" 
analysis o f glycans that had been fully characterized by NMR. Then experimental spectra for 
unknown glycans were manually scanned for motifs that appeared in the catalog. Figure 20(a)
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shows one m otif from the catalog, while (b) shows the same m otif appearing at a reduced 
intensity as part of the spectrum for a larger structure. The authors therefore conclude that the 
cataloged substructure must be a component o f the unknown. Multiple motifs appearing in the 
same experimental spectrum can identify potentially overlapping substructures, bringing some 
structural clarity to the overall glycan.
The catalog described contained only five entries and the authors write (Tseng 83) that "a 
new biological source may, however, require a new catalog based on a different group of 
substructural motifs." It is unclear why a single "master catalog" could not be constructed and 





































Figure 20: (a) A motif derived from a well-characterized fragment, 
(b) The same motif as it appears as part of a larger structure.
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4.8. STAT: Saccharide Topology Analysis Tool
STAT (Gaucher 31; Leavell 55) is a Web-based tool that attempts to sequence glycans o f up 
to ten residues. STAT accepts a non-hierarchical list of ions selected from multiple MSn spectra, 
but does not derive information from the generative relationship between precursor and 
product ions. Operators manually select between multiple compositions for ambiguous ions. 
STAT then computes every possible branching topology for the selected starting composition. 
Next, each ion is considered as a subtree, and topologies that do not embed all subtrees are 
eliminated from consideration. The remaining structures are scored, w ith a penalty levied for 
each cleavage required to extract the fragment from the full glycan. The structures are then 
sorted by score and presented to the user.
When processing A/-glycans, STAT excludes certain structures to reduce the candidate set. 
For example, bisecting HexNAcs are disallowed, as are substitutions on the reducing-end 
HexNAc. These restrictions would exclude many reported structures.
Because STAT computes all possible topologies for a given composition, it does not scale 
well with glycan size. For example, it analyzes glycans w ith eight residues "nearly 
instantaneously," nine residues "in 1 minute," and 10 residues "in ~5-10 min," w ith execution 
time increasing "exponentially" from there. The underlying issue is that "the number of tree 
structures generated and requiring evaluation increases exponentially." For comparison, OSCAR 
does not need to generate structures to eliminate them (Lapadula 52).
STAT uses the penalty scoring system because it operates on native glycans. Here, the tool 
cannot directly observe the number of cleavages required to liberate a fragment from its 
precursor structure. Because it accepts permethylated glycans, OSCAR extracts cleavage counts 
directly from the observed masses, eliminating many candidate structures that would have
41
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
merely been penalized by STAT. As a simple example for permethylated glycans, a terminal 
hexose residue can be distinguished from an internal hexose. With native glycans, the two 
residues have the same mass and cannot be differentiated.
STAT does not support cross-ring fragment ions, whereas OSCAR accepts and processes a 
wide variety o f these to  propose interresidue linkages.
4.9. Cartoonist
Cartoonist (Goldberg 32) is a high-performance tool that automatically annotates MS profile 
scans o f /V-linked permethylated glycans, attaching putative topologies to  observed peaks. See 
Figure 21, taken from (Goldberg 32).
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Figure 21: Sample Cartoonist output for portion of a mouse kidney profile spectrum. 
All matching cartoons are shown, with those of lower rank deemphasized.
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Cartoonist first creates a database o f potential glycans, along w ith their masses and 
predicted isotopic envelopes. Next, from a manually-determined set o f 300 reference N- 
glycans, Cartoonist applies a series of biologically-derived rules to create a set o f 2800 
"cartoons"—that is, the set o f topologies it is capable o f assigning.
Next a linear calibration is applied to  the spectrum by measuring errors from high- 
confidence peaks. This allows the precisely calibrated spectrum to  be used when making 
composition assignments.
Finally, the tool examines the spectrum. For each isotopic envelope, every cartoon whose 
mass matches the envelope's putative glycan peak is given a confidence score based upon the 
match between the experimental and theoretical envelopes. Cartoons with "uncommon" 
features have their scores penalized. The highest-scoring cartoon is used to annotate the peak, 
although lower scoring cartoons are available for examination. Impressively, the tool can 
annotate a typical spectrum in several seconds.
Cartoonist is capable o f discovering low-intensity peaks that may represent glycans. 
Flowever, the lack of MS2 fragmentation casts some doubt on how often the composition and 
topology results are correct. Cartoonist does not assign interresidue linkages. Further, it is 
uncertain how the presence of isomers might affect the program's output.
As w ith StrOligo, the biosynthetic restrictions used may reduce the applicability o f the tool 
in certain contexts. Again we see that the m/z  1928 C. elegans glycan from (Lapadula 54) would 
be excluded from consideration, as would several other structures reported in this document. 
The authors admirably mention this lim itation and state that "these constraints can be removed 
or altered."
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GlySpy's OSCAR algorithm offers de novo sequencing capabilities: it accepts a set of MSn 
fragmentation pathways as input and reports all possible glycans that are consistent w ith those 
data. In this chapter, we present a continuing example of how OSCAR generates structures 
compatible w ith the disassembly pathway m/z 1187.6 -> 894.4 -> 649.2 -> 431.1 -> 259.0.
5.1.1. Deriving Composition and Topology from MSn Data
To assign the topology of a glycan, OSCAR accepts ion m/z values ordered as fragmentation 
pathways. Using its built-in mass/composition database (Section 3.5), it maps the m/z values to 
plausible fragment compositions, which are then used to infer possible topologies of the original 
glycan. As described in Section 2.6.3, because the glycans are methylated, their fragments 
preserve hints o f their original linkage. OSCAR uses these cleavages and the constraints 
imposed by the tree-like structure of glycans to compute the branching of the original structure.
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Figure 22: MS" disassembly of the simplest N-glycan along 
the pathway m /z  1187.6 -» 894.4 -» 649.2 -» 431.1 -> 259.0.
Figure 22, adapted from (Lapadula 54), illustrates how OSCAR utilizes the masses and
inferred compositions o f an MS" fragmentation pathway to produce a diminishing set of
candidate structures (or, in this case, a single structure). The pathway processed here is m/z
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1187.6 -> 894.4 -> 649.2 -> 431.1 -> 259.0 and the structure is the simplest W-glycan, namely 
the H3Nn trimannosyl core. The left-hand column shows the spectrum for each step. The center 
column displays the structures consistent with all ions processed to that point: bold type 
substructures match the product ion composition introduced at each step and lost residues are 
shown italicized in brackets. By the end of the pathway, only a single structure remains. The 
right-hand column contains the final assignments of selected ions.
This example is of course a very simple one, containing a single input pathway and a single 
output structure, neglecting OSCAR's ability to  combine multiple pathways and, when 
necessary, to output multiple structures. However, this example was carefully chosen and 
forms the basis for an ongoing discussion of OSCAR's implementation.
5.1.3. Invoking OSCAR via GlySpy Commands
The above analysis is accomplished through application of the commands AddPathway and 
Summarize. These commands expose OSCAR's core analytical capabilities and are described, 
along w ith other important commands, in Section 5.2. Sections 5.3 and 5.4 cover OSCAR's data 
structures and the algorithm itself, respectively. Results and discussion then follow.
5.2. Commands and Options
Recall that OSCAR is one component of the GlySpy command-line executable. In this section 
we discuss a few common OSCAR commands. This will give a sense o f how the analyst can use 
OSCAR to  speed structural analysis.
5.2.1. The LabelPathway Command
Compositions for the ions in a pathway are provided by the LabelPathway command, which 
has this format:
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LabelPathway [NoCrossRing] [DoNotOptimize] pathway
A sample input is shown in Listing 1; the three invocations of LabelPathway are labeled (A), 
(B), and (C). The command's optional parameters are defined in Table 5.
; Specify that the reducing-end residue must be a reduced HexNAc 
-ReducingEndResidue n
; A) First show all possible compositions by specifying DoNotOptimize 
LabelPathway DoNotOptimize 1187.6_894.4_649.2_431.1_259.0
; B) Now optimize the pathways and throw away impossible compositions 
LabelPathway 1187.6_894.4_649.2_431.1_259.0
; C) Further optimize by excluding cross-ring compositions 
LabelPathway NoCrossRing 1187.6_894.4_649.2_431.1_259.0
Listing 1: Three examples of the LabelPathway command using 
(A) the DoNotOptimize option, (B) no options, and (C) the NoCrossRing option.
Table 5: LabelPathway options.
NoCrossRing Disallow compositions that include a cross-ring fragment. (Results in 
glycosidic fragments only.)
DoNotOptimize Do not apply logical constraints to  exclude impossible product/precursor 
composition combinations.
Listing 1A (LabelPathway DoNotOptimize . . . )  results in an enormous list of possible 
compositions for each ion in the pathway. Table 6 shows a small selection of these ions. 
Highlighted in the right column are counts o f the many ions excluded from the table. For 
example, the ion m/z 894.4 matches 78 possible compositions with masses within the default 
±0.5 Da error window—the four shown plus 74 more, many of which involved cross-ring 
cleavages. This simple five-ion pathway has returned a total o f 163 possible compositions!
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Table 6: Selected compositions returned by the LabelPathway DoNotOptimize command 














259.0 259.12 H-(oh)' 
...and 10 more
Many of these compositions are logically inconsistent. For example, there is no possibility 
that a precursor ion H3Nn (m/z 1187.61) could yield a product ion NS2-(ene)4(oh)’ (m/z 898.38). 
The precursor has no S residues but the product has two! Further, many of the 163 
compositions represent exotic cross-ring cleavages that have the correct mass, but which could 
not have arisen from any listed precursor. (For example, ion m/z 259.0 returns 11 compositions, 
ten of which are cross-ring cleavages that can be ruled out by context.) Clearly the results of 
Table 6 need to be pruned for these precursor/product relationships. OSCAR scans the 
composition list multiple times, removing any product composition that could not conceivably 
come from any o f its putative precursor compositions. Likewise, a precursor composition is 
removed if it could not generate any of the product compositions listed. This sifting is repeated
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until the composition list converges. This is the default behavior o f the LabelPathway 
command—that is, when the user does not specify the DoNotOptimize flag. (In practice, the 
analyst would never specify the DoNotOptimize flag. It is provided solely to illustrate the 
importance of pruning according to  precursor/product relationships.) W ith this optimization 
enabled. Listing IB  produces the unabridged composition list of Table 7—a total o f only eight 
compositions, down from 163. Clearly this optimization is an important step in controlling the 
complexity of composition lists.
Table 7: All compositions returned by the LabelPathway command 
for each ion in the pathway m /z  1187.6 -> 894.4 -> 649.2 431.1 259.0.■
1187.6 1187.61 H3Nn
894.4 894.43 H3N-(ene)' 
894.45 H2N-1,5A[n]'
649.2 649.30 H3-(ene)’ 
649.33 H2-1,5A[n]'
431.1 431.19 H2-(ene)(oh)' 
431.21 t-H o h ^A tn ]'
259.0 259.12 H-(oh)’
Listing 1C shows the LabelPathway command used with the NoCrossRing option given. 
As you would expect, this causes cross-ring compositions to be excluded from consideration. 
The corresponding output is summarized in Table 8. Now only one possible composition is listed 
for each ion m/z.
The analyst uses the NoCrossRing option when convinced that the observed fragments 
can be explained by glycosidic cleavages, as is usually true o f high-abundance fragments. (See
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Section 2.6.3 on page 13.) Requiring the use of this option follows GlySpy's guiding design 
principle that all possibilities should be considered unless otherwise instructed by the analyst.
Table 8: All compositions returned by the LabelPathway NoCrossRing command 







The LabelPathway command is useful as a stand-alone command, allowing the analyst to 
quickly ascertain likely compositions for prospective pathways. However, the same composition 
list optimization described here is crucial for the next command, AddPathway.
5.2.2. The AddPathway and Summarize Commands
As shown in Figure 12 on page 19, OSCAR accepts one or more disassembly pathways and 
produces a set of glycan structures that are consistent with all o f the constraints implied by 
those pathways. The process occurs in two steps. First the analyst issues one or more 
AddPathway commands and, second, executes a Summarize command to  generate the 
structures. This is demonstrated in Listing 2. When executed, this input generates a single 
topology, H(H)HNn, which is the expected A/-linked core.
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AddPathway 1187.6_894.4_649.2_431.1_259.0 
Summarize
Listing 2: A simple demonstration of the AddPathway and Summarize commands.
5.2.3. The AddSpectrumFile Command
Several GlySpy commands operate on entire spectra instead of analyst-selected pathways. 
Currently, GlySpy supports the ".raw" file format produced by Thermo Fisher LTQ ion trap. To 
add a spectrum file fo r processing, the analyst uses the command AddSpectrumFile 
filename.
5.2.4. The LabelSpectra Command
One useful command that processes spectra added by the AddSpectrumFile command is 
LabelSpectra. This command scans each added spectrum and reports the plausible disassembly 
pathways found, along with composition assignments for every ion in every pathway. The 
command has the format:
LabelSpectra [NoCrossRing] [NLinked] MZ-target rel-intensity
The MZ-target parameter gives the m/z o f the unfragmented glycan. The rel- 
intensity parameter specifies a relative intensity cutoff; peaks which fall below this threshold 
are ignored. The NoCrossRing and NLinked options restrict assigned compositions in the 
obvious ways. The command also supports an EstimateTopologies option, but discussion of 
this option is beyond the scope o f this chapter.
-ReducingEndResidue n 
AddSpectrumFile OVA_1187_894_676.raw 
LabelSpectra NoCrossRing 1187.61 2
Listing 3: Sample input demonstrating the AddSpectrumFile and LabelSpectra commands.
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Listing 3 shows a simple use o f the AddSpectrumFile and LabelSpectra commands. The 
spectrum added is shown as Spectrum A-39 on page 229 in the appendix. The output o f the 
LabelSpectra command identifies six pathways terminating on this spectrum that have non­
cross-ring composition interpretations. The interpretation of the first three ions in each 
pathway is identical, and shown in Table 9.
Table 9: Composition assignments for the 




Table 10: Composition assignments for the 







The terminating ions for each of the six pathways are shown in Table 10. Several ions on 
Spectrum A-39 are above the 2% relative intensity cut-off, but are not output by the command. 
This is because these ions have no possible glycosidic interpretation. For example, ion m/z 
519.3 represents a cross-ring fragment.
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5.3. Data Structures
OSCAR's main data structures are fork, solution, mono, and box, which can be understood as 
follows:
• A fork is one interpretation o f the input MS" ions, and can produce a set o f glycans 
that are consistent w ith that interpretation. Since each ion can map to  multiple 
compositions and/or specific residues, a separate fork is created for every 
combination of these mappings4.
•  A solution contains a set o f forks that covers all possible interpretations o f the input
ions. The union of the glycans produced by all contained forks represents all
possible glycan structures given the selected ions.
•  A mono is a single monosaccharide residue.
•  A box encloses a set of monos that are known to belong to  a single MS" ion.
Roughly speaking, a fork represents one "slice" of the entire problem, which is itself 
represented by the solution. Each fork contains a set of monos, along w ith a series of boxes that 
encloses subsets o f those monos. Each box groups together monos that are assumed, in this 
fork, to form a connected subtree that is embedded in the final glycan structure. (Referring to 
the equivalent terms defined in Table 1 on page 10 may be useful.)
Figure 23 illustrates the relationships between solutions, forks, monos and boxes.
4 The term "fork" comes from a quote attributed to Yogi Berra: "When you come to a fork in the road, 
take it." This is exactly the search strategy used by OSCAR: when multiple interpretations are possible, all 
of them are explored, one per fork.
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Figure 23: A solution containing three forks, numbered 0..2. Each fork contains a set of monos 
and boxes. Fork 1 has been marked as dead because some internal inconsistency was 
discovered. Forks 0 and 2 are still alive and can generate glycan topologies when requested.
5.3.1. Fork
A fork is one interpretation of the input MS" ions, and can produce a set of glycans that are 
consistent w ith that interpretation. (Consistent glycans are those that are not refuted by any of 
the input MS" data. For example, if the input MS" data specify that the only F in a glycan is 
definitely connected to n, then the solution will only generate glycans where F is connected to 
n.) As more ions are selected and added to  the fork, the fork becomes more specific, generating 
fewer and fewer consistent glycans. When a fork is found to  generate no consistent glycans, it is 
marked as "dead," as demonstrated by fork 1 in Figure 23.
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A fork contains:
•  A set o f monos
•  A list o f boxes that describe how the various MS" inputs have been mapped to those 
monos
• A score that indicates how constrained the fork is, with a lower score representing a 
more constrained and therefore more specific fork. (The score is roughly analogous 
to  the degrees o f freedom remaining within a fork and is described in Section 
5.4.3.4 on page 76.)
Glycan structures generated by the forks may overlap. In Figure 23, forks 0 and 2 both 
generate the branched A/-linked core m otif H(H)HNn. Fork 2 also produces a linear HHHNn 
structure. Before the results are presented to  the analyst, these three structures are collected 
and the duplicate is eliminated.
5.3.2. Solution
A Solution is simply a set o f forks. The solution as a whole can generate the entire set of 
consistent glycans. As new MS" ion fragments are added to  GlySpy, the solution can grow or 
shrink. Forks are added when multiple search paths must be explored, and are removed when 
they are discovered to  be internally inconsistent or redundant w ith another fork in the solution.
5.3.3. Mono
A mono represents a monosaccharide residue and contains:
•  The type of mono (H, F, N, S, h, f, or n)
•  The index of the mono (running from 0 to N -l, if there are N residues in the glycan)
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• A set representing the monos that might possibly be this mono's parent in the 
glycan (called ParentPossible)
•  A set that represents the mono that is definitely this mono's parent 
(ParentDefinite)
•  A set representing the monos that might possibly be this mono's children in the 
glycan (childrenPossible)
•  A set that represents the monos that are definitely this mono's children
(Chi.ldrenDefini.te)
•  A set containing the number o f possible children this mono might have 
(NumChildrenPossible)
• A set containing the possible linkage positions (2, 3, 4, or 6) between this mono and 
its parent (Linkage)
When created, the mono's fields are initialized as follows:
• ParentPossible: All monos except self
• ParentDefinite: Empty
• ChildrenPossible: All monos except self
•  ChildrenDef inite: Empty
• NumChildrenPossible: { 0, 1, 2, 3, 4 }
• Linkage: { 2, 3, 4, 6 }
OSCAR restricts ParentPossible, ChildrenPossible, NumChildrenPossible, and
Linkage to  fewer and fewer possible values. When the identity o f a Mono's parent or child is
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learned w ith certainty, the ParentDefinite and childrenDefinite fields are set. For 
example, if a Mono has NumChildrenPossible = { 1 } (meaning that the given mono must 
have exactly one child) and ChildrenPossible = { H °}, then ChildrenDefinite can be set 
to { H°}.
Implementation digression: Some inference rules, discussed both below and in APPENDIX B: 
SAMPLE OSCAR INFERENCE RULES, can draw useful inferences knowing only the possible parents 
and children, whereas other inference rules apply only when the parent and children are 
definitely known. This is why both Possible and Definite sets are computed. It could also 
be argued that having both parent and child information available is redundant, since one can 
be computed from the other. In our experience, some inference rules are much easier to write, 
understand, and debug given parent information, whereas others are more naturally expressed 
in terms of children. The minimal additional storage space pays for itself in ease of program 
maintenance and improved execution time.
5.3.4. Box
A box represents a single ion and maps that ion to a set o f monos plus a number of 
reducing-end and non-reducing-end scars. The monos within the box must form a connected 
subtree embedded within the glycan. The scars on the box represent the cleavages necessary to 
extract this subtree from the glycan.
Each box contains:
•  A set of monos contained by this box
•  The type o f the ion's reducing-end scar, and the number and types of its non- 
reducing-end scars.
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o If an MS" ion maps to  H3-(oh)3', there w ill be one corresponding box that
contains three H monos and has two non-reducing-end (oh) scars and one
reducing-end (oh) scar.
•  A unique ordinal index, with the first box in a fork always numbered zero (called 
index)
•  A link to a complementary box, if any (more on complementary boxes later)
•  A set that represents the monos that might possibly be the root o f this box
(RootPossible)
•  A set that represents the mono that is definitely the root of this box 
(RootDefinite)
•  A set that represents the mono that this box's root might possibly connect to 
(RootParentPossible)
•  A set that represents the mono that this box's root definitely connects to 
(RootParentDefinite)
•  A set containing the possible linkage positions (2, 3,4, or 6) between this box and its 
parent (Linkage)
As w ith mono, box maintains Possible and Definite variations o f both Root and 
RootParent. Again, this is because some inference rules can be applied knowing only which 
roots and root parents are possible, but other inference rules are valid only when the root and 
root parent are known with certainty.
When created, the box's fields are initialized as follows:
•  RootPossible: All monos contained by this box
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• RootDefinite: Empty
• RootParentPossible: Usually, any mono not contained by this box. However, if 
the box has no parent scar, then the subtree defined by this box must include the 
root o f the entire glycan, and RootParentPossible is initialized to  empty.
• RootParentDef inite: Empty
• Linkage: { 2, 3, 4, 6  }
Over time, OSCAR attempts to  restrict RootPossible, RootParentPossible, and 
Linkage to  fewer and fewer possible values. When the identity o f a box's root or root parent is 
learned with certainty, the RootDefinite and RootParentDef inite fields are set.
5.4. Algorithm
The Oligosaccharide Subtree Constraint Algorithm is the computational heart of GlySpy. It 
accepts MS" input pathways, adds/removes forks to/from  the solution, and applies logical 
constraints to reduce the number o f glycans generated by each fork.
We w ill describe the algorithm largely by way of example, showing how OSCAR derives the 
branching topology of the A/-linked core (Figure 24) by processing the single input pathway m/z
1187.6 894.4 -> 649.2 431.1 259.0 (Listing 4).
Figure 24: The five-residue AMinked core.
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Listing 4: The input used as an example to  illustrate the operation of OSCAR.
A complete description of even this simple example is beyond the scope o f this (or any 
reasonable) document, but we strive to present enough detail to illustrate the key data 
structures and algorithmic steps.
5.4.1. Overview
OSCAR maintains a single solution that contains a set of forks, each o f which can generate a 
number o f consistent glycans. Each MS" input pathway selected by the user is mapped to a 
number of entries in the composition database; each of these compositions is then applied to 
the existing forks. Existing forks may need to be copied ("forked") before this application can be 
done.
Forks are tentative hypotheses that are discarded if discovered to contain internal 
contradictions. They are small data structures that are easy to copy and discard, and are 
created whenever multiple interpretations o f an input ion must be examined.
Logical inference rules are then applied iteratively to each fork. Forks that can generate no 
consistent glycans are marked as dead and removed from the solution. Also, isomorphic 
(redundant) forks are removed from the solution, to ensure that the solution does not grow to 
include an exponential number o f isomorphic forks.
It is important to note that OSCAR is de novo and utilizes no knowledge o f previously- 
reported glycans or presumed biosynthetic pathways. Almost all o f the constraints applied are 
straightforward corollaries that arise from the tree structure o f glycans; a few remaining
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constraints are command-line options available to the operator (such as whether the glycan 
search should be constrained to W-linked glycans only).
5.4.2. Boxes, Subtrees and Ions
A glycan is a well-formed tree in the classic computer science sense: every node (mono) in 
the tree (glycan) has exactly one parent, except for the root of the tree, which has no parent; 
cycles are not allowed. This means that the initial box, which contains the entire glycan, also, by 
definition, represents a well-formed tree.
A product ion is also a well-formed subtree. You can visualize a product ion as a subtree 
that was embedded in the original glycan. The MS" process used to fragment precursor ions 
into product ions severs individual parent/child bonds in the glycan, but rarely forms new bonds.
Since each box in a fork represents either the initial glycan or a product ion of the glycan, it 
follows that every box in the fo rk  represents a well-formed subtree. This observation is key to 
understanding how OSCAR both makes progress and discards inconsistent forks.
For example, since a box is a subtree and every subtree has exactly one root, we know that 
exactly one of the monos in the box must be the root o f that subtree. If OSCAR at some point 
deduces that two different monos must be the root o f the same box, or that no monos can 
possibly be the root of the box, then the algorithm has detected an inconsistency. The fork 
containing that box will be marked as inconsistent and removed from the solution. Consistency 
checks like these are applied to every box in every fork, and in practice prove very efficient at 
pruning inconsistent forks.
5.4.3. OSCAR’s Main Phases
An outline of how OSCAR's AddPathway command processes disassembly pathways is 
shown in Figure 25.
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Figure 25: A flowchart representing OSCAR's AddPathway command.
5.4.3.1 Initial State
The solution is set to empty (containing no forks).'
5.4.3.2 AddPathway 1187.6_894.4_649.2_431.1_259.0
The AddPathway 1187.6_894.4_649.2_431.1_259.0 command from Listing 4 defines 
the observed monoisotopic mass o f the glycan of interest as 1187.6. Because the default error 
tolerance is 0.5 Da, GlySpy retrieves from its database all compositions whose theoretical mass 
falls within the range m/z 1187.6±0.5. Two compositions are found, H2N2h and H3Nn, but 
because the input listing also includes the option -ReducingEndResidue n, only the second is
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retained—the first does not contain an n residue. Fork 0 is created for the glycan composition 
H3Nn. Within the fork, box 0 is created to represent the ion m/z 1187.6, as shown in Table 11. 
Because of the structure o f trees, a mono may not be its own parent or child, and so these 
possibilities have been excluded, as indicated by the boldface, double-strikeout entries. As this 
example progresses, these excluded entries will be removed from future fork diagrams, and the 
boldface, double-strikeout text w ill be reserved fo r the latest set o f changes in the fork.
Because box 0 has no parent scar, its RootParent is initialized to the empty set. Recall that 
RootParent represents the mono to  which this box's subtree connects. However, as the box has 
no parent scars, it must contain the root o f the glycan and will not connect to  any mono— 
hence, the initial empty value for RootParent.
Table 11: Fork 0 after adding H3Nn as the glycan's composition.
©:.X- Ha H1 H2 N3 n4 tt*  H1 H2 N3 n4 0 1 2  34
H1 H° H4  H2 N3 n4 H° B4 H2 N3 n4 0 1 2 3 4
H2 H°H1 r f N 3 n4 H° H1 «*  N3 n4 0 1 2 3 4
N3 H° H1 H2 H3 n4 H° H1 H2 fi3 n4 0 1 2 3 4
n4 H°H1 H2 N3 **4 H°H1 H2 N3 « 4 0 1 2 3 4
OSCAR continues to process the pathway m/z 1187.6_894.4_649.2_431.1_259.0 one ion at 
a time. As it converts each ion to its set o f possible compositions, those compositions are 
reduced via the same process as outlined in Table 6  and Table 7 (pages 48 and 49): impossible 
precursor and product compositions are excluded from further consideration. In the end, only
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the compositions of Table 7 remain to be processed. A subset o f these compositions end up
gathered in fork 0 as shown in Table 12; additional forks, not shown, are created to address 
other possibilities.
Table 12: Fork 0 after adding an additional Box for each ion in the pathway.
This is the initial state to  which inference rules will be applied.
oV'X:; H1 H2 N3 n4 H1 H2 N3 n4 0 1 2 3 4
H1 H° H2 N3 n4 H° H2 N3 n4 0 1 2 3 4
H2 H° H1 N3 n4 H° H1 N3 n4 0 1 2 3 4
N3 H° H1 H2 n4 H° H1 H2 n4 0 1 2 3 4
n4 H° H1 H2 N3 H° H1 H2 N3 0 1 2 3 4
0 1187.61 H3Nn H° H1 H2 N3 n4 H° H1 H2 N3 n4
' 1 1 ■'■■■ 894.43 H3N-(ene)' H° H1 H2 N3 H° H1 H2 N3 n4
2 CH-.l PAR:0 n4 n4
3 649.30 H3-(ene)’ H° H1 H2 H° H1 H2 N3 n4
4 CH:1 PAR:1 N3 N3 H° H1 H2 n4
5 431.19 H2-(ene)(oh)’ H° H1 H° H1 H2 N3 n4
6 CH:0 PAR:1 H2 H2 H° H1 N3 n4
7 259.12 H-(oh)' H° H° H1 H2 N3 n4
Boxes 0, 1, 3, 5, and 7 represent the five ions in the pathway. Each has the expected 
composition and has been assigned a matching set o f monos. For example, ion m/z 649.3 has 
been assigned the composition H3-(ene)', w ith the three hexose residues designated as H°, H1, 
and H2. This means that, in this fork, these three hexose residues must form a connected 
subtree that can be removed from the glycan with a single reducing-end cleavage.
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5.4.3.2.1 Complementary Boxes
The three remaining boxes—2, 4, and 6 —are known as complementary boxes, w ith each 
box containing a set of residues that form a connected subtree within the glycan. OSCAR can 
often assign the residues lost during fragmentation to their own box. For example, when ion 
m/z 1187.6 was fragmented to  produce m/z  894.4, the lost residue (n4) was placed by itself in 
box 2. In this particular example, all the complementary boxes contain a single residue, but this 
is not true in all cases. When a disaccharide or larger fragment is lost, OSCAR places all o f the 
lost residues in their own box if the algorithm can prove that they in fact must form a subtree. 
In cases where multiple residues may have been lost because of multiple cleavages, no 
complementary box is created.
Complementary boxes can be identified by their lack o f a composition in the table and 
always follow the box to which they are complementary (e.g., box 2  is complementary to  box 1 ). 
Even though we do not have a full composition for the complementary boxes, we can calculate 
the total number of child (non-reducing end) and parent (reducing end) scars on the monos 
contained by the box. These are listed, respectively, as CH and PAR in the Comp/Scars column.
Complementary boxes are created only when OSCAR can prove that the precursor required 
exactly one cleavage to  create the product and the lost residues. The product ion and its 
complement w ill therefore have, combined, one more parent scar and one more child scar than 
their common precursor did. (If the cleavage occurs between monos X and Y in the precursor, 
then X and Y will end up in different products and either X or Y w ill have a new parent scar and 
the other w ill have a new child scar.)
These relationships can be represented algebraically:
ParentScarsprecursor =  P arentS carsPr0duct +  P arentS carsCOmpiement - 1
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C hildS C arS p recu rso r ChildScarSproduct ^  ChildSCarScomplement " 1
Rearranging yields a form that lets us compute the number o f parent and child scars on the 
inferred complementary ion:
ParentScarscompiement = ParentScarsprecursor - ParentScarsProduct + 1
ChildSCarScomplement =  ChildScarsPrecursor -  ChildScarsProdu(;t +  1
In Table 12, we are able to calculate that complementary box 2 must have 0 parent scars (0- 
1+1) and 1 child scar (0-0+1). In this way, OSCAR knows that the monos in box 2 must 
collectively have no parent scars and one child scar when those monos are cleaved from the 
glycan. In this case, since box 2 contains the single mono n4, we see that OSCAR can quickly 
infer that n4 must have only a single child. Transferring information from box 2 to mono n4 
illustrates how information can flow freely around the fork. It is precisely this free-form 
information exchange that makes OSCAR efficient and versatile, but, as we shall see, also makes 
it very difficult to  describe w ith any brevity.
5.4.3.2.2 Forking
Table 12 shows just one fork, but for the input o f Listing 4, a total of seven forks are created. 
Several composition forks  are created to cover the various cross-ring compositions of Table 7, 
and several selection forks  are created where different H monos are selected for boxes 5, 6 , and 
7. In the end, six forks will be marked as dead, five because they are isomorphs o f other forks, 
and the sixth because it is internally inconsistent. The details o f these forks are omitted for 
brevity, and we instead focus on how OSCAR's inference rules drive fork 0 toward the single 
expected structure. Even here, many details must be omitted.
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5.4.3.3 Run Inference Rules
Next, OSCAR executes a series of inference rules on each fork, stopping when each fork's 
score stabilizes, meaning that no further progress is being made. (Scoring is discussed in Section 
5.4.3.4, and a selection of inference rules is detailed in APPENDIX B: SAMPLE OSCAR INFERENCE 
RULES.) Each inference rule is implemented as a separate C++ function and has one of three 
types, based on the data structure that the rules wishes to interrogate: (1 ) a box data structure, 
(2) a mono data structure, or (3) an fork data structure. These rules, classified as box-centric, 
mono-centric, and fork-centric, are partitioned and applied by type. See the pseudocode of 
Listing 5 for details. Note that this architecture makes it straightforward to add a new inference 
rule: implement the rule as a function and add the function to the list o f inference rules.
For each fork F in the solution do {
while F is alive and F 1s score is decreasing do {
Apply every box-centric inference rule to each box in fork F 
Apply every mono-centric inference rule to each mono in fork F 
Apply every fork—centric inference rule directly to fork F
}
)
Listing 5: Pseudocode for the application of inference rules to the forks in a solution.
Three difference types of rules (box-centric, mono-centric, and fork-centric) are 
repeatedly applied to each fork until the fork's score stabilizes, signaling that 
no further progress is being made.
The inference rules modify the various fields o f the monos and boxes in a fork, attempting 
to infer the set of glycans that are consistent w ith constraints imposed by each mono and box. 
Each inference rule is written in such a way that it can be applied at any time, in any order; this 
eliminates the problem of ordering the execution of the inference rules and opens the 
possibility of a future parallel or distributed implementation.
In all cases, inference rules attempt to use the subtrees defined by a fork's boxes to:
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•  Shrink the Possible sets (ParentPossible and ChildrenPossible in mono;
RootPossible and RootParentPossible in box;MSRootPossible in fork)
•  Grow the Definite sets (ParentDefinite and ChildrenDefinite in mono;
RootDefinite and RootParentDef inite in box)
•  Shrink the NumChildrenPossible set in mono
•  Shrink the Linkage set in both mono and box
Currently, GlySpy implements over 50 inference rules. To illustrate a few of them, we 
continue to trace the evolution of the fork shown in Table 12. When an interesting inference
rule changes the fork, we note what it is doing and why the change is valid. The vast majority of
these rules use the properties of trees to make progress; the actual amount of chemistry- or 
glycan-specific knowledge in these rules is insignificant.
As mentioned above, a complete accounting of the processing o f even this single fork is 
beyond the scope of this document. For this extremely simple example, 55 separate 
applications of 24 different inference rules were able to  constrain the fork during processing5. 
Multiply this by the seven forks created and you may appreciate why the following presentation 
is heavily abridged.
5.4.3.3.1 Apply Inference Rule ApplyMSRootToAnnBox to Box 0
Because the fork's composition includes a reduced residue (n4), and because reduced 
residues must be at the reducing end o f the glycan, we know that n4 is the root o f the entire
5 For this example, many of the 50+ inference rules—for example, those dealing with cross-ring 
cleavages—contributed nothing to the processing of this fork. They were still executed, but caused no 
change to the fork. Other rules were successfully applied multiple times.
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tree. The rule ApplyMSRootToAnnBox applies this information to each box6. If the box contains 
the root mono, then that mono must also be the root of the subtree defined by the box. (Recall 
that the monos in a box by definition must form a connected subtree.) This rule affects the Root 
field of box 0, eliminating H°, H1, H2, and N3 as possibilities, leaving only n4. See Table 13.
Because the inference rule ApplyMSRootToAnnBox is applied to  a box, we consider this rule 
to be box-centric. The next few examples w ill also be box-centric, but a mono-centric rule will 
be discussed in Section 5.4.3.3.5.
Table 13: Fork 0 after applying the inference rule ApplyMSRootToAnnBox to box 0.
H° H1 H2 N3 n4 H1 H2 N3 n4 0 1 2  3 4
H1 H° H2 N3 n4 H° H2 N3 n4 0 1 2 3 4
H2 H° H1 N3 n4 H° H1 N3 n4 0 1 2 3 4
N3 H° H1 H2 n4 H° H1 H2 n4 0 1 2  3 4
n4 H° H1 H2 N3 H° H1 H2 N3 0 1 2 3 4
0 1187.61 H3Nn H° H1 H2 N3 n4
1 894.43 H3N-(ene)‘ H° H1 H2 N3 H° H1 H2 N3 n4
CH:1 PAR:0 n4 n4
3 649.30 H3-(ene)' H° H1 H2 H° H1 H2 N3 n4
4 CH:1 PARrl N3 N3 H° H1 H2 n4
5 431.19 H2-(ene)(oh)' H° H1 H° H1 H2 N3 n4
6 CH:0 PAR:1 H2 H2 H° H1 N3 n4
7 259.12 H-(oh)' H° H° H1 H2 N3 n4
6 Rules are named according to their implementing C++ functions, hence the slight awkwardness.
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5.4.3.3.2 Apply Inference Rule InferNumChildrenForSingleton to Box 2
Next, the inference rule InferNumChildrenForSingleton is successfully applied to  box 2. This 
rules states that if a box has N child scars and contains a single mono, then each o f those child 
scars must belong to that mono. In this case, the rule applies to box 2 and its single mono, n4. 
Because box 2 has a single child scar (as shown in the Comp/Scars column o f Table 14), n4 must 
also have a single child scar. This is reflected in the Number o f Children field fo r n4, eliminating 
0, 2, 3, and 4 as possibilities, leaving only 1.
Table 14: Fork 0 after applying InferNumChildrenForSingleton to  box 2.
H° H1 H2 N3 n4 H1 H2 N3 n4 0 1 2 3 4
H1 H° H2 N3 n4 H° H2 N3 n4 0 1 2 3 4
H2 H° H1 N3 n4 H° H1 N3 n4 0 1 2 3 4
N3 H° H1 H2 n4 H° H1 H2 n4 0 1 2 3 4
n4 H° H1 H2 N3 H° H1 H2 N3 8 1 2 3 4
0 1187.61 H3Nn H°H1 H2 N3 n4 n4 H° H1 H2 N3 n4
1 894.43 H3N-(ene)' H° H1 H2 N3 H° H1 H2 N3 " 4
2 CH:1 PAR:0 n4 n4
3 649.30 H3-(ene)' H°H1 H2 H°H1 H2 N3 n4
4 CH:1 PAR:1 N3 N3 H° H1 H2 n4
5 431.19 H2-(ene)(oh)' H° H1 H° H1 H2 N3 n4
6 CH:0 PARil H2 H2 H° H1 N3 n4
7 259.12 H-(oh)' H° H° H1 H2 N3 n4
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5.4.3.3.3 Apply Inference Rule FindRootDefinite to Box 0 and Box 2
Next the inference rule FindRootDefinite is applied to box 0 and then to box 2. This rule 
states that if a box has a single mono that is possibly the root of the box, then it is definitely the 
root o f the box. In the case o f both box 0 and box 2, we see that n4 is the only possible root for 
either box, and so we promote it to  definitely being the root of each box. We indicate this in 
Table 15 by the rectangle around the n4 entry in the Root column for boxes 0 and 2.
Other inference rules will use these definite, boxed values to  make further progress. By 
designating these values as "definite", the implementation of these other inference rules is 
greatly simplified.
Table 15: Fork 0 after applying FindRootDefinite to box 0 and then to box 2.
H° H1 H2 N3 n4 H1 H2 N3 n4 0 1 2 3 4
H1 H° H2 N3 n4 H° H2 N3 n4 0 1 2 3 4
H2 H° H1 N3 n4 H° H1 N3 n4 0 1 2 3 4
N3 H° H1 H2 n4 H° H1 H2 n4 0 1 2 3 4
n4 H° H1 H2 N3 H° H1 H2 N3 1
0 1187.61 H3Nn H° H1 H2 N3 n4
0 H° H1 H2 N3 n4
1 894.43 H3N-(ene)' H° H1 H2 N3 H° H1 H2 N3 n4
2 CH:1 PAR:0 n4 n4
3 649.30 H3-(ene)' H° H1 H2 H° H1 H2 N3 n4
4 CH:1 PAR:1 N3 N3 H° H1 H2 n4
5 431.19 H2-(ene)(oh)' H° H1 H° H1 H2 N3 n4
6 CH:0 PAR:1 H2 H2 H° H1 N3 n4
7 259.12 H-(oh)' H° H° H1 H2 N3 n4
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5.4.3.3.4 Apply Inference Rule ApplyRootDefinite to Box 0
The fact that box 0 has a definite root mono is exploited by the very next inference rule, 
ApplyRootDefinite. Consider box 0. It contains five monos, has a definite root (n4), and no child 
scars. From this, OSCAR can infer that non-root monos in the box may each have at most 3 
children. Why is this? Since n4 is the root o f this box, at least one o f the other monos in the box 
(call it M) must attach to n4. At that point only three monos remain in the box—even if they all 
attached to  M, we know that M cannot have more than three children. The rule can therefore 
exclude 4 as a possible value for the Number of Children field for monos H°, H1, H2, and N3. See 
Table 16.
Table 16: Fork 0 after applying ApplyRootDefinite to box 0.
H° H1 H2 N3 n4 H1 H2 N3 n4 0 1 2 3 4
H1 H° H2 N3 n4 H° H2 N3 n4 0 1 2 3 4
H2 H° H1 N3 n4 H° H1 N3 n4 0 1 2 3 4
N3 H° H1 H2 n4 H° H1 H2 n4 0 1 2 3 4
n4 H° H1 H2 N3 H° H1 H2 N3 1
0 1187.61 H3Nn H° H1 H2 N3 n4
0
H° H1 H2 N3 n4
1 894.43 H3N-(ene)' H° H1 H2 N3 h° h ‘ h ! n s n4
2 CH:1 PAR:0 n4 n4
3 649.30 H3-(ene)' H° H1 H2 H° H1 H2 N3 n4
4 CH:1 PAR:1 N3 N3 H° H1 H2 n4
5 431.19 H2-(ene)(oh)' H° H1 H° H1 H2 N3 n4
6 CH:0 PAR:1 H2 H2 H° H1 N3 n4
7 259.12 H-(oh)' H° H° H1 H2 N3 n4
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Consider what has happened here. This inference rule has taken multiple facts about box 0 
(child scar count, contained monos, definite root mono) and updated the possible child counts 
fo r all of the non-root monos in that box. This unorthodox, seemingly unstructured data flow  is 
the hallmark o f OSCAR.
5.4.3.3.5 Apply Inference Rule ApplyLeaf to Mono H°
We have seen several inference rules that were applied primarily to boxes. Let us now skip 
ahead several inference rule applications to demonstrate an inference rule that takes a mono as 
its input. The now-current state of fork 0 is shown in Table 17.
Notice how much progress has been made up to this point. For example, the Root and 
RootParent have been decided for many boxes, as evidenced by the many rectangle-enclosed 
monos in the table. Also, all five monos know exactly how many children they each must have: 
H° has none, H1 has two, and so on. There is no remaining ambiguity in child counts, but there is 
in child identity: N3 must have one child, but it is undecided whether that child is H° or H1.
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Table 17: Fork 0 after many inference rules have been applied.
ForkO
H° H1 N3 0
H1 H° N3 H° H2 2
H2 H° H1 0
N3 0 H° H1 1
n4 0 1  '
0 1187.61 H3Nn H° H1 H2 N3 n4 0
1 894.43 H3N-(ene)' H°H1 H2 N3 0 n4
2 CH:1 PAR:0 n4 n4
3 649.30 H3-(ene)' H° H1 H2 H° H1 0
4 CH:1 PAR:1 N3 0 nl
5 431.19 H2-(ene)(oh)' H° H1 H° H1 0
6 CH:0 PAR:1 H2 0 H° H1
7 259.12 H-(oh)’ H° 0 H1 N3
From this we know that H° and H2 are both leaves, that is, they have no children. Let us 
execute the ApplyLeaf inference rule on mono H° to  see what further progress can be made.
This inference rule states that if mono M is a leaf, then (1) M cannot be the parent o f any 
mono, and (2) any box containing M cannot have M as its root or root parent. We can see the 
effects o f this inference rule in Table 18. Part (1) leads to H° being removed from the Parent 
Monos sets for H1 and H2; part (2) causes H° to be removed from the Root set fo r boxes 3 and 5 
and from the RootParent set for box 6 .
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,.. H1 N3 ' . ' ■:P
H1 a® N3 . H° H2 2
H2 a® h 1 0
N3 n4 H° H1 1
n4 N3 1
; f : f f : 1187.61 H3Nn H° H1 H2 N3 n4 0
1 894.43 H3N-(ene)' H°H1 H2 N3 N3 n4
CH:1 PAR:0 n4 n4
649.30 Hr (ene)' H°H1 H2 a® ^ 0
■ 4 CH:1 PAR:1 1; J * N3 3
431.19 H2-(ene)(oh)' H° H1 a®H2 0
: '  6 . . ^ ; - CH.O PAR:1 H2 0 a®H1
7 259.12 H-(oh)’ H° 0 H1 N3
5.4.3.3.6 Final Results for Fork 0
Inference rules are applied to  fork 0 until no changes are detected after application o f any 
rule. At this point, the fork has converged as far as OSCAR can manage. The final result for fork 
0 is shown in Table 19.
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Table 19: The final result for fork 0.
ForkO
H° 0 0. ; S | .
H1 0 H° 0
H2 h]
N3 0 0 l
n4 0
0 1187.61 H° H1 H2 N3 n4 0
l 894.43 H3N-(ene)‘ H°H1 H2 N3 0 0
2 CH:1 PAR:0 n4
0
3 649.30 H3-(ene)' H° H1 H2 0 0
4 CH:1 PAR-.l N3
0 0
5 431.19 H2-(ene)(oh)' H° H1
6 CH:0 PAR:1 H2 !i! 0
7 259.12 H-(oh)’ H° 0 0
We see that OSCAR has successfully eliminated ail ambiguity from this fork. Every mono is 
fully specified, having a definite parent and definite children. Every box is similarly completed, 
with the Root and RootParent fields all known. At this point, further applications o f inference 
rules will make no more progress, and OSCAR will end its processing o f this fork.
5.4.3.4 Calculate Scores
From the above discussion, it is clear that OSCAR needs an efficient way to detect when the 
inference rules are no longer making progress in simplifying a particular fork. For this, OSCAR 
uses the notion of scores to represent progress. A decreasing score implies that the fork has
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been made more specific, and a score that does not change between applications of the set of 
inference rules means that the fork has stalled and will not benefit from further applications of 
the inference rules.
Each fork computes its score as a simple summation (where |X| represents the number of 
elements in set X):
•  Add the score o f each mono in the fork
•  Add the score o f each box in the fork
The methods mono and box use to  compute their scores are very similar to each other. 
Recall that the Possible sets shrink over time and the Definite sets grow, and that a 
decreasing score implies progress is being made. OSCAR therefore adds |Possible| and 
subtracts |Definite | when computing the score for a mono or box. Similar reasoning is 
applied to  the other sets contained by mono and box: the shrinking sets
NumChildrenPossible and Linkage are added.
Specifically, each mono computes its score as follows:
•  Add |ParentPossible|, |ChildrenPossible|, |NumChildrenPossible), 
|Linkage|
•  Subtract |ParentDefinite|, |ChildrenDefinite |
Each box computes its score as follows:
•  Add |RootPossible|, |RootParentPossible|, |Linkage|
•  Subtract |RootDefinite |, |RootParentDefinite |
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Interestingly, a fork's score does not always correlate closely w ith the number o f consistent 
glycans it produces. The score is used for only two purposes: to  terminate the iterative 
application of the inference rules, and to  prune isomorphic forks, as described in Section 5.4.3.6.
5.4.3.5 Check Consistency
After the inference rules have been applied to each fork, OSCAR examines each fork for 
logical inconsistencies. If any are found, the fork is marked as inconsistent and removed from 
the solution.
Here are some o f the conditions examined to ensure that a fork is consistent, along with 
necessary caveats:
•  Each mono must have at least one entry in its NumChildrenPossible set
o Even if the mono is a leaf, the NumChildrenPossible set should include 
0. An empty set implies that no integer correctly describes the number o f 
children the mono has.
•  Each mono must have at least one mono in its ParentPossible set
o Unless the mono is possibly root of the glycan, in which case it would 
correctly have no parent
•  Each box must have at least one mono in RootPossible
o Because every box specifies a subtree and every subtree must have a root
Other consistency checks are performed as well, all o f which verify that the constraints of a 
logical tree are not violated by any mono or box in the fork.
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5.4.3.6 Isomorph Pruning
Selection forking can introduce forks that are guaranteed to generate identical sets of 
consistent glycans. These redundant forks are called isomorphs. Two forks are isomorphic if (1) 
a one-to-one mapping exists from one fork's monos to the other fork's monos, and (2 ) a one-to- 
one mapping exists from one fork's boxes to  the other fork's boxes. In other words, tw o forks 
are isomorphic if one fork's monos and boxes can simply be renumbered to  yield the other fork.
Consider Table 20, which represents the initial state o f fork 0 while processing the pathway 
m/z 1187.6_894.4_649.2_431.1_259.0. Pay special attention to box 5, highlighted. This box 
required the selection of two hexose residues from a precursor that contained three (H°, H1, H2). 
In this fork, residues H° and H1 were selected for box 5. However, another fork was created 
where residues H1 and H2 were selected instead; and yet another fork where H° and H2 were 
selected. OSCAR simply creates a fork for each possible combination.
It should be clear that the structures produced by these other forks will be the same as the 
ones produced by fork 0 , w ith the exception that residues hV h 1 w ill be renumbered h V h 2 and 
H°/H2 in the other forks. No structural differences will be apparent, and retaining all three forks 
would be a waste of computational resources7. These three forks are isomorphs o f one another, 
and tw o can be discarded. We call this process isomorph pruning.
7 W ithout isomorph pruning, not only would the isomorphic forks consume resources and time, but 
would themselves generate more isomorphs as additional disassembly pathways were entered, and so 
on. OSCAR would be buried beneath an avalanche of isomorphic forks that all produce the same 
structures.
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Table 20: The initial state of fork 0.
ForkO
©■X H1 H2 N3 n4 H1 H2 N3 n4 0 1 2 3 4
H1 H° H2 N3 n4 H° H2 N3 n4 0 1 2 3 4
H2 H° H1 N3 n4 H° H1 N3 n4 0 1 2  3 4
N3 H° H1 H2 n4 H° H1 H2 n4 0 1 2 3 4
n4 H°H1 H2 N3 H°H1 H2 N3 0 1 2 3 4
1187.61 H3Nn H° H1 H2 N3 n4 H° H1 H2 N3 n4
{. 1 ■: 894.43 H3N-(ene)’ H° H1 H2 N3 H° H1 H2 N3 n4
2 CH:1 PAR:0 n4 n4
3 649.30 Hs-(ene)' H°H1 H2 H° H1 H2 N3 n4
4 CH:1 PAR:1 N3 N3 H° H1 H2 n4
5 431.19 H2-(ene)(oh)' H° H1 H° H1 H2 N3 n4
6 CH:0 PAR:1 H2 H2 H° H1 N3 n4
7 259.12 H-(oh)' H° H° H1 H2 N3 n4
A naive implementation of isomorph pruning could compare every fork against every other 
fork, but that would have a run-time complexity of 0 (n2), a poor choice as n (the number of 
forks in the solution) becomes large.
Instead, OSCAR searches for isomorphic forks after the inference rules have been applied to 
all forks, which, as a side-effect, assigns a score to every fork. Because the inference rules never 
base their actions on the indices of the monos or boxes, isomorphic forks receive the same 
score. OSCAR sorts the forks by score, puts forks with identical scores into buckets, and then 
searches for isomorphic pairs only w ithin each bucket. This implementation of isomorph 
pruning is critical in achieving OSCAR's fast execution times.
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5.4.3.7 The Summarize Command
When the Summarize command is issued, OSCAR generates and displays a set of glycans 
consistent w ith all selected disassembly pathways. OSCAR then displays some solution 
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Figure 26: A simplified view of the Summarize command.
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5.4.3.7.1 Generate Consistent Glycans
This phase generates the output that the analyst is most interested in: the complete set of 
consistent glycans as restricted by the selected MS" pathways.
To do this, OSCAR iterates over all remaining forks in the solution. For each fork, the 
ParentPossible set for each Mono is examined. A candidate glycan is assembled w ith every 
mono attached to one of its possible parents. Then the glycan is subjected to  further 
consistency checks (more below) and, if found to be valid, displayed. This process iterates until 
every possible mono parent-child combination, and therefore every possible glycan, is 
examined.
Each candidate glycan is subjected to these consistency checks, and more, before it is 
considered to be consistent:
•  Every mono in the glycan should be reachable from the root of the proposed glycan
•  The number of children any mono has must be consistent with that Mono's 
NumChildrenPossible
•  If the mono has any definite (instead o f merely possible) children, then that parent- 
child relationship must be present in the proposed glycan
• For every box in the fork:
o The monos in that box must form a connected subtree embedded in the 
proposed glycan
o The embedded subtree must have the same number of child scars (children 
of the glycan that fall outside the box) as the box
o The root Mono's Linkage must agree with the Box's Linkage
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These checks can be thought of as a second line o f constraints, above and beyond those that 
manipulate the fork, mono and box data structures.
For the input example shown in Listing 4 on page 60, the single topology output matches the 
expected glycan of Figure 24. GlySp/s text output of glycan structures follows the time- 
honored computer science approach o f indenting to  indicate a child relationship. Additionally, 
the parenthesized numbers following each node represent the possible linkage o f that node to 
its parent. Also given are two linear code representations of the structure, one with 
interresidue linkage details and one w ithout. See Listing 6 .
Generated 1 unique glycan (from 1 consistent, 1 total): 
======== Begin 1 Unique Glycan ========
- - - - Begin unique glycan - - - - 
Linear code (branching): H(H)HNn 






Glycan is supported by 1 specific Fork/Glycan pair:
0 /0
- - - - End unique glycan - - - - 
======== End 1 Unique Glycan ========
Listing 6: GlySpy's output for the topology of the five residue /V-linked core.
5.4.3.7.2 Display Execution Statistics
Following the set o f consistent glycans, OSCAR displays some execution statistics. For the 
example being discussed, some of the statistics displayed are shown in Listing 7.
Total forks: 7 Live: 1 Dead: 6 (Inconsistent: 1 Isomorph: 5) 
RunlnferencesOnce called 27 times
Listing 7: OSCAR execution statistics.
This shows that over the course o f the program's execution, a total o f seven forks were 
created, but six o f them were removed from the solution, leaving a lone consistent fork. Of the
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six removed forks, one was inconsistent and five were isomorphs. We also see that the full set 
o f inference rules was applied a total of 27 times. The -tim e  command-line switch causes this 
additional output:
GlySpyCLI: Total elapsed time: 0.01 secs
5.5. Results for a Fourteen-Residue Glvcan (HfiNdS^n. m/z 3618.8)
Now we apply OSCAR to a larger glycan, specifically, a 14-residue glycan isolated from fetal 
calf fetuin, an important blood glycoprotein. As shown in Figure 27, this glycan's A/-linked core 
(residues H°/HVH2/N 6/n 13) is decorated with three separate SHN antennae (S10/H 3/N 7, S11/H 4/N 8, 
and S12/H 5/N 9). In this section we demonstrate how an analyst might select observed MS" 
pathways to allow OSCAR to compute this glycan's branching topology, 
SHNISHNJH'ISHNH'JH'N'n1. To our knowledge, de novo topology analysis has not previously 
been reported for any glycan o f this size.
A simplified view of the glycan is shown in Figure 28.
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Figure 27: A tri-sialylated glycan (m /z  3618.8) as isolated from fetuin.
13
10
Figure 28: Simplified diagram of glycan m /z  3618.8.
For a variety of reasons, this glycan is difficult to  analyze by MS" alone. It has three identical
SHN antennae (which conspire to confuse the analysis), has a large number o f facile cleavages 
(which tend to absorb the collision energy and lim it the variety of fragments generated), and is a 
large structure (even doubly-charged, its m/z o f 1820.92+ is near the 2000 Da lim it of the LTQ. 
mass spectrometer).
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We first present the idealized fragmentation pattern one might expect from this glycan, and 
how the analyst might select from these pathways for use by OSCAR. Then we revisit this glycan 
using actual data, to show the trade-offs an analyst must make attempting a de novo analysis of 
a large structure.
What types o f fragmentation should we expect from this structure? The glycosidic bonds 
originating from HexNAc residues (N) are generally the weakest bonds in the glycan and tend to 
rupture most easily. The bonds from sialic acid residues (S) are also quite weak. These 
heuristics can be affected by the exact conformation o f the glycan, but serve as reasonable 
guides. As such, we would expect cleavages at the reducing end o f residues N6, N7, N8, N9, with 
additional cleavages at the reducing ends o f residues S10, S11, and S12. (That is, from Figure 28, 
we expect the bonds to the right o f N and S residues to  break relatively easily.) This in fact is 
largely what we observe in Spectrum A - l on page 208 o f the appendix. The peaks of this 
spectrum are detailed in Table 21.
The charge state of an ion can be reliably inferred from the spacing o f peaks in the isotopic 
window. Spectrum A-2 details the isotopic envelope for m/z 847.4. This series o f peaks is 
caused by the random inclusion of 13C isotopes, instead o f the more common 12C, which causes a 
shift o f one mass unit. Because the peaks are separated by intervals of 1 m/z, the charge state is 
known to be +1. (We know m changes by one, and so z must also be one to register an m/z 
difference of one.) Spectrum A-3 shows several peaks separated by approximately 0.5 mass 
units (1258.1, 1258.5 and 1259.0; 1262.0, 1262.5 and 1263.1) revealing a charge state o f +2. 
(Again, m changes by one, but z = 2 gives m/z differences o f 1/2.) This spectrum also shows that 
monoisotopic peaks (1258.1 and 1262.0) may not be the most intense in the envelope. Careful 
interpretation is required to assign charge states and ascertain monoisotopic masses.
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Table 21: Ions observed on the spectrum for fetuin m /z  1820.92* (H6N4S3n).
nn
847.4 +1 847.4 HNS-(ene)' 847.41 Any SHN antenna
1221.1 2419.21 H5N3Sn-(oh)2 2419.21 Loss of SHN and S
1258.1 2493.21 H6N4n-(oh)3 2493.25 Loss o f all three S
1262.0 2501.01 H5N3S2-(ene)(oh)’ 2501.22 Loss o f SHN and n
1299.1 2575.21 H6N4S-(ene)(oh)2' 2575.25 Loss o f two S and n
1408.6 2794.21 H5N3S2n-(oh) 2794.40 Loss o f SHN antenna
1445.6 2868.21 H6N4Sn-(oh)2 2868.44 Loss of two S
1486.6 +2 Y-viv' 2950.21 H6N4S2-(ene)(oh)' 2950.44 Loss of S and n
1633.2 +2 3243.41 H6N4S2n-(oh) 3243.63 Loss of S
1674.3 +2 3325.61 H6N4S3-(ene)' 3325.63 Loss of n
All o f the fragments in this table can be explained by reducing-end cleavages of one or more 
N or S residues. The lone exception from Spectrum A -l, minor ion m/z  1805.3, appears to be 
caused by electronic noise. Spectrum A-4 shows detail near m/z 1805.3; the nature o f this signal 
is consistent with electronic noise periodically experienced by the Glycomics Center's LTQ mass 
spectrometer. Spectra in this work were often selected for their avoidance of the high-m/z area 
where this noise is most prevalent.
These results suggests a strategy for approaching the glycan with OSCAR: cleave o ff an SHN 
antenna, sequence the antenna, and then repeat fo r the second and third antennae. The 
expected fragments for this strategy are shown in Figure 29 through Figure 32.
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m /z 3618.8 (1820.92+)
Figure 29: Cleavage of one SHN antenna leads to m /z  847.4 and 1408.62+ fragments.
398.2 472.2 620.3
m/z 847.4




Figure 31: Cleavage of a second SHN antenna.





Figure 32: Cleavage of the final SHN antenna.
At this point, OSCAR will have determined that three separate SHN antenna exist, but will 
not yet know where they are located on the W-linked core. The analyst might then look for the 
loss o f the reducing-end n residue (Figure 33) followed by an analysis o f the remaining H3N core 
residues (Figure 34). Such a theoretical strategy is in fact successful and leads to  the GlySpy 
input shown in Listing 8. This input produces a single correct branching topology, 
SHN(SHN)H'(SHNH')H'N'n‘. Many other successful strategies also exist, though OSCAR may 




Figure 33: Cleavage of the reducing-end n residue.






Figure 34: Some expected fragments of the H3N /V-linked core.
-NLi.nkedBranchi.ng
; Treat, each lost branch as complementary to the remaining residues 
-DisjointComplements
; Lose three SHN- branches in sequence
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_1145.3
; Sequence first SHN- branch (complementary to 1820.9x2_1408.6x2) 
AddPathway NoCrossRing 1820.9x2_847.4_620.1 
AddPathway NoCrossRing 1820.9x2_847.4_398.1
; Second SHN- branch (complementary to 1820.9x2_1408.6x2_996.5x2) 
AddPathway NoCrossRing 1820.9x2_1408.6x2_847.4_620.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_847.4_398.1
; Third SHN- branch (complementary to 1820.9x2_1408.6x2_996.5x2_1145.3) 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_847.4_620.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_847.4_398.1
; Lose reducing-end n
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_1145.3_852.4
; 852 represents the H3N N-linked core (minus the reducing end n). 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_1145.3_852.4_458.4 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_1145.3_852.4_662.2
Summarize
Listing 8: A successful disassembly strategy based on expected fragments.
90
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Instrument sensitivity limitations make some theoretical spectra unobtainable in practice, 
and so alternate ions must be selected by the analyst. Listing 9 shows a sequencing strategy 
supported by the experimental data (Spectrum A -l, plus Spectrum A-5 through Spectrum A-9).
-NLinkedBranching
; Treat each lost branch as complementary to the remaining residues 
-DisjointComplements
; Lose three SHN- branches in sequence
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_1145.3
; Sequence first SHN- branch (complementary to 1820.9x2_1408.6x2) 
AddPathway NoCrossRing 1820.9x2_847.4_620.1 
AddPathway NoCrossRing 1820.9x2_847.4_398.1
; Second SHN- branch (complementary to 1820.9x2_1408.6x2_996.5x2) 
AddPathway NoCrossRing 1820.9x2_1408.6x2_847.4_620.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_847.4_398.1
; Third SHN- branch (complementary to 1820.9x2_1408.6x2_996.5x2_1145.3) 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_847.4 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_602.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_472.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_398.1










Listing 9: A successful disassembly strategy based on experimental data. 
The » symbols represent line breaks inserted for formatting purposes.
There are two main differences moving from Listing 8 to  Listing 9:
1) The third SHN branch cannot be sequenced through these two pathways:
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AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_847.4_620.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_847.4_398.1
because the ion m/z 847 is not intense enough to fragment. The normalization level of the
precursor (Spectrum A-6) is already quite low, at 8.63E-1. Instead of isolating and fragmenting
ion m/z 847, the analyst notices that the desired ions are available in the precursor spectrum
and uses them directly. Because o f the lack o f context, however, more ions are required:
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_847.4 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_602.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_472.1 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_398.1
2) The theoretical pathway to  the m/z 852 /V-linked core residues (Figure 34) was
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_1145.3_852.4_458.4 
AddPathway NoCrossRing 1820.9x2_1408.6x2_996.5x2_1145.3_852.4_662.2
However, again, the low intensity of the 996.52+ spectrum forces the analyst to use a









Here we see a common analytical trick. The ion m/z 852.3 is established by the first
command, and then ion m/z 695.5 is given next and interpreted as a cross-ring fragment. (Note
that the second AddPathway command does not specify the NoCrossRing option.) This ion, a
loss of 157 mass units, represents a 3,5A cleavage of a reducing-end HexNAc (specifically, residue
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N6), and specifies that the m/z 852 fragment under consideration must have a reducing-end N. 
The analyst then selects the familiar m/z  458.4 and 662.2 ions to complete the assignment.
Listing 9 also produces a single correct structure, although more slowly than the idealized 
Listing 8. See Table 22. However, we have shown that GlySpy is capable of de novo analysis of 
relatively large glycans w ithout resorting to biosynthetic rules, database lookups, or spectrum 
fingerprint matching. The structure generated results strictly from the W-linked core m otif 




Table 22: Execution times for the input shown in Listing 8 and Listing 9.
5.6. Limitations/Future Work
OSCAR has proven to be a capable tool for expert-level analysts. However, several 
enhancements would increase its utility.
First, and most obviously, a friendly graphical user interface (GUI) would enable non-expert 
analysts to derive more benefit from the tool.
Next, facile N and S cleavages could be used as further constraints. For example, if N and/or 
S residues are present in a precursor, all the major products should be considered as resulting 
from parent cleavages of those residues.
Last, auto assignment of charge states and monoisotopic peaks would be o f great value. 
Removing this tedious step would greatly improve the analyst's productivity. However, any
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automated spectral analysis would need to deal w ith a variety o f practical considerations: 
Electronic noise, low normalization levels, poor instrument calibration, and so on.
More speculatively, there may be other problem domains amenable to OSCAR's 
computational approach. One possible example is the derivation o f phylogenetic trees from a 
series o f individual genomes. Assuming that all represented species can be placed within an 
evolutionary tree, OSCAR's technology might be adapted to  discover the exact shape o f that 
tree. Current approaches in comparative genomics often group species into subtrees whose 
exact internal topology is incompletely known; these groups might map well to  OSCAR's box 
data structure and subsequent processing.
Beyond being an expert-level tool, OSCAR has become a building block for the other main 
GlySpy algorithms: IsoDetect, IsoSolve, and Intelligent Data Acquisition. These are covered in 
following chapters.
5.7. Discussion
A few topics beyond OSCAR's implementation and analytical results are worth brief 
mention.
5.7.1. Comparisons with Algorithm Archetypes
OSCAR shares some characteristics of various well-known algorithm archetypes. At its core,
OSCAR maintains a set o f directional graphs that represent possible connectivity between
monosaccharide residues. It applies constraint-based rules derived from fragmentation
pathways to remove links between nodes in these graphs. The rules are based on the logical
properties of trees, and are applied iteratively until no further links can be severed. On request,
the algorithm extracts the set of trees that are embedded in these graphs; these trees are the
glycans that are consistent with all selected fragmentation pathways.
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Given this, we can now very briefly compare OSCAR to  expert systems, constraint-based 
systems, and blackboard systems. This discussion is not meant to be exhaustive, but rather to 
point out OSCAR's similarities and differences with these architectures. Much of this section is 
based upon (Russell and Norvig 74).
5.7.1.1 Expert Systems
Expert systems encode a large amount o f very domain-specific knowledge in the attempt to 
match the performance of a human expert.
DENDRAL (Buchanan 12; Feigenbaum 27; Lederberg 56; Lindsay 57) is generally regarded as 
one of the first expert systems. Coincidentally, it was designed to infer molecular structure from 
mass spectra! The input was the elementary formula for the compound and a spectrum of 
fragments generated by electron bombardment. Rules were determined through extensive 
consultation w ith analytical chemists. One example rule (Russell and Norvig 74) is given to 
identify a ketone group (C=0, mass: 28 Da) in a molecule whose mass is M Da:
if there are two peaks at xl and x2 such that:
(a) xl + x2 = M + 28
(b) xl - 28 is an intense peak
(c) x2 - 28 is an intense peak
(d) At least one of xl and x2 is an intense peak 
then there is a ketone subgroup present.
The rule encodes the case where peaks x l  and x2 represent different fragments o f the 
precursor molecule, but where x l  and x2 both contain the ketone group. The xl-28 and x2-28 
peaks represent those fragments both losing the ketone group.
It could be argued that the tree-based constraint rules at OSCAR's core comprise a type of 
expert system. The rules are generally short and self-contained, similar to the one shown 
above. As a simple example, consider the ApplyLeaf inference rule from Section 5.4.3.3.5 on 
page 73. Here, OSCAR has determined that a mono has no possible children, that is, it
95
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
represents a terminal residue. Clearly the mono is a leaf and cannot be the parent o f any mono 
in the graph. OSCAR sweeps over all monos and removes the leaf from the possible parent list 
o f each (and performs several other leaf-based restrictions as well).
There is a clear difference in the domains in which DENDRAL and OSCAR can be considered 
experts. DENDRAL encodes chemical and spectral rules, whereas OSCAR encodes tree-based 
rules8.
5.7.1.2 Constraint-Based Systems
The problem OSCAR intends to  solve can be viewed as a naive constraint satisfaction 
problem—see, for example. Chapter 5 of (Russell and Norvig 74). Given multiple fragmentation 
pathways as inputs, a program could generate all possible ion composition interpretations, and 
then screen all possible glycans against them to rule out inconsistent structures. (Such a tool, 
STAT, is discussed in Section 4.8 on page 41.) Obviously, such an implementation is doomed to 
failure given larger glycans. Even the capabilities o f advanced generic constraint-based systems 
might be overwhelmed by the explosive growth in the size o f the problem space.
However, OSCAR performs a highly optimized version o f this computation. It does indeed 
start w ith all possible composition interpretations, but performs significant pruning of these 
possibilities. It is also capable o f generating all possible glycan structures for a given starting 
composition, but again manages its data structures very carefully to improve its performance. 
As this chapter has shown in some detail, OSCAR goes to great lengths to  avoid the 
combinatorial problems associated w ith glycan analysis.
8 Recall that the inference rules seen in Section 5.4 were based almost entirely on the properties of 
trees, not on the specific chemical or spectral properties of glycans.
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5.7.1.3 Blackboard Systems
In a blackboard architecture, the current state of a partially-solved problem is kept on a 
shared data structure known as a blackboard. Multiple experts are implemented as logically 
separate modules, and each given a chance to  contribute what they can to  the overall solution. 
Experts can read, add, change, or even remove information from the blackboard, which leads to 
a rich, but unpredictable, interaction between the experts. Much work has been done to 
guarantee that blackboard systems will converge on a solution, or at least declare that one is 
not forthcoming, instead of becoming stuck in an endless reasoning cycle. The choice o f which 
expert to  execute next is a crucial design decision that is often difficult for designers to 
implement w ithout significant experience with the system.
OSCAR can be viewed as a very specialized blackboard system. In this view, the solution 
data structure and its contained forks are the blackboard and each inference rule is a miniature 
expert. The crucial difference, though, is that OSCAR's "experts" are constrained from making 
changes that could lead to cyclic reasoning, guaranteeing that the algorithm will terminate. (See 
Section 5.7.2.)
OSCAR's selection of which expert to execute next is also greatly simplified: they are all tried 
in order, iteratively, until no further changes to the data structures are made.
5.7.2. Algorithm Termination
Consider the question of algorithm termination: How do we know that OSCAR will always 
terminate regardless o f the selected input pathways? A brief explanation is warranted here.
Recall from Section 5.3 on page 53 that OSCAR maintains Possible and Definite sets of 
parent and child monos. A key property of every inference rule is that Possible sets are only 
allowed to  shrink and Definite sets are only allowed to grow. We see that progress is
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monotonic: it is never possible for two rules to get caught in an endless battle o f adding and 
then removing the same elements. Because these rules are applied iteratively until no changes 
in the sets are observed, OSCAR is guaranteed to terminate.
5.8. Summary
We have seen how OSCAR processes analyst-selected MS" pathways to propose glycan 
topologies. In the following chapters, we will learn how GlySpy's higher-level tools—IsoDetect, 
IsoSolve, and Intelligent Data Acquisition—build upon OSCAR to perform their functions.




Analysts can easily be overwhelmed by the volume of data contained in even a handful of 
spectra. IsoDetect has been developed to  automatically determine which disassembly pathways 
are consistent with (and which are inconsistent with) a set o f expected glycan structures. The 
set o f consistent pathways neatly summarizes the evidence in support o f the expected 
structures, but the inconsistent pathways are typically more prized, as they may indicate the 
presence of previously-unreported structural isomers. This serves to focus the analyst's 
attention on the pathways most likely to lead to the assignment of these alternative structures. 
This "isomer detection" capability gives IsoDetect its name.
More specifically, IsoDetect accepts a set of raw spectral files (the ".raw" files produced by 
the Thermo Fisher LTQ mass spectrometer) along with a list o f structures expected to  be found 
at a given mass, and outputs a summary of the disassembly pathways found and the structures, 
if any, with which each pathway is consistent.
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6.2. Commands
To input the raw spectral files to examine, the analyst uses the AddSpectrumFile command 
discussed in Section 5.2.3 on page 51. Other relevant commands include the 
AddProposedGlycan and IsoDetect commands.
6.2.1. The AddProposedGlycan Command
The analyst uses the linear code notation described in Section 3.7 to describe each expected 
structure. As an example, consider the G M la and G M lb  glycoconjugates from Figure 11 on 
page 16. To add these two structures to the set o f expected glycans, the analyst would issue to 
commands:
AddProposedGlycan HN(S)HH-(oh) ; GMla
AddProposedGlycan SHNHH— (oh) ; GMlb
As indicated by the comments, the first command represents the topology of G M la and the 
second, GM lb.
6.2.2. The IsoDetect Command
After using the AddSpectrumFile and AddProposedGlycan commands to provide input, 
the IsoDetect command may be issued. It has the form:
IsoDetect [NoCrossRing] MZ-target rel-intensity XML-output
The NoCrossRing option restricts processing to those input pathways that can be 
described by glycosidic fragmentations only. The MZ-target parameter gives the observed m/z 
fo r the target glycans, rel-intensity specifies a relative intensity cut-off below which 
pathways are ignored, and XML-output specifies the path to an optional XML file that contains 
the command's output in a machine-readable format. The XML format is not covered by this
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
document and all examples will use "nul" as the XLM-output parameter, meaning that no file 
should be written.
Listing 10 shows sample IsoDetect input where only G M la is given as an expected structure; 
Listing 11 provides both G M la and G M lb  as expected structures. In both listings, the spectrum 
files used are those collected automatically via Intelligent Data Acquisition. (The process of 
using IDA to  collect these particular spectra is discussed in Section 9.2.1.1 on page 160.) Also in 
both cases, a relative intensity cut-off o f 2% is used.
These listings will be used as the basis for discussion o f the IsoDetect algorithm (Section 6.3) 
and its results (Section 6.4).
-ReducingEndResidue unreduced 
-UnmethylatedReducingEnd







AddSpectrumFile GMlab l877_1273_898 449.raw 
AddSpectrumFile GMlab_1877_1273_898_472.raw
; Add topology for just one of the expected structure (GMla) 
AddProposedGlycan HN(S)HH-(oh) ; GMla
; Run IsoDetect, but do not generate the XML file (output file is nul) 
IsoDetect NoCrossRing 1273.65 2 nul
Listing 10: IsoDetect input where only G M la  is given as an expected structure.
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-ReducingEndResidue unreduced 
-UnmethylatedReducingEnd









; Add topologies for both expected structure (GMla and GMlb) 
AddProposedGlycan HN(S)HH-(oh) ; GMla
AddProposedGlycan SHNHH-(oh) ; GMlb
; Run IsoDetect, but do not generate the XML file (output file is nul) 
IsoDetect NoCrossRing 1273.65 2 nul
Listing 11: IsoDetect input where both G M la  and G M lb  are given as expected structures. 
The AddSpectrumFile commands are identical to those in Listing 10.
6.3. Algorithm
IsoDetect accepts a list of expected structures, plus a set o f spectral data files from which it 
extracts all pertinent disassembly pathways. IsoDetect's goal, then, is to determine the 
consistency of every pathway/structure pair. Intuitively, a pathway and structure are consistent 
if some sequential disassembly of the structure yields all of the ions in the pathway.
IsoDetect is implemented as a layer above OSCAR. To determine the consistency o f one 
pathway/structure pair, OSCAR first creates a solution containing one fork (Section 5.3.1 on 
page 54) but instead of initializing the fork to represent all possible structures, OSCAR initializes 
it to  represent only the expected structure. For the G M la and G M lb  structures specified in 
Listing 11, IsoDetect would initialize two forks as shown in Table 23 (for G M la) and Table 24 (for 
GM lb). Notice that every parent/child relationship has been definitively assigned, as indicated 
by the boxed text, and that the root of the glycan is known to be H°.
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Table 23: The IsoDetect fork as initialized to match GMla's branching topology.
Fork fo r G M la
H° 0 1
H1 0 0
H2 0 @ 0 2
N3 0 @ 1
S4 0 0
Table 24: The IsoDetect fork for G M lb's branching topology.
■
H° 0 1
H1 0 i 1
H2 0 0 1
N3 0 0 1
S4 0 0
The pathway then is analyzed for compatibility with this expected structure, using OSCAR's 
normal method of recognizing and applying the structural constraints imposed by each pathway. 
IsoDetect adds the pathway to  the solution and then applies constraints exactly as if 
AddPathway and Summarize commands had been given. If the application of OSCAR's
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inference rules leaves at least one fork alive in the solution9, the pathway/structure pair is 
considered to be consistent. However, if no live forks remain in the solution, the 
pathway/structure pair is inconsistent.
This process is repeated until each pathway has been tested for consistency against each 
expected structure. See Figure 35, which illustrates the processing done for the G M la /G M lb  
example of Listing 11. Notice that separate solutions are created, in turn, to  represent G M la 
and G M lb, and each pathway is tested against these solutions.
9 Notice that adding the pathway to the solution can cause forks to be created, for example, through 
selection forking (Section 5.4.3.2.2 on page 70). This ensures that all possible interpretations of the input 
pathway are considered.
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f  Input: >
I Topologies for G M la  & G M lb  
\ ______Spectrum Files_______ /
Command: \
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OSCAR
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with a single fork 
initialized to 
represent G M la
Test pathway P for 
consistency with 








Repeat for G M lb
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Fork for G M la
-Create Solution-





Fork for G M lb
Done
Figure 35: IsoDetect processing of the G M la /G M lb  example from Listing 11.
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6.4. Results
6.4.1. Results for GM1a/GM1b
We now look at IsoDetect's results given the input from Listing 10, where only G M la is 
given as an expected structure, and Listing 11, where both G M la and G M lb  are given.
6.4.1.1 GM1a Only (Listing 10)
IsoDetect extracts a tota l o f 32 fragmentation pathways for analysis. Of these, 15 are 
deemed to be consistent w ith GM la and 17 are inconsistent. One example of each type of 
pathway is found directly on Spectrum A-10 (see page 213), the MS2 spectrum for the 









Table 25: Two selected pathways from the G M la /G M lb  mixture. 
The first is consistent w ith G M la , the second is not.
Looking again at Figure 11 on page 16, we can see that the pathway terminated by ion m/z 
435 is easily explained by GM la. Because its composition has two hexoses and three scars, this 
pathway maps neatly to residues H° and H2. These hexoses would require two cleavages to be 
removed from the structure (cleaving above N3 and S4), w ith the third scar coming from the 
open hydroxyl at the glycan's reducing end.
The second pathway, with composition 449.20 H2-(oh)2’, does not f it GM la. There is no way 
to cleave a pair of connected hexoses from G M la to yield a fragment w ith only two scars. This
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pathway, along w ith many others in the IsoDetect report, is strong evidence that a structural 
isomer is present.
6.4.1.2 GM1a and GM1b (Listing 11)
Now assume that the analyst has successfully identified both G M la and G M lb. Are there 
still pathways that point at the possibility o f yet another structural isomer? This is answered by 
IsoDetect's output for Listing 11, as summarized in Table 26. Here all 32 processed pathways 
are given, along w ith the composition assigned to each ion in each pathway. For brevity, the 
initial ion m/z 1273.62 H3NS-(oh)' is omitted from each pathway.
Reading down the second column, we see that 1273.62 435.18 is consistent w ith G M la 
(but not GM lb), as are 1273.62 486.23, 1273.62_810.37, and so on through to 
1273.62_898.43_435.18_213.08, fo r a total o f 13 consistent pathways. The next column shows 
that only two observed pathways-1273.62_898.43 and 1273.62_898.43_676.32-are compatible 
w ith both GM la and GM lb. The last column shows 17 different pathways consistent with 
G M lb  (but not GMla).
Significantly, the combination o f GMla and G M lb  explains every observed pathway (13 + 2 
+ 17 = 32 pathways). Other structural isomers may still be present, perhaps hidden due to low 
abundance or a clever structure that mimics parts of G M la and G M lb, but Table 26 is strong 
evidence that G M la and G M lb  are likely the only isomers present down to  the 2% relative 
intensity threshold selected by the analyst.
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1 : x 435.18 H2-(oh)3' 898.43 H3N-(oh)2' 449.20 H2-(oh)2'
2 486.23 HN-(ene)’ 898.43 H3N-(oh)2’ 
676.32 H2N-|ene)(oh)’
472.22 HN-(ene)(oh)'
3 810.37 H2S-(oh)2' 847.41 HNS-(ene)’
4 588.26 HS-(ene)(oh)' 898.43 H3N-(oh)2' 
472.22 HN-(ene)(oh)’















































14 898.43 H3N-(oh)2' 
472.22 HN-(ene)(oh)' 
227.09 H-(ene)(oh)'
15 898.43 H3N-(oh)2’ 
472.22 HN-(ene)(oh)’ 
245.10 H-(oh)2'
16 898.43 H3N-(oh)2' 
472.22 HN-(ene)(oh)‘ 
268.12 N-(ene)(oh)'
17 898.43 H3N-(oh)2' 
472.22 HN-(ene)(oh)’ 
250.11 N-(ene)2'
Table 26: Summarized IsoDetect output for Listing 11, where both 
G M la  and G M lb  have been identified as expected structures. 
The initial ion m /z  1273.62 H3NS-(oh)' is omitted from each pathway.
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6.4.2. Results and Execution Times for All Studied Glycans
Having shown in detail how IsoDetect processes spectra for G M la /G M lb , we now 
summarize in Table 27 results for a variety o f glycans from three different biological sources.
To evaluate IsoDetect, we have elected to compare structures that have been reported in 
the literature against spectra collected from equivalent samples. The spectra were collected 
using GlySpy's Intelligent Data Acquisition; as such, no effort was made to  collect spectra that 
would confirm or refute the expected structures.
For all tests, IsoDetect used the NoCrossRing flag to  eliminate cross-ring fragment 
interpretations of the data. This option may discard a few structurally informative ions, but it 
also reduces the number of possible compositions for each observed ion, increasing throughput. 
Future versions of IsoDetect, which will attempt to perform linkage analysis, will of course need 
to  find and use appropriate cross-ring fragments. For branching topology analysis, glycosidic 
fragments are sufficient. A relative intensity cut-off of 2% was specified.
For the IgG and ovalbumin tests, the -NLinkedBranching and -NLinked options were 
not given. Similarly, only -ReducingEndResidue reduced was specified, not the more 
restrictive -ReducingEndResidue n that the W-linked m otif would demand. In both cases, 
these settings allow IsoDetect to call out pathways that appear to result from glycosidic 
cleavages but which do not f it  the dogmatic A/-linked core motif.





8 32/32 100% 0.49
1606.83 NH^H'JH’N^FJn’ 11 55/69 80% 0.33
1636.84 HNH'IH'JH’N'n’ 7 20/45 44% 0.19
IgG 1677.87 NH'(NH')H'N'n* 12 46/54 85% 0.40
1810.93 HNH'(H')H’N'(F)n 8 10/59 17% 0.49
1851.96 NH’fNfOH’N’fFJn' • ■ : 9 41/41 100% 0.35
1187.61 H'(H')H'N'n' 25/49 51% 0.16
1636.84 NH’fHFOH'N’n' 11 45/81 56% 0.80




14 73/89 82% 2.50
Table 27: IsoDetect results and execution times for a variety of glycans.
If the reported structures enumerated all o f the glycans actually present, we would expect 
the Consistent Pathways column o f Table 27 to  register 100% in every case. We see, however, 
that this was the result in only two instances, G M la /G M lb  and IgG m/z 1851. Clearly there are 
unreported structures lurking in these data. We will apply GlySpy's automated abilities to these 
structures in Chapter 9: AUTOMATED GLYCAN TOPOLOGY ANALYSIS. As we will see, the 
quantity and variety of unexpected glycans makes fully-automated analysis quite difficult.
Even w ith these limitations, the demonstrated high performance of IsoDetect (see the 
Execution Time column of Table 27) enables much more efficient analysis o f complex mixtures 
o f isomeric glycans. The most time-consuming example here executed in only 2.5 seconds.
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6.5. Summary
This chapter has presented the IsoDetect algorithm and experimental results. We feel that 
IsoDetect will prove to  be a valuable tool for identifying fragments from unreported isomeric 
structures. But, w ith only OSCAR and IsoDetect available, the analyst would still be required to 
perform all structural analysis manually to assign these isomers. Clearly there is the need to 
improved tools to  automatically assign these structures. Such an algorithm, called IsoSolve, is 
the subject of the following chapter.




We have seen how OSCAR and IsoDetect improve analysts' capabilities and efficiency, but 
more can be done to automate the task assigning glycan topologies. In this chapter and the 
next, we discuss IsoSolve and Intelligent Data Acquisition (IDA), algorithms designed to operate 
with little or no human guidance.
IsoSolve takes as input a set of spectra (the ".raw" files generated by the LTQ) and extracts 
structurally-informative fragmentation pathways. IsoSolve then produces a ranked list of 
isomeric branching topologies that, taken together, account for the observed pathways. As 
structures are proposed, all pathways consistent w ith those structures are marked as explained. 
Intuitively we see that, if isomers are present, any single structure will explain only a fraction of 
the tota l set of fragmentation pathways. Unexplained pathways will be used to seed the search 
for additional isomers. As these isomers are identified, the total fraction of explained pathways 
will increase, until the set of proposed structures cumulatively explain all input pathways.
7.2. The IsoSolve Command
The spectra to be examined by IsoSolve are input via the AddSpectrumFile command
(Section 5.2.3 on page 51). The IsoSolve command has the following format:
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IsoSolve [NoCrossRing] MZ-target rel-intensity
As before, the NoCrossRing option specifies that compositions containing cross-ring 
fragments should be excluded from the analysis. The MZ-target parameter gives the m/z o f 
the unfragmented glycan. The rel-intensity parameter specifies a relative intensity cutoff; 
peaks which fall below this threshold are ignored.
We show two example input listings for the IsoSolve command. Listing 12 shows the input 
fo r IgG m/z 1851.96, and Listing 13 for IgG m/z 1677.87. These examples will be discussed in 
some detail below. A 2% relative intensity cut-off has been specified.
In both cases, as with nearly every example in this and the following chapters, the spectrum 
files were collected via Intelligent Data Acquisition. Any spectra collected manually will be 
identified in the text. The goal here is to  demonstrate GlySpy's ability to  begin to replace the 















IsoSolve NoCrossRing 1851.96 2
Listing 12: IsoSolve input fo r IgG m /z  1851.96.
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-ReducingEndResidue reduced 
-NLinkedBranching














IsoSolve NoCrossRing 1677.87 2
Listing 13: IsoSolve input fo r IgG m /z  1677.87.
7.3. Algorithm
7.3.1. IsoSolve Goals
IsoSolve was designed to meet a variety of goals, including:
•  Produce a set of isomeric topologies that together explain most or all of the 
observed disassembly pathways
• Produce one or more topologies per round of search, and perform additional rounds 
until all pathways have been explained
•  Use a seed (a set o f pathways) to begin each round
•  Efficiently find the next seed to be used
• Delay generating candidate topologies until only a handful remain
•  Use OSCAR's pathway constraint processing to narrow the candidate topologies
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•  Avoid producing the same topology more than once
•  Rank the produced topologies according to the quantity and quality o f supporting 
evidence for each structure
7.3.2. IsoSolve Overview
Figure 36 shows a high-level overview o f the IsoSolve algorithm. As you can see, 
"interesting" seeds are generated in sequence and used to begin each search round. OSCAR's 
solution data structure (Section 5.3.2 on page 55) is used to convert pathways into topologies, 
and when a single topology is found, it is added to  the ProposedStructures output set. After 
producing this structure, IsoSolve finds the next "interesting" seed to  begin the next search 
round, and continues until no seeds remain.
Much of the following discussion focuses on how IsoSolve finds these "interesting" seeds 
and what it does w ith them. First, however, we cover some necessary background, including 
how IsoSolve delays generating structures until necessary (Section 7.3.3) and how the generated 
structures are scored for ranking (Section 7.3.4). Then we move on to a detailed examination of 
the algorithm, presented in pseudocode, and conclude with execution results.
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Figure 36: A very high-level overview of the IsoSolve algorithm.
7.3.3. Estimating Topology Counts for a Pathway
During its execution, IsoSolve adds sets o f pathways into an OSCAR solution data structure, 
in effect performing an AddPathway command (Section 5.2.2) for each pathway. However, 
because under-constrained solutions may generate a vast number of topologies, IsoSolve delays
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asking OSCAR to generate topologies from the solution until the solution can guarantee that 
only a handful of topologies will be produced. In effect, IsoSolve delays executing the 
Summarize command until enough pathways have been added to  reduce the structure 
candidate set to manageable proportions.
To do this, IsoSolve calculates an upper bound on the number of branching topologies the 
solution can produce. To count all possible permutations o f structures that this fork could 
produce, IsoSolve simply computes the product of the Parent Monos count fo r each mono. To 
see this, imagine that all monos in a fork have exactly one definite parent, except for some 
mono M l which has three. Clearly that fork could produce only three topologies: one where 
M l is connected to parent 1, one where it is connected to parent 2, and one where it is connect 
to  parent 3. No other topologies can be generated because there is no uncertainty regarding 
the parent o f any other mono.
Now if a second mono M2 in the fork had 2 possible parents, the fork would generate up to 
six topologies: each o f the three topologies generated above would now have two variants, one 
with M2 connected to its first parent and one with M2 connected to its second parent. This 
logic extends to all monos in the fork, resulting in an upper bound equal to  the product o f the 
possible parent count for each mono.
Consider Table 28, which duplicates the "mono" portion of Table 12 from page 64. In this 
case, each o f the five monos has four possible parents, and so the fork will produce no more 
than 45 = 1024 topologies. In reality, the fork will produce fewer distinct structures, as 
overlapping isomorphs are eliminated. Still, taking the product of | Parent Monos | is an 
extremely fast way to generate an upper bound on topology count. Notice that the Children 
Monos and Number of Children fields of the table are ignored in this computation.
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This calculation was only for one fork. To generate a similar upper bound for the entire 
solution, simply sum the upper bound from each fork.
Table 28: A portion of the fork from Table 12 on page 64.
H° H2H2N3n4 H1 H2 N3 n4 0 1 2 3 4
H1 H° H2N3n4 H° H2 N3 n4 0 1 2 3 4
H2 H° H1 N3 n4 H° H1 N3 n4 0 1 2 3 4
N3 H° H1 H2 n4 H° H1 H2 n4 0 1 2 3 4
n4 H° H1 H2 N3 H° H1 H2 N3 0 1 2 3 4
Table 29 shows a portion of the same fork after many more inference rules have 
successfully been applied. Now the upper bound is 2x2x2xl = 8. This follows because H°, H1, 
and H2 each have 2 possible parents (HVN3, H°/N3, and H°/H1, respectively, and so 2x2x2) and N3 
has one possible parent (n4, and so x l). The mono n4 has no parent because it is the root, but 
we obviously do not multiply a zero into our upper bound, and so the fork can produce no more 
than 8 distinct branching topologies. Again notice that only the Parent Monos column is used in 
this calculation; the Children Monos and Number of Children columns are ignored10.
10 Eagle-eyed readers may notice a seeming inconsistency in Table 29: H1 has H° as a possible parent, 
but H° does not have H1 as a possible child. If this asymmetry seems galling, recall that OSCAR is not done 
processing this fork. Additional inference rules will be applied to eliminate H° as H^s parent. However, 
this is all irrelevant to the matter at hand: efficiently estimating topology counts for a fork.
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Table 29: A portion of the fork from Table 17 on page 74.
The Mono Portion of Fork 0
H° H1 N3 0
H1 H° N3 H° H2 2
H2 H° H1 0
N3 0 H° H1 1
n4 g 1
Clearly as more inference rules are applied and the Parent Monos column is reduced 
further, the topology upper bound will approach one. It is through these estimates that IsoSolve 
measures its progress: as it tentatively adds a pathway to the solution, it can determine if the 
pathway helped the solution converge toward a single topology. If it did, the pathway is 
retained; if not, the pathway is discarded. IsoSolve adds all pathways in this fashion, one by 
one, until either a single topology is found or all pathways have been tried. In either case, 
structures are not generated until very late in the search. This is an essential design detail that 
leads to  improved performance.
7.3.4. Rank Scoring
The isomers produced by IsoSolve are scored and ranked in order to provide the analyst 
w ith additional information about how well each structure fits with the accumulated data.
As each isomer is generated, its consistency is checked with every input pathway. So if 
there are 100 pathways, each isomer has a computed subset of consistent pathways. (This 
computation is done using GlySpy's IsoDetect technology.) These pathways form the basis of 
the structure scoring.
119
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A simple scoring strategy was implemented first, where a simple count o f consistent 
pathways was performed. If structure SI was consistent w ith 60 pathways, its score was 60/100 
= 60%. This was quickly seen to be unacceptable. In this case, SI is not consistent w ith 40 
pathways—perhaps because those 40 pathways reside on spectra that could not possibly have 
come from structure SI. Because MS" allows for the separation of isomers directly in the mass 
spectrometer, we should not penalize SI simply because we collected 40 pathways from a 
different isomer. An example may help.
When processing the G M la /G M lb , one input spectrum has the pathway 1273.6_847.4 
(Spectrum A-13 on page 214). Three pathways terminate on this spectrum: 
1273.6_847.4_398.1, 1273.6_847.4_472.2, and 1273.6_847.4_620.3. However, none o f these 
are expected to be consistent with G M la because 1273.6_847.4, the spectrum's disassembly 
pathway, is not consistent with GM la. Ion m/z 847.4 has composition HNS-(ene)' and could 
only have come from G M lb, not GM la. Clearly we should not penalize GM la's score because 
we collected spectra specific to G M lb!
IsoSolve's final implemented scoring scheme addresses these problems. Each structure's 
final score is ConsistentPathways/AvailablePathways, expressed as a percentage, where:
•  ConsistentPathways is the number of pathways consistent w ith the structure, and
•  AvailablePathways is the total number of pathways that terminate on consistent 
spectra.
In the G M la /G M lb  example, G M la is consistent with 15 pathways and a tota l of 20 
pathways terminate on spectra consistent w ith GMla. Therefore, GMla's final score is 15/20 = 
75%. Similarly, G M lb 's score is 19/26 = 73%.
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7.3.5. IsoSolve Pseudocode
With that necessary background behind us, we now move on to a detailed discussion of the 
IsoSolve algorithm as implemented by three procedures: DolsoSolve, DolsoSolveForSeed, and 
ProposeStructuresFromSeed. We also briefly discuss IsoSolve's input and variables.
Roughly speaking, the three procedures fu lfill these roles:
•  DolsoSolve: Guarantees that every pathway has the chance to be a seed
•  DolsoSolveForSeed: Generate the next interesting seed
• ProposeStructuresFromSeed: Propose at least one well-supported structure
consistent with the given seed
7.3.5.1 The AllPathways and ProposedStructures Variables
Listing 14 defines two variables used by IsoSolve: AllPathways and ProposedStructures.
•  INPUT: AllPathways is the set o f disassembly pathways to be examined
•  OUTPUT: ProposedStructures collects the topologies proposed by IsoSolve; these
topologies are presented to the user when the algorithm concludes.
These variables will be referenced in the pseudocode and flowcharts that follow. Although 
these variables are presented as if they are globals, they are in fact encapsulated in a proper C++ 
class. Similar liberties have been taken below in an attempt to  simplify implementation details 
into more presentable pseudocode.
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01: // INPUT: The set AllPathways contains all pathways to be examined
02: Variable AllPathways has type Set of Pathways;
03 :
04: // OUTPUT: The set ProposedStructures collects topologies as
05: // IsoSolve proposes them.
06: Variable ProposedStructures has type Set of Topologies;
Listing 14: The variables AllPathways and ProposedStructures as used by IsoSolve. 
AllPathways is the input set of disassembly pathways to be considered; 
ProposedStructures is the output set of proposed glycan topologies.
A Note on Line Numbers
The listings in this chapter (Listing 14 through Listing 17) are shown with line numbers (01- 
06 in the listing above). These line numbers are intentionally continued from one listing to  the 
next, to minimize confusion when the following text refers to, say, line 20.
7.3.5.2 The DolsoSolve Procedure
The DolsoSolve procedure guarantees that every pathway has the chance to be a seed. It is 
illustrated in Figure 37 and described in pseudocode in Listing 15. This procedure loops over all 
o f the input pathways and, one by one, uses each as the seed parameter to DolsoSolveForSeed. 
The necessity of this w ill become clearer as our discussion continues, but intuitively we should 
recognize that every pathway has an equal opportunity to be a seed that generates matching 
structures. We do not bias the structures generated by the order in which pathways are 
selected as seeds.
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For each pathway P, 
set Seed = { P }
Call DolsoSolveForSeed(Seed) 
to generate structures 
consistent with Seed
/  Are there any 
. pathways left to 
try? /
No





Figure 37: A flowchart for the procedure DolsoSolve.
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07 Procedure DolsoSolve()
08 {
09 // Initially, no structures have been proposed, so
10 // the ProposedStructures set is empty.
11
12
ProposedStructures = { };
13 // The variable AvailableSeeds is the set of pathways available
14 // to be added to the seed. Initially, AvailableSeeds contains
15 / /  all pathways, but it shrinks over time.




19 // Every pathway gets to be the starting seed of a new search.
20 for each pathway P in AllPathways do {
21 // The variable Seed is the set of pathways used as
22 / /  the starting point for the structure search.
23 // Give pathway P its chance to be the seed.
24 Variable Seed has type Set of Pathways;
25
26
Seed = { P };
21 // Remove pathway P from the available seeds. P is already
28 // in Seed, so it is no longer available to be added.
29
30
Remove P from AvailableSeeds;
31 // Run a search starting with this seed. This will





36 // The output includes the structures found, the pathways
37 // and spectra consistent with each structure, and the pathways
38 // that were required to generate the structure.
39 Report ProposedStructures to the user;
40 }
Listing 15: Procedure DolsoSolve implements the top-level IsoSolve processing. Proposed 
topologies are gathered in the variable ProposedStructures and reported to the user.
However, do not think that a seed must be a single pathway. As we will see, seeds are more 
commonly a set o f pathways.
In fact, perhaps the key observation in understanding IsoSolve is this: A seed is a collection 
o f pathways fo r  which no consistent structure has yet been proposed. (A structure is consistent 
with a seed if it is consistent with all of the pathways in the seed.) So, IsoSolve's main task is to
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generate a small number o f seeds and then to propose a small number o f topologies fo r  each 
seed.
However, generating the seeds is not a trivial undertaking. If there are N pathways, there 
are 2N-1 possible non-empty subsets o f pathways. For the examples in this document, N ranges 
from 32 to  89, yielding astronomical numbers of possible seeds: 289- l  is
618,970,019,642,690,137,449,562,111. To deal with this explosion, the next procedure 
discussed, DolsoSolveForSeed, recognizes when a seed is consistent with a previously- proposed 
structure.
To improve pathway selection, IsoSolve sorts the available pathways in order of information 
content, the goal being to move the most structurally informative pathways to the beginning of 
the list, so IsoSolve can reduce the number o f candidate structures quickly. For each pathway, 
IsoSolve computes an upper bound for the number of topologies that pathway alone could 
generate (Section 7.3.3). It then sorts the pathways in increasing order, so that the pathways 
that generate the fewest structures are processed first.
7.3.5.3 The DolsoSolveForSeed Procedure
The DolsoSolveForSeed procedure generates interesting seeds for which topologies should 
be produced. This procedure is detailed in Figure 38 and Listing 16.
This procedure examines the given seed, generates consistent structures from it (if 
necessary), and then removes the appropriate pathways from the AvailableSeeds set. The 
AvailableSeeds variable tracks those pathways that might profitably be combined with the 
current seed to  form a new seed for the next search round. If the current seed contains N 
pathways, the next seed generated will contain N+l. This seed augmentation is done in such a 
way as to guarantee that each successive seed cannot produce a previously-proposed structure.
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As such, IsoSolve quickly finds "interesting" seeds worthy of further consideration w ithout ever 
wasting time generating duplicate structures.
Call
ProposeStructuresFromSeed(Seed) 
to propose well-supported  
striirture(s) consistent with Seed







 ........ . . i . . . ____
Remove from 
AvailableSeeds 
any pathway consistent 
with structure(s)
Choose pathway P from
. empty?
Add P to Seed;
Remov»» P from AvailableSeeds
Yes
(  Recurse using now Seed 
and AvailableSeeds
Done
Figure 38: A flowchart for the procedure DolsoSolveForSeed(Seed, AvailableSeeds).
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41: Procedure DolsoSolveForSeed(Seed, AvailableSeeds)
42: // Seed is the set of pathways used to start the search.
43: Parameter Seed has type Set of Pathways;
44:
45: // AvailableSeeds is the set of pathways available
46: // to be added to the seed.
47: Parameter AvailableSeeds has type Set of Pathways;
48: {
49: if (Seed is consistent with at least one proposed structure) {
50: // There is no reason to generate new structures for this
51: // Seed since we already have structures compatible with
52: // Seed. Instead, remove any pathway consistent with those
53: // structures from AvailableSeeds, since those pathways
54: // also no longer need to be explained.
55: for each proposed structure S that is consistent with Seed
56: Remove S.ConsistentPathways from AvailableSeeds;
57: } else {
58: // Seed is not consistent with any proposed structure.
59: // Use this Seed to generate one or more Structures that are
60: // well-supported by the full pathway set, not just the
61: // remaining AvailableSeeds.
62: NewStructures = ProposeStructuresFromSeed(Seed);
63:
64: // The structure(s) just proposed will be consistent with a
65: // number of pathways. Remove those pathways from
66: // AvailableSeeds, since they no longer need to be explained.
67: // Also, add each structure to the ProposedStructures set.
68: for each structure S in NewStructures do {
69: Add S to ProposedStructures;




74: // If AvailableSeeds is an empty set, search is completed.
75: if (AvailableSeeds is not empty) {
76: // Some available seeds are still not consistent with any
77: // structure generated from this seed. Select one still-
78: // unexplained pathway P, add it to Seed and remove it from
79: // AvailableSeeds.
80: P = Choose pathway from AvailableSeeds;
81: Add P to Seed;
82: Remove P from AvailableSeeds;
83:
84: // Recurse to start a new search using the augmented seed.
85: DolsoSolveForSeed(Seed, AvailableSeeds);
8 6 : }
87: }
Listing 16: Procedure DolsoSolveForSeed manages the search for structures 
consistent with a given seed of pathways. It finds well-supported structures consistent 
with Seed and consumes the AvailableSeeds set until it becomes empty.
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As you can see, the first action taken by DolsoSolveForSeed is to determine if the given seed 
is consistent w ith any structure that has already been proposed. If it is, the algorithm examines 
these structures and removes their consistent pathways from the AvailableSeeds set. So, if the 
current seed is consistent w ith proposed structure SI, and SI is consistent with pathways PI, 
P5, and P6, the algorithm removes PI, P5, and P6 from AvailablePathways. Intuitively, this 
means that there is no need to  combine the current seed w ith pathway PI, P5 or P6 at any time 
in the future. If we did, the seed would just lead us back to structure SI!
However, if the seed is not compatible with any proposed structure, the procedure calls 
ProposeStructuresFromSeed, discussed next. That function returns one or more structures 
consistent w ith the given seed. As above, we examine each of these newly generated structures 
and remove their compatible pathways from AvailablePathways. This, again, is to prevent us 
from considering a future seed that leads back to previously-proposed structures.
After this initial structure lookup or creation, DolsoSolveForSeed must decide if there are 
any interesting seeds left to be examined. If AvailableSeeds is empty at this point, there are no 
useful ways to extend the seed, and the procedure is done.
However, consider the case when AvailableSeeds is not empty. For example, suppose 
AvailableSeeds contains just one pathway, P9, and seed contains P4 and P5. This means that no 
structure has yet been proposed that is consistent with all three pathways, P4, P5, and P9. 
Obviously, we should attempt to generate a structure consistent w ith all three of these 
pathways, and so we extend seed from { P4, P5 } to { P4, P5, P9 } and run DolsoSolveForSeed 
again with this new seed. In this way we have quickly identified an interesting seed by merely 
observing what single-pathway augmentation of the seed has not yet yielded a proposed 
structure.
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Also note that we remove great swaths o f pathways from AvailablePathways each time a 
structure is proposed—namely, every pathway consistent w ith that new structure. In practice, 
the AvailablePathways set shrinks very rapidly, allowing the algorithm to  achieve a high
performance regardless of the 2N-1 possible seeds discussed in Section 7.3.5.2.
7.3.5.4 The ProposeStructuresFromSeed Function
The ProposeStructuresFromSeed function proposes at least one well-supported structure 
consistent with the seed it is given. See Figure 39 and Listing 17.
The function performs this task in a relatively straightforward manner. Using the topology 
count estimation technique o f Section 7.3.3, it tracks the number of topologies that an OSCAR 
solution could generate for a given set of pathways. It then tentatively adds another pathway 
from the full data set and asks if the solution now generates fewer structures. If yes, the 
pathway is kept as part of the solution; if no, the pathway is discarded. In either case, all 
pathways in the full data set are tentatively added in this fashion, until the solution generates a
single topology. The function then exits, returning the topology to the caller.
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Function
P ro p o s e S tru c tu re s F ro m S e e d (S e e d )
Add all pathways from  Seed 
into an OSCAR Solution
For each pathway P in the  
entire pathway set (not 
just AvailableSeeds) do:
r Yes. P = Next Pathway
Does adding P \  
:ause Solution to 
generate fewer 
structures? /
/  N .
<  pathways ) < . - N o  
■V left? /
Yes
Add P to the Solution
/ '  Does Solution 





Caller will add structures to 
the ProposedStructures set
Done
Figure 39: A flowchart fo r the function ProposeStructuresFromSeed(Seed).
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88: Function ProposeStructuresFromSeed(Seed)
89: Parameter Seed has type Set of Pathways;
9 0 :
91: Returns Set of Structures;
92: {
93 :  // The variable Solution is implemented by
9 4 :  // OSCAR's "Solution" data type
95: Variable Solution has type OSCAR Solution;
96 :
9 7 :  // Execute "AddPathway P" for each pathway P in Seed
98: Add all pathways from Seed to Solution;
9 9 :
1 0 0 :  // If the seed cannot produce any structures, abort
1 0 1 :  // the search: Return the empty set and exit the function.
102: if (Solution is sterile)
103: return { );
104:
1 0 5 :  // Search all pathways in order, looking for ones that help
1 0 6 :  // Solution converge toward a single structure
107: for each pathway P in AllPathways do {
108: if (adding P to Solution makes progress) {
109: Add P to Solution;
110:
1 1 1 :  // If we have converged on a single topology, return it
112: // and exit the function.




1 1 7 :  // The algorithm did not converge on a single structure, so
1 1 8 :  // return the set of all structures that Solution can generate.
119: return Solution.GenerateStructures();
120: )
Listing 17: The ProposeStructuresFromSeed function returns a set o f well-supported 
structures tha t are consistent w ith  the given set of Seed pathways.
It tentatively combines Seed w ith  all pathways in IsoSolve's data set (not just the 
AvailableSeeds) to  converge toward a small number of proposed topologies.
A few clarifications are in order here.
First, because ProposeStructuresFromSeed tentatively adds every available pathway, there 
is no bias against selecting pathways that are consistent with some previously-proposed 
structure. We know at this point that the seed is guaranteed to lead to  new structures, and so 
duplicate structures are not an issue. However, we cannot lim it this tentative pathway selection
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to  some subset o f the pathways, or we may fail to  generate a valid structure. Just because 
pathway P I is part of structure SI doesn't mean it can't also be part o f structure S2. For 
example, recall from the G M la /G M lb  example (Table 26 on page 108) that some pathways can 
be compatible w ith multiple isomers. In that case, both 1273.6_898.4 and 1273.6_989.4_676.3 
are compatible w ith GMla and G M lb. When searching for GM lb, it would be a mistake to 
ignore pathway 1273.6_898.4 just because the pathway is consistent with GMla.
Second, it is possible that an isomer is present but there are insufficient data for 
ProposeStructuresFromSeed to find a combination o f pathways that yields exactly and only that 
structure. In this case, the OSCAR solution manipulated by the function would fail to  converge 
on a single structure before running out of pathways to tentatively add. Here, 
ProposeStructuresFromSeed will return multiple structures—namely, all o f the structures 
produced by the solution. These structures are marked w ith a count o f structures produced in 
this batch, and so the analyst can easily identify the structures that were produced as a "bunch" 
due to insufficient data. A skilled analyst could then determine which further spectra to collect 
to resolve the ambiguity.
7.4. Limitations/Future Work
From the above discussion, we can see a number of areas where IsoSolve can be improved 
in future efforts:
1. ProposeStructuresFromSeed could be modified to perform a more intelligent 
selection of the next pathway to tentatively add to the OSCAR solution. Currently 
the selection is made based on the estimated information content of the pathways 
(as estimated by the technique described in Section 7.3.3 on page 116), but other 
selection strategies should be considered. For example, selecting a complementary
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ion may be profitable, as we saw when sequencing the fetuin glycan m/z 3618.8 
(Section 5.5 on page 84).
2. ProposeStructuresFromSeed uses OSCAR to calculate an upper bound on the 
number o f structures the solution might generate, but that upper bound can 
sometimes be quite a bit higher than the actual number. This could lead IsoSolve to 
discard a pathway that actually reduced the number o f candidate structures. Better 
techniques for quickly estimating topology counts would be beneficial here.
3. The scoring algorithm used to rank proposed structures suffers slightly in the 
presence of isobars, as discussed in Section 7.3.4. One improvement would be to 
avoid penalizing scores if multiple fragments on one spectrum are inconsistent w ith 
each other. That is, inconsistent pathways wouldn't all count toward 
AvailablePathways; rather, only the largest subset of consistent pathways would be 
counted.
7.5. Results and Discussion
We now demonstrate how IsoSolve processes two tests cases from IgG, m/z  1851.96 and 
m/z 1677.8. Line numbers called out in the following discussion refer to the pseudocode of 
Listing 14 through Listing 17.
7.5.1. IgG m/z 1851.96
Intelligent Data Acquisition was used to collect nine spectra fo r IgG glycan m/z 1851.96, 
from which IsoSolve extracted 41 pathways. These pathways were then sorted by estimated 
information content. A portion of this sorted pathway list is shown in Table 30.
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Table 30: The firs t 20 pathways extracted from  the spectrum files fo r IgG glycan m /z  1851.96.
Now DolsoSolve begins iterating over the pathways (line 20), trying each as a seed. The first 
seed is a set containing the sole pathway { P I } , and is passed to DolsoSolveForSeed (line 33).
Since no structures have yet been proposed, we execute line 62, calling 
ProposeStructuresFromSeed with seed = { P I }.
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Pathway PI is estimated to produce up to  three structures. Because this count is small, 
ProposeStructuresFromSeed actually generates all possible structures, and three structures are 
created. DolsoSolveForSeed then iterates over all of the pathways (line 107), adding each in 
turn to the seed, { P I }. The pathway P2 is tentatively added to the seed, and { PI, P2 } is found 
to generate exactly one structure: NH,(NH,)H'N'(F)n', designated SI. DolsoSolveForSeed returns 
SI to the caller (line 114).
Back in DolsoSolveForSeed (line 69), SI is added to the ProposedStructures set. Next, the 
pathways consistent w ith this structure are removed from AvailableSeeds. But every pathway is 
consistent w ith SI, and so AvailableSeeds becomes empty, and the function exits.
Returning to DolsoSolve (line 33), the algorithm loops (line 20) and passes { P2 } as the seed 
for the next invocation o f DolsoSolveForSeed (line 33 again). This time, however, the condition 
on line 49 is met and we do not generate a structure fo r the seed { P2 }. Instead, we examine 
the previously-generated structure (SI) and remove all o f its compatible pathways from 
AvailableSeeds, which again becomes empty, and again causes DolsoSolveForSeed to  exit.
The loop in DolsoSolve (line 20), continues, trying seeds { P3 }, { P4 },..., { P41}, but in each 
case DolsoSolveForSeed finds that structure SI is compatible with the seed and so no further 
processing is done.
For this example, only a single structure is proposed, and the minimum possible number of 
seeds (41) has been considered. The algorithm has clearly performed very well for this case, 
where isomers do not appear to be present. Next we look, more succinctly, at IgG glycan m/z 
1677.8, where two isomers are present.
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7.5.2. IgG m/z 1677.8
For IgG glycan m/z 1677.8, a total o f 12 spectra were collected by Intelligent Data 
Acquisition, from which 47 pathways were extracted. The first 15 of these are shown in Table 
31.
Table 32 gives an abridged representation o f how IsoSolve processes these pathways. The 
Context column provides some indication o f what the algorithm is doing, and the Action/Result 
column describes what is accomplished at this step. The "Seed = { Pn }" context entries 
represent the loop in DolsoSolve, where each pathway is given a chance to be its own seed. 
Indented entries, like 'Try { PI, P2 }" and "Recurse with seed = { PI, P13 }" represent the 
processing in DolsoSolveForSeed.
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Table 31: The firs t 15 pathways extracted from  the spectrum files fo r IgG glycan m /z  1677.8.
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Context Action/Result
Seed = { P I } Generates 3 structures, so try  adding more pathways
Try { PI, P2} Still generates 3 structures, so discard P2
Try { PI, P3} Generates one structure, NH’JNH’jH 'N 'n1, designated SI
Structure SI is consistent w ith every pathway except P13, 
so AvailableSeeds shrinks to  { P13}
Recurse w ith seed = { PI, P13} Generates 2 structures, so try  adding more pathways. 
None help converge until P10.
Try { PI, P10, P13 } Generates one structure, NH'tNKH'JH'N'n', designated
S2. SI and S2 combined are consistent w ith all input 
pathways.
AvailableSeeds becomes empty
Seed = { P2 } P2 is consistent with SI and S2, so AvailableSeeds 
becomes empty.
Seed = { P3 } P3 is consistent w ith only SI, so AvailableSeeds becomes 
{ pi3 }
Recurse with seed = { P3, P13} Generates no topologies (P3 and P13 are inconsistent 
w ith each other), so exit
Seed = { P4} P3 is consistent with only SI, so AvailableSeeds becomes 
{ P13)
Recurse w ith seed = { P4, P13 } P4 and P13 are inconsistent, so exit
Seed = { P5 } P5 is consistent with only SI, so AvailableSeeds becomes 
{ P13}
Recurse with seed = { P5, P13 } P5 and P13 are inconsistent, so exit
— ...
Seed = { P8 } P8 is consistent with SI and S2, so AvailableSeeds 
becomes empty.
Seed = { P9 } P9 is consistent with SI and S2, so AvailableSeeds 
becomes empty.
Seed = { P47 } P47 is consistent with SI and S2, so AvailableSeeds 
becomes empty.
Table 32: A compressed representation o f IsoSolve's execution 
over the pathway data set fo r IgG glycan m /z  1677.8.
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Note how quickly IsoSolve discovered structures SI and S2. SI is generated after trying only 
three seeds, { P I }, { PI, P2 }, and { PI, P3 }; S2 is generated after just two more seeds, { PI, P13} 
and { PI, P10, P13 }.
Once SI and S2 are proposed, the algorithm searches fo r seeds that are inconsistent with 
these structures. For example, { P2 } is discarded because it is consistent w ith SI and S2, which 
are themselves consistent w ith all input pathways. This indicates that P2, by itself, is not 
guaranteed to  lead to a structure that has not already been proposed, and is discarded.
Seed { P3 } is tried next. Because P3 is consistent with SI, and SI is consistent w ith every 
pathway except P13, the only seed worth considering is { P3, P13 }. That is, this seed is the only 
one that includes P3 and could possibly generate a new structure. However, this pair of 
pathways is internally inconsistent—they generate no structures when given to  OSCAR—and is 
also discarded.
The pattern occurs through the rest o f the outer loop, where some pathways such as P4 and 
P5 are combined with P13 to  yield sterile seeds (seeds that generate no structures), and other 
seeds, such as P8 and P9, are consistent w ith SI and S2 and therefore have no unexplained 
pathways w ith which to be combined.
An enterprising analyst might at this point wonder why pathway P13 is called back several 
times. This pathway, m/z  1677.87_1384.64_1125.54_866.40_662.36_444.11, represents 
disassembly down to an /V-linked core that contains a bisecting HexNAc. This contrasts with 
pathways that pass through ion m/z 458.2 (such as P3 and P4). This ion represents the A/-linked 
core m otif w ithout a bisecting HexNAc. Clearly ions m/z 444.1 and 458.2 must come from 
structural isomers, and IsoSolve has automatically focused its attention on these ions.
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Listing 18 shows some o f IsoSolve's output fo r this case. We see that two topologies have 
been proposed (NH'INH'jH'N'n1 and NH'lNXH'JH'N'n'), and we see the calculated score for each 
(97.87% and 91.30%, respectively). We are shown which seeds were used in both cases (<1> 
and <1,13>, which represent { P I } and { PI, P13 }, respectively), and the exact pathways that 
combined to  produce the structures (<1,3> and <1,10,13>). Importantly, IsoSolve also presents 
the complete list o f pathways that are consistent with each structure, allowing the analyst to 
make further judgments about the quality o f support for each.
IsoSolve results:
Structures found: 2
--------  Structure 1 of 2 --------
Linear code (branching): NH'(NH')H 1N 'n '
FINAL SCORE: 97.87 
Order found: 1 
Seed Pathways: <1>
Generated from these Pathways: <1,3>
Compatible Pathways:
46 compatible out of 47 possible: 97.87%
46 compatible out of 47 total: 97.87%
<1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29 
,30, 31, 32, 33, 34, 35, 36,37,38,39,40,41,42,43,44,45,46,47>
--------  Structure 2 of 2 --------




Generated from these Pathways: <1,10,13>
Compatible Pathways:
42 compatible out of 46 possible: 91.30%
42 compatible out of 47 total: 89.36%
<1,2,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31, 
32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47>
Listing 18: Abridged IsoSolve output fo r IgG glycan m /z  1677.8.
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7.6. Validation
IsoSolve was applied to a variety o f glycan samples whose spectra were collected by use of 
the Intelligent Data Acquisition module. See Chapter 9: AUTOMATED GLYCAN TOPOLOGY 
ANALYSIS for a discussion of these results along w ith  their execution times.
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CHAPTER 8:
INTELLIGENT DATA ACQUISITION (IDA)
8.1. Overview
Higher-order MS" analysis brings challenges that have hindered its adoption as the premier 
glycoanalytic methodology. Of course, the overriding problem has been the lack o f analytical 
tools and techniques to interpret the collected spectra. These issues are the focus of the GlySpy 
algorithms OSCAR, IsoDetect, and IsoSolve.
However, another significant drawback is the lack of tools to collect these spectra 
automatically. When an analyst is confronted with spectra generated from a glycan, the obvious 
question is, "Which ion should be fragmented next?" This is the question that GlySpy's 
Intelligent Data Acquisition (IDA) module attempts to answer. Given a set of spectra input by 
the AddSpectrumFile command (Section 5.2.3), IDA's SuggestPeaks command provides 
several inquiry modes to suggest ions worthy of further fragmentation.
Many mass spectrometers are capable of automated data acquisition, where the analyst 
typically defines masses and neutral losses o f interest, and the instrument dutifully collects sets 
of mass spectra for ions that meet these constraints. However, these capabilities are currently 
quite limited and often result in the collection of many redundant or useless spectra. Even the 
best commercially-available data acquisition software, for example Thermo Fisher Scientific's,
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remains inadequate for oligosaccharide analysis, often collecting redundant or uninformative 
spectra (Ashline 8).
GlySpy's Intelligent Data Acquisition module attempts to address these shortcomings, 
effectively replacing the analyst as the director o f data acquisition.
8.2. The SuggestPeaks Command
GlySpy exposes IDA's capabilities via the SuggestPeaks command, which has this form: 
SuggestPeaks [NoPrune] Mode Relint Abslnt SortOrder pathway
Mode defines the desired collection mode, that is, the type of fragment search the analyst 
wishes to perform, and is detailed in Table 33. Relint specifies a minimum relative intensity as 
a percentage; the command will not return peaks below this intensity. Abslnt specifies an 
analogous absolute intensity cut-off value, where the absolute intensity is approximated by the 
product o f the peak's relative intensity and its spectrum's normalization level. SortOrder 
specifies the sort order of the suggested peaks (Table 34). The pathway parameter limits the 
search's scope to spectra that have an equivalent disassembly pathway prefix. Finally, the 
NoPrune option, if given, allows the command to return peaks that are likely to be structurally 
redundant w ith spectra that have already been collected; the default behavior, w ithout the 
option, will prune these ostensibly redundant peaks to avoid swamping the analyst with spectra 
o f questionable value.
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Table 33: The Mode parameter for the SuggestPeaks command.
Returned Peaks Intended Use
Auto Variety o f peaks useful 
fo r making structural 
assignments.
Automate data collection. 
See Section 9.2.3.
MajorGlyco Highest intensity peaks 
that could have 
resulted strictly from 
glycosidic cleavages.
Traverse deepest MS" pathway. 
See Section 9.2.1.
MissingComplements Peaks that are 
complementary to an 
existing spectrum's 
pathway.
Identify and isolate lost 
complementary fragments. 
See Section 9.2.2.
IsoDetect Peaks that IsoDetect 
has flagged as 
indicating possible 
isomers.
Collect spectra that likely come 
from isomeric structures.
See Section 9.2.4.
OnlyReducingEndScarred Peaks that have a 
composition where only 
the reducing end is 
scarred.
Isolate all losses on reducing 
end o f fragment.
OnlyNonReducingEndScarred Peaks that have a 
composition where only 
the non-reducing end is 
scarred.
Isolate all losses on non­
reducing end o f fragment.
SingleSideScarred Peaks that have a 
composition where only 
the reducing end or the 
non-reducing end is 
scarred, but not both.
A combination of 
OnlyReducingEndScarred and 
OnlyNonReducingEndScarred.
EneScar Peaks that have a 
composition containing 
at least one (ene)-type 
scar.
Isolate B-type ions likely to 
produce structurally informative 
cross-ring fragments.
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Table 34: The S o rtO rd er parameter for the SuggestPeaks command.
Sort Criterion Sort Order
RankByAbsInt Absolute intensity Decreasing
RankByRellnt Relative intensity Decreasing
RankByEstTopologies Number of estimated topologies Increasing
compatible with this pathway
RankByMSnDepth MS" depth Decreasing
Listing 19 shows several possible uses of the SuggestPeaks command. Notice that the 
Mode and SortOrder parameters can be used in any combination. The Pathway parameter 
can specify either a full, unfragmented glycan (single m/z) or a pathway (e.g., 
1677.87_1125.54_662.5), and serves to restrict the scope of the search. In all cases shown, the 
relative intensity cut-off is given as 5% and the absolute intensity cut-off is 100.
SuggestPeaks Ma jorGlyco 5 100 RankByRel Int 1677.87
SuggestPeaks IsoDetect 5 100 RankByEstTopologies 1677.87_,1384.5
SuggestPeaks MissingComplements 5 100 RankByAbsInt 1677.87,,1125 . 54_662 .5
SuggestPeaks EneScar 5 100 RankByMSnDepth 1677.87,,1384.5
Listing 19: A few possible SuggestPeaks commands, 
showing a mixture of collection modes and sort orders.
The SuggestPeaks command refrains from suggesting peaks that already have an 
associated spectrum. For example, if the spectrum for m/z 1677.9 contains an interesting peak 
at m/z 1384.5, the command will suggest the peak only if a spectrum for m/z 1677.9 -> 1384.5 
has not yet been input via the AddSpectrumFile command.
Figure 40 summarizes the processing done by IDA's SuggestPeaks command.
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Input: Acquisition Mode and 
Set of Spectra
Output: Pathways to suggest
Remove duplicate pathways
Collect all pathways from 
spectra that satisfy Mode
Sort remaining pathways 
according to SortOrder
Remove pathway if terminal ion 
is a monosaccharide
Remove pathway if on do-not- 
suggest list
Remove pathways that fall 
below relative/absolute 
intensity cut-off
If NoPrune option absent, 
remove if pathway's two final 
ions already collected in other 
spectrum
Figure 40: An overview of the Intelligent Data Acquisition algorithm 
as implemented by the SuggestPeaks command.
Typically, for de novo analysis, the analyst will collect the spectra suggested by the 
SuggestPeaks Auto command, add the spectra via AddSpectrumFile, and then repeat 
until SuggestPeaks Auto returns no further peaks. If the analyst is interested in collecting 
peaks that appear to come from unreported structural isomers, the SuggestPeaks 
IsoDetect command can be used. In fact, the vast majority of data collected for this work was 
collected using only the Auto and IsoDetect modes. The human has largely been removed 
from the data acquisition task.
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The "scar" modes of Table 33 (namely, OnlyReducingEndScarred, 
OnlyNonReducingEndScarred, SingleSideScarred, and EneScar) are largely self- 
explanatory, returning peaks whose m/z values map to  compositions which match the given 
scarring pattern. The other modes are described in detail below. For succinctness, we describe 
below only one scarring mode (OnlyNonReducingEndScarred).
8.2.1. The MajorGlyco Mode
All IDA modes examine the current set o f spectra and suggest one or more ions to fragment. 
For the MajorGlyco mode, each spectrum is examined for the highest intensity peak whose 
putative composition can be explained as resulting from glycosidic cleavages; cross-ring 
cleavages and unknown compositions are ignored by this mode.
Because this mode returns the highest intensity peak at each step, in essence following the 
highest signal-to-noise ratio through the data, it generates the deepest possible MS" pathway. 
This major glycosidic pathway becomes the backbone of the growing MS" spectrum tree. Figure 
41 shows the spectra suggest by five repeated applications o f SuggestPeaks MajorGlyco to 
ion m/z 1851.9 as isolated from IgG. The first pathway suggested is 1851.9 1384.5, the
second is 1851.9 -> 1384.5 -> 1125.4, and so on. The terminal spectrum in this tree, m/z 458.2, 
does not generate a suggested peak because the spectrum represents a disaccharide, and 
fragmenting the monosaccharide residues on that spectrum would not be structurally 
informative to GlySpy.
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m /z  1851.9 
H3FN3n
Figure 41: The MS" spectrum tree built by repeated applications 
of the SuggestPeaks MajorGlyco command.
The spectra generated by this sequence of commands are available in Section A.3 as
Spectrum A-28 through Spectrum A-33. Although the peaks returned at each stage happen to
be the highest intensity peak on each spectrum, this is not always the case, especially with
spectra whose precursor ion contains only a few residues.
8.2.2. The OnlyNonReducingEndScarred Mode
In the OnlyNonReducingEndScarred mode, as with all of the scarred modes, each
spectrum is examined for the highest intensity peak that matches the given scarring pattern. As
the name suggests, OnlyNonReducingEndScarred returns peaks whose compositions can be
inferred to have scars only on their non-reducing end. When applied to the spectra shown in
Figure 41, only a single pathway is returned: m/z 1851.9 -> 1592.7. The result is shown in
Spectrum A-34 and Figure 42. The terminal m/z  1592.7 is interpreted as having composition
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H3FN2n-(oh). Because the reducing end residue n is included in the composition, IDA infers that 
the (oh) scar must be at the non-reducing end. All other peaks on the existing spectra have 
scars on both their reducing and non-reducing ends, or are below an intensity threshold, and so 
are not suggested in this mode.
m /z  1851.9 
H3FN3n
Figure 42: The MS" spectrum tree after executing the 
SuggestPeaks OnlyNonReducingEndScarred command.
As is customary in this document, the major glycosidic pathway is shown as a vertical series
of spectra. Spectra that branch o ff this backbone were suggested by other modes, such as, in
this case, OnlyNonReducingEndScarred.
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8.2.3. Pruning
If the SuggestPeaks Ma jorGlyco command were given again at this point, the result 
would be as shown in Figure 43 /  Spectrum A-35. The ion m/z 1125.4 has been selected from 









m J S ^ .  3 













Figure 43: S u g g e s tP e a k s  Ma jo r G ly c o  adds the 
pathway m /z  1851.9 -> 1592.8 1125.4, but pruning prevents
the addition of the redundant m /z  866.3 spectrum.
One might expect that the next application o f the SuggestPeaks Ma jorGlyco command
would continue to extend the MS" tree under the rightmost m/z 1125.4 spectrum. However,
the spectra so collected would typically be of little value. They would merely mimic the m/z
866.3, 662.2, and 458.2 spectra already collected under the left branch. This occurs because the
m/z 1125.4 ion in both branches specifies the same substructure. In the left branch we have
lost a reducing end Fn disaccharide and then a terminal N; in the right branch the order o f the
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losses is reversed, but the result is the same. (Notice the extreme similarity between Spectrum 
A-30 and Spectrum A-35.)
To prevent the collection o f these redundant spectra, IDA implements spectrum pruning. 
Suppose the SuggestPeaks command would return a pathway X Y -> Z, but a spectrum for 
W -> Y Z had already been collected. SuggestPeaks will notice that the two trailing ions Y 
Z have been collected before from the precursor W, and will not suggest them again under the 
precursor X. Note, though, that the spectrum for Y is collected twice (as X ^  Y and W Y), 
allowing for manual inspection to confirm their equivalence.
Spectrum pruning is an important technique for keeping the MS" spectrum trees of 
manageable size. W ithout pruning, every branch in the tree would lead to the collection of 
many redundant spectra. However, in cases where the analyst decides that these spectra 
should be collected, the NoPrune option may be given to the SuggestPeaks command.
8.2.4. The MissingComplements Mode
Ions sometimes fragment into complementary pairs of products. For example, if the masses 
o f two product ions sum to the mass of the precursor, a natural assumption is that the precursor 
has cleaved into two complementary fragments. More correctly, because both product ions 
contain a charge adduct, a complementary relationship is revealed when
Precursor -  Charge Adduct -  Productl -  Charge Adduct + Product2 -  Charge Adduct 
holds true w ithin the user-specified mass error tolerance.
If one of the product ions has been fragmented, it is often informative to isolate and
fragment the complementary ion, if possible. This is the function of the MissingComplements
mode and is illustrated in Figure 44. Ion m/z 1592.8 lost an Fn disaccharide to form the m/z
1125.4 product. Because this example uses a sodium ion (mass: 23.0 Da) as the charge adduct,
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SuggestPeaks determines that the complementary ion, if present on the m /z  1592.8 
spectrum, would have an m/z o f approximately 490.4. (Solve 1592.8 -  23.0 = 1125.4 -  23.0 + 
Product2 -  23.0 for Product2.) Spectrum A-34 does in fact contain such an ion, though o f very 





Figure 44: S u g g e s tP e a k s  M is s in g C o m p le m e n ts  returns the 
pathway m /z  1851.9 ->  1592.8 490.2 because m /z  490.2 and m /z  1125.4
appear to be complements of the precursor m /z  1592.8.
If the complementary nature of these products is not merely coincidental, then sequencing 
the m/z  1125.4 ion and the m/z 490.2 ion separately will reveal non-overlapping substructures 
within the glycan, which can then be combined to  reveal the structure o f the m/z 1592.8 ion. 
This is a good example of IDA ignoring many higher-intensity ions and ferreting out a low- 
intensity ion that promises to be structurally informative.
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8.2.5. The Auto Mode
The preceding modes each have their strengths but share the weakness that the analyst 
must decide which mode to apply next. The Auto mode addresses this by integrating the most 
useful modes into one, moving GlySpy toward its goal of automated data collection.
Specifically, the Auto mode is a combination o f the MajorGlyco, 
OnlyReducingEndScarred, OnlyNonReducingEndScarred, and MissingComplenients 
modes. As shown in Figure 45, the Auto mode algorithm is as follows: If any MajorGlyco 
peaks have not been collected yet, suggest them. Otherwise, search fo r peaks that satisfy either 
OnlyReducingEndScarred or OnlyNonReducingEndScarred; if any are found, return 
them. Otherwise, search for a MissingComplements ion that is complementary to  an existing 
spectrum; return it if found. Otherwise, return no pathways.
The pathways returned by Auto mode are subject to  intensity cut-off limits, duplicate 
removal, and spectrum pruning.
In practice, high-quality MS" spectrum trees can be collected merely by the mechanical 
repetition o f the SuggestPeaks Auto command: apply the command, collect the spectra, add 
the spectra via AddSpectrumFile, and repeat until SuggestPeaks Auto returns no 
pathways. For example, applying this methodology to  IgG glycan m/z 1851.9 will collect exactly 
the spectra shown in Figure 44. Significantly, these spectra are selected w ith no guidance from 
the analyst. Although the analyst is still required to physically acquire the suggested spectra, 
IDA has clearly moved us toward automating the data acquisition process.
One final detail requires attention. What if the pathway suggested by IDA's Auto mode 
cannot be obtained? Perhaps the mass spectrometer's sensitivity lim it has been reached, or the 
analyst is dealing with a large legacy data set that does not contain the suggested pathway. In
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this instance, the analyst may issue a DoNotSuggestPathway command. For example, 
DoNotSuggestPathway 1851.9_1592.8_1125.4 would exclude that pathway (and all 
similar pathways within the user's selected mass error tolerance) from being suggested. This 
exclusion list applies to all o f IDA's acquisition modes, but is most useful in preventing the Auto 
mode from becoming stuck in an infinite loop of asking for an unacquirable spectrum.







Output: No pathways Output: Pathways found
Search for pathways that satisfy 
MajorGlyco
Search for pathways that satisfy 
MissingComplements
Search for pathways that satisfy either 
OnlyReducingEndScarred or 
OnlyNonReducingEndScarred
Figure 45: The S u g g e s tP e a k s  A u to  mode algorithm.
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8.2.6. The IsoDetect Mode
Because GlySpy is a single application, it provides for rich communication between its 
component algorithms. In this case, IDA and IsoDetect combine to guide the analyst to  acquire 
spectra for fragments that appear to come from structural isomers.
After collecting spectra via the SuggestPeaks Auto mode, the analyst might perform 
manual analysis w ith OSCAR or automated analysis w ith IsoSolve to  identify structures that are 
likely to be present. Next, these structures and spectra are presented to IsoDetect, which 
returns a list o f ions that appear to derive from structural isomers. SuggestPeaks 
IsoDetect will then apply intensity cut-offs, spectrum pruning, and so on, to generate a final 
list o f isomeric pathways worthy o f further examination. These pathways can then be selected 
for fragmentation via repeated application of the SuggestPeaks Auto command. Figure 46 
illustrates this workflow.
A short example may clarify the procedure. In examining IgG ion m/z 1636.84, first the 
analyst applies SuggestPeaks Auto repeatedly to gather the initial set o f spectra. IsoSolve 
returns NHH'(H’)H'N'n' as a strong candidate structure. The analyst then performs these three 
commands to identify pathways that are incompatible with the candidate:
AddProposedGlycan NHH'(H')H 'N 'n '
IsoDetect NoCrossRing 1636.84 2 nul
SuggestPeaks IsoDetect 2 500 RankByEstTopologies 1636.84
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Done
Run SuggestPeaks Auto repeatedly, 
collecting and adding suggested spectra
Generate candidate structures 
via OSCAR or IsoSolve
Use IsoDetect to identify likely 
isomeric pathways
Perform final analysis on 
full set of spectra
Run SuggestPeaks IsoDetect to filter and 
prune isomeric pathways
Run SuggestPeaks Auto repeatedly on 
each isomeric pathway, collecting and 
adding spectra until no further suggestions
Figure 46: Integrating IsoDetect and SuggestPeaks 
to collect MS" spectra for an isomeric mixture.
The final command returns the single pathway 1636.84_1139.45 as a likely isomeric 
fragment. (The ion m/z 1139.45 is identified to have the composition H3N2-(ene)', which is 
incompatible with the candidate.) This pathway then becomes a parameter to  successive 
invocations of SuggestPeaks Auto:
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; Ask for suggestions anywhere under the 1636.84_1139.45 spectrum 
SuggestPeaks Auto 2 500 RankByEstTopologies 1636.84_1139.45
; Returned 1636.84_1139.45_880.32, so collect and add that spectrum 
AddSpectrumFile IGG_1636_1139_880.raw
; Run SuggestPeaks on 1636.84_1139.45 again
SuggestPeaks Auto 2 500 RankByEstTopologies 1636.84_1139.45
; Returned 1636.84_1139.45_880.32_676.34, so add that spectrum, too 
AddSpectrumFile IGG_1636_1139_880_676.raw
; Run SuggestPeaks on 1636.84_1139.45 again 
SuggestPeaks Auto 2 500 RankByRellnt 1636.84_1139.45
; No peaks suggested, so done adding spectra
Note that all o f the SuggestPeaks commands in this example use 1636.84_1139.45 as the 
pathway parameter. This restricts suggested pathways to those with that prefix, which in this 
case means we are collecting pathways to elucidate a structure that is incompatible w ith the 
candidate NHH'(IT)H'N'n'. SuggestPeaks has harnessed the output of IsoDetect to guide its 
suggestions toward these isomeric structures.
8.3. Validation
The specific spectra collected by IDA for a variety o f glycan samples are detailed in Chapter 
9: AUTOMATED GLYCAN TOPOLOGY ANALYSIS. There we list the spectra collected for each 
sample and discuss why each spectrum was selected. Suggestions for improving IDA are also 
given.
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CHAPTER 9:
AUTOMATED GLYCAN TOPOLOGY ANALYSIS
9.1. Overview
In this chapter we present analytical results for a series o f glycans isolated from a variety of 
biological sources. In each section below, we use Intelligent Data Acquisition to collect a set of 
spectra for a given m/z. These spectra are then analyzed by IsoSolve, and the proposed 
structures are listed. These structures are then compared to  the expected structures at that 
m/z. The list o f expected structures from IgG is taken from Table II o f (Butler 13); expected 
ovalbumin structures are from (Harvey 37); G M la and G M lb  are from (Svennerholm 80). These 
previously-reported structures are collected in Table 4 on page 27. For each example, we 
discuss how well GlySpy performed, indicate difficulties encountered and suggest future 
improvements.
It bears repeating that the vast majority of the analysis in this chapter was performed 
without human intervention. Exceptions to this w ill be noted.
9.2. Results and Discussion
For each in a series of glycans, we applied Intelligent Data Acquisition to collect a series of
spectra, and then submitted these spectra to  IsoSolve for structural analysis. The resulting
topologies are evaluated for correctness, w ith interesting results discussed in detail.
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Table 35 summarizes the main Intelligent Data Acquisition results, and Table 36 does the 
same for IsoSolve. Notice should be taken of the execution times in both tables, as they indicate 
that GlySpy's performance may enable it to  be the centerpiece of a high-throughput glycomics 
analysis platform.
Number of Execution 
Document Spectra Time




G M la : HN(S)HH-(oh) 
G M lb : SHNHH-(oh)
9.2.1.1 8 1.06
1606.83 NH,{H,)H,N,(F)n' 9.2.2.1 11 0.25
1636.84 HNH'JH'JH'N'n' 9.2.3.1 7 0.11
IgG 1677.87 NH'fNH'JH'N'n' 9.2.4.1 12 0.74
1810.93 HNH'(H')H'N'(F)n 9.2.5.1 8 0.25
1851.96 NH'INH'jH'N'IFJn' 9.2.6.1 9 0.54
1187.61 H'(H')H'N'n' 9.2.7.1 9 0.11
1636.84 NH'IHH'jH’N’n' 9.2.8.1 11 0.71
Ovalbumin
1677.871 NH'lNKH'jH’N'n’ 9.2.9.1 17 3.28





Table 35: Summary of IDA results and execution times. 
1 The NoPrune option was specified for this test.
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9.2.1.2 32 2 and 3 1.89
1606.831 NH’fH’JH'N'fFJn' 9.2.2.2 68 27 1 10.91
1606.83 NH’IH'JH'N'IFJn’ 9.2.2.2 60 4 1 1.22
IgG
1636.84 HNH'fH'lH'N'n1 92 .3 .2 23 N/A 0.55
1677.87 NH'tNH’JH'N'n' 9.2.4.2 47 : 1 0.94
1810.93 HNH'(H')H'N'(F)n 9.2.5.2 28 11 . N/A 1.72
1851.96 NH'fNH'JH’N'IFJn’ 9.2.6.2 41 . - 1 1 " 0.46
1187.611 H'(H')H'N'n' 9.2.7.2 49 10 1 1.80
1636.84 NH’fHH'JH’N'n’ 9.2.8.2 67 12 6 4.54
OVA 1677.87 NH'lNXH'jH'N'n’ 9.2.9.2 61 5 2 2.98
1922.99
NfNjH'fNXH’JH'N'n’
N H 'tN H 'H N lH W
9.2.10.2 74 5 1 and 5 6.46
Table 36: Summary of IsoSolve results and execution times.
BBG = Bovine Brain Gangliosides, OVA = Ovalbumin.
1 Test of AMinked structures executed without the -NLinkedBranching switch.
9.2.1. GM1a/GM1b m/z 1273.65
9.2.1.1 IDA
Listing 20 shows a typical input script used to collect spectra via GlySpy's Intelligent Data 
Acquisition module. The listing begins by giving the -ReducingEndResidue unreduced 
option, which specifies that only unreduced residues are to be considered as the reducing-end 
sugar. Next, -UnmethylatedReducingEnd specifies that the reducing end carbon o f this 
structure is not methylated. In this case, it is a hydroxyl group, a scar left behind by the cleavage 
of this glycan from the ganglioside. See Figure 11.
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Next, AddSpectrumFile GMlab_1877_1273. raw is given, adding the spectrum 
generated from the fragmentation o f the m/z 1273.65 ion. This spectrum will be the starting 
point for future spectrum suggestions. The script then issues a SuggestPeaks Auto 2 100 
RankByRelint 1273.65 command, which returns the output shown in Listing 21. The 
parameters 2 and 100 specify cut-offs fo r relative and absolute intensity, respectively, and 
RankByRellnt sorts the suggested peaks by relative intensity. IDA suggests that the analyst 
acquire a spectrum for m/z  1273.40_898.21 and, as an aid fo r the analyst, lists the compositions 
o f these ions as well. At this point the analyst acquires the spectrum and saves it to  the file 
GMlab_1877_1273_898.raw, to be added by the next AddSpectrumFile command.
This cycle—SuggestPeaks Auto, collect spectrum, AddSpectrumFile-is repeated until 
SuggestPeaks returns no suggested peaks. A summary o f all m/z 1273 spectra collected using 
this method is given in Table 37 and the spectra themselves are presented as Spectrum A-10 
through Spectrum A-17. The spectra are listed in the order in which they were suggested.
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-ReducingEndResidue unreduced 
-UnmethylatedReducingEnd
; Add the MS2 spectrum to start 
AddSpectrumFile GMlab_1877_1273.raw
; Run "SuggestPeaks Auto" to select next spectra to 
SuggestPeaks Auto 2 100 RankByRellnt 1273.65
collect.
; Add the suggested spectra and repeat SuggestPeaks 
; until no further suggestions 
AddSpectrumFile GMlab_1877_1273_898.raw 
SuggestPeaks Auto 2 100 RankByRellnt 1273.65
AddSpectrumFile GMlab_1877_1273_898_486.raw 
SuggestPeaks Auto 2 100 RankByRellnt 1273.65
AddSpectrumFile GMlab_1877_1273_847.raw 
AddSpectrumFile GMlab_1877_1273_898_435.raw 
SuggestPeaks Auto 2 100 RankByRellnt 1273.65
AddSpectrumFile GMlab_1877_1273_847_472.raw 
SuggestPeaks Auto 2 100 RankByRellnt 1273.65
; SuggestPeaks wants 1273.40_449.14, but since this is a 
; legacy data set and that spectrum was not collected,
; we substitute a close match instead: 1273.5_898.3_449.2 
DoNotSuggestPathway 1273.40_449.14 
AddSpectrumFile GMlab_1877_1273_898_449.raw 
SuggestPeaks Auto 2 100 RankByRellnt 1273.65
AddSpectrumFile GMlab_1877_1273_898_472.raw 
SuggestPeaks Auto 2 100 RankByRellnt 1273.65
; No further peaks suggested
Listing 20: The input script used to collect the spectra of Table 37.
IDA's SuggestPeaks command is used to repeatedly request new spectra collect. 
The process concludes when SuggestPeaks Auto returns no spectra.
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* * * * * * *  Begin SuggestPeaks Results (1 Peak Found) * * * * * * *
Peak 1 of 1:
iASP: 0 Rellnten: 100.0000 Abslnten: 3.44E+04 
Spectrum: 0
Pathway: 1273.40_898.21[100.0000%]





Ion 0 has 1 possible composition: 
MSn: 1273.62 H3NS- (oh) '
Ion 1 has 1 possible conposition: 
MSn: 898.43 H3N-(oh)2'
******* End SuggestPeaks Results *******
Listing 21: Sample output for the first SuggestPeaks command in Listing 20.
Table 37: Spectra suggested by IDA for G M la /G M lb  m /z  1273.65.
P1 1274.40 N/A 1273.62 H3NS-(oh)‘ Initial
2 1273.40_898.21 100.0 898.43 H3N-(oh)2’ M ajor(l)
3 1273.40_898.30_486.07 100.0 486.23 HN-(ene)' Major(2)
4 1273.40_847.20 29.5 847.41 HNS-(ene)' REScar(l)
5 1273.50_898.30_435.12 23.0 435.18 H2-(oh)3‘ Complement(3)
6 1273.40_847.30_472.05 100.0 472.22 HN-(ene)(oh)’ Major(4)
7 1273.5_898.3_449.2 2.9 449.20 H2*(oh)2' Complement(4)
8 1273.50_898.30_472.05 23.2 472.22 HN-(ene)(oh)' Complement(7)
IDA had requested 1273.40_449.14 for spectrum number 7 o f Table 37, serving as a 
complement to spectrum 4. However, this is a legacy data set and the samples were unavailable 
to collect this spectrum. However, a close match was available, and so 1273.5_898.3_449.2 was
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used instead. A DoNotSuggestPathway 1273.40_449.14 command was then given to 
prevent IDA from continuously requesting this unacquirable spectrum.
The "Reason Added" column of Table 37 explains why IDA selected the spectrum for 
inclusion. The selection criteria are detailed in Table 38.
Table 38: Shorthand for IDA's spectrum selection criteria.
Initial The initial fragmentation spectrum of the target structure.
Major(n) The highest-intensity glycosidic peak on spectrum n.
Complement(n) The complement of spectrum n's terminal ion.
REScar(n) A fragment from spectrum n that has only reducing-end scars.
NREScar(n) A fragment from spectrum n that only has non-reducing-end scars.
From this we see that IDA successfully identified several complementary ions (entries 5, 7, 
and 8 in Table 37, complementary to entries 3, 4, and 7, respectively). For example, entries 3 
(1273.40_898.30_486.07) and 5 (1273.50_898.30_435.12) are complementary because the 
terminal ions (486.07 and 435.12) sum to their shared precursor (898.30), after the sodium 
adducts (22.99 Da on each ion) are accounted for. Complementary ions can be extremely 
valuable when making structural assignments, but are difficult or impossible to collect using 
other automated data acquisition tools.
Even experienced analysts may miss low intensity complementary peaks. The requested 
peak 1273.40_449.14 has a relative intensity of only 2.9%, so low that it is not even labeled 
on Spectrum A-10—and, more to the point, so low that the analyst who collected this legacy 
data set did not fragment it, despite collecting literally dozens o f spectra. Clearly, automated 
identification o f complementary fragment ions is a valuable capability.
164
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
We also see that entry 4 was selected because it contained only a reducing-end scar. As 
such, IDA could surmise that this fragment represented a terminal branch, which is another 
desirable ion for structural assignment. This pathway was extended by entry 6, chosen because 
it was the major glycosidic peak on entry 4's spectrum.
9.2.1.2 IsoSolve
IsoSolve was executed using the input shown in Listing 22. First, the appropriate options are 
set: -ReducingEndResidue unreduced and -UnmethylatedReducingEnd. Next, the
spectrum files collected by IDA in the previous section are each added via AddSpectrumFile. 
(The DoNotSuggestPathway command is included for symmetry with the IDA process, but 
does not affect the results of this test.) Lastly, IsoSolve NoCrossRing 1273.65 2 is 
executed. Here, the parameter 2 means to consider all pathways at or above a 2% relative 















IsoSolve NoCrossRing 1273.65 2
Listing 22: Input to execute IsoSolve on the spectra collected by IDA.
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Table 39: IsoSolve results for the spectra shown in Table 37.
1 83.33 HNH(S)H-(oh) 20/24 62.50% (20/32)
2* 75.00 HN(S)HH-(oh) 15/20 65.63% (21/32)
3* 73.08 SHNHH-(oh) 19/26 100.00% (32/32)
4 71.43 SNH(H)H-(oh) 20/28 100.00% (32/32)
5 69.23 SHN(H)H-(oh) 18/26 100.00% (32/32)
6 60.71 S(N)HHH-(oh) 17/28 100.00% (32/32)
7 59.09 NHH(S)H-(oh) 13/22 100.00% (32/32)
8 46.15 S(H)NHH-(oh) 12/26 100.00% (32/32)
9 45.45 HNSHH-(oh) 5/11 100.00% (32/32)
10 45.45 NHS(H)H-(oh) 5/11 100.00% (32/32)
11 45.45 NHSHH-(oh) 5/11 100.00% (32/32)
The score associated with each structure represents the percentage of possibly compatible 
pathways that were actually compatible. (If a structure were compatible w ith 10 spectra 
containing a total o f 100 pathways, but the structure was only compatible with 50 of these 
pathways, its score would be 50/100, or 50%.) This fraction is explicitly given in the Compatible 
Pathways column.
The Cumulative column indicates the percentage of all pathways compatible w ith this 
structure or any previous structure. In this case there are 32 total pathways, and the first 
structure is compatible with 20. Combined, structures 1 and 2 are compatible with 21 of the 32 
pathways. Structures 1, 2, and 3 combined are compatible with all 32 pathways. This column 
shows how many o f the proposed structures are required to  cover any fraction o f the available 
pathways. It could be used in the future as a cut-off for structure reporting, e.g., limiting
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IsoSolve's output to  the highest-scoring structures that collectively cover a user-selected 
percentage of the pathways.
9.2.1.3 Discussion
Structures 2 and 3, asterisked, represent the expected structures GM la and G M lb, 
respectively. As such, IsoSolve combined with this simple scoring system were sufficient to 
place the correct structures in two o f the top three output slots.
The scoring system could be improved by looking for fragments arising from expected facile 
cleavages. For example, structure 4, SNH(H)H-(oh), would be expected to cleave at the N, 
yielding SN-(ene) and H3-(oh)2 fragments, leading to the observed fragments m/z 643.31 and 
m/z, 653.29 respectively. Since neither of these fragments is present in Spectrum A-10, 
structure 4 should be suitably penalized. Further, this improved scoring system could be 
implemented for every spectrum gathered. That is, if a spectrum was consistent w ith a given 
structure, then it should be examined for expected fragments, and the more that are missing, 
the higher the penalty.
Interestingly, this extended scoring strategy would not penalize structure 1, HNH(S)H-(oh). 
From the facile HexNAc cleavage, we would expect to  find fragments HN-(ene) and H2S-(oh)2 as 
ions m/z 486.23 and m/z 810.37, respectively. However, we do find those fragments, both from 
structure 2! Here, only the location of the S has changed, but this is not revealed by the single 
HexNAc cleavage. Fragmenting the H2S-(oh)2 ion would also fail to distinguish between 
structures 1 and 2, as they would yield the same expected fragments: H2-(oh)2, S-(ene), and H- 
(oh)2. This analysis is greatly complicated by the fact that the reducing-end H is not reduced, 
and comes w ith a reducing-end scar. If the reducing-end scar were not present, fo r example,
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the fragment HS-(oh) would be diagnostic o f structure 1, while H2-(oh) would be diagnostic of 
structure 2.
However, despite these limitations, IsoSolve identified the GMla and G M lb  isomers as two 
o f the top three suggested structures. Eliminating structure 1 from contention using mass 
spectrometric techniques only would be beyond the capability of many human analysts.
9.2.2. IgG m/z 1606.83
9.2.2.1 IDA
Intelligent Data Acquisition was performed on IgG ion m/z 1606.83. This and all subsequent 
IDA examples followed the same data acquisition process as described in Section 9.2.1.1: Run 
SuggestPeaks Auto, manually collect the spectrum, add via AddSpectrumFile, and repeat 
until SuggestPeaks runs dry.
Examining Table 40, we see that the initial spectrum spawned a deep MSn probe into the 
structure, yielding entries 2-5 as MajorGlyco fragments. Interestingly, entries 8 and 9 were both 
selected as reducing-end-scar (REScar) fragments from m/z 1139.5. Typically, the only the 
highest intensity REScar fragment is reported, but in this case, there were two spectrum scans 
available. On one scan m/z 486.17 was slightly more abundant than m/z  912.35, but on the 
other scan, the relative intensities were reversed. As seen in Table 40, these fragments' 
intensities are extremely similar.
The initial ion m/z 1606.83 represents a glycan with seven residues. From this a tota l o f 11 
spectra were collected, a reasonable number for a structure of this size. A single spectrum 
typically requires 15 to 30 seconds of acquisition time, so the entire spectrum set represents 
approximately three to five minutes of instrument usage. However, because the analyst must
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manually transcribe suggested m/z pathways to acquire spectra, the actual data acquisition time 
was much longer.
Table 40: Spectra suggested by IDA fo r IgG m/z  1606.83.
p1 1606.83 N/A 1606.83 H2FN3h
1606.83 H3FN2n
Initial
2 1606.83_1139.46 100.0 1139.56 H3N2-(ene)' M ajor(l)
3 1606.83_1139.55_880.34 100.0 880.42 H3N-(ene)(oh)' Major(2)
4 1606.83_1139.55_880.50_
676.26
100.0 676.32 H2N-(ene)(oh)’ Major(3)
5 1606.83_1139.55_880.50_676.36_
431.12
100.0 431.19 H2-(ene)(oh)' Major(4)
6 1606.83_1347.54 38.5 1347.69 H2FN2h-(oh)
1347.69 H3FNn-(oh)
REScar(l)
7 1606.83_490.20 3.7 490.23 HN-(oh)2' 
490.26 Fn-(oh)
Complement(2)
8 1606,83_1139.55_486.17 2.6 486.23 HN-(ene)1 REScar(2)
9 1606.83_1139.55_912.35 2.6 912.44 HjN-(oh)' REScar(2)
10 1606.83_1139.46_912.35_
653.27
100.0 653.30 H3-(oh)2' Major(9)





For the collected spectra in Table 40, we executed two separate IsoSolve tests. The results 
summarized in Table 41 were generated w ithout using the -NLinkedBranching switch, and 
hence produced structures that do not contain the H3Nn core. By contrast, the results of Table
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42 were generated with the use o f the -NLinkedBranching switch. (Analyses o f all A/-linked
structures in this document use the switch unless otherwise stated.)
Table 41: IsoSolve results for the spectra shown in Table 40. 
The -NLinkedBranching switch was not used for this analysis.
■
1* 80.88 NH(H)HN(F)n 5 5 /6 8 80.88% (55/68)
2 78.69 NN(H)HH(F)n 4 8 /6 1 86.76% (59/68)
3 69.49 HN(NH)FI(F)n 4 1 / 59 89.71% (61/68)
4 67.80 NH(N)(H)H(F)n 4 0 /5 9 92.65% (63/68)
5 64.00 HN(H)HN(F)n 1 6 /2 5 92.65% (63/68)
6 64.00 HNHHN(F)n 1 6 /2 5 92.65% (63/68)
7 63.49 NHN(H)HFn 4 0 / 63 94.12% (64/68)
8 58.82 NNH(H)HFn 3 0 /5 1 94.12% (64/68)
9 57.35 NHHHN(F)n 3 9 /6 8 95.59% (65/68)
10 56.76 NHNH(NF)h 2 1 /3 7 97.06% (66/68)
11 52.63 N(H)NHHFn 3 0 /5 7 98.53% (67/68)
12 51.35 N(N)H(F)(H)Hn 1 9 /3 7 98.53% (67/68)
13 51.35 NHNN(F)(H)h 1 9 /3 7 98.53% (67/68)
14 51.35 NHN(NF)(H)h 1 9 /3 7 98.53% (67/68)
15 51.35 NHNF(N)(H)h 1 9 /3 7 98.53% (67/68)
16 48.65 NHNN(F)Hh 1 8 /3 7 98.53% (67/68)
17 48.65 NHN(NFH)h 1 8 /3 7 98.53% (67/68)
18 48.65 NHNFH(N)h 1 8 /3 7 98.53% (67/68)
19 47.54 NNHHHFn 2 9 /6 1 98.53% (67/68)
20 47.06 HHH(N)N(F)n 2 4 /5 1 100.00% (68/68)
21 46.03 NHNHHFn 2 9 /6 3 100.00% (68/68)
22 45.95 NHNNH(F)h 1 7 /3 7 100.00% (68/68)
23 43.24 N(N)HN(F)(H)h 1 6 /3 7 100.00% (68/68)
24 43.24 NHNH{FN)h 1 6 /3 7 100.00% (68/68)
25 42.11 N(N)HHHFn 2 4 / 57 100.00% (68/68)
26 40.54 NNHNH(F)h 1 5 /3 7 100.00% (68/68)
27 32.43 N(H)N(N)(F)Hh 1 2 /3 7 100.00% (68/68)
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Table 42: IsoSolve results for the spectra shown in Table 40. 
The -NLinkedBranching switch was used for this analysis.
p1* 91.67 NH’fH'jH'N’fFJn’ 55/60 91 67% (55/60)
2 63.64 NH’fH'jH'fFjN'n' 14/22 98.33% (59/60)
3 56.52 NfFjH’IH’JH'N'n’ 13/23 98.33% (59/60)
4 47.83 H,(H,)H’(N)N,(F)n‘ 22/46 100.00% (60/60)
9.2.2.3 Discussion
A comparison o f these results is instructive. Notably, the expected structure was ranked 
number one in both instances. However, in the first case, IsoSolve returned 27 structures from 
68 total pathways; in the second, only four structures from 60 total pathways. Not only does 
the -NLinkedBranching switch lead to a marked reduction in the number of structures 
produced, it also reduces the total number of pathways considered. In this case, eight pathways 
were excluded by the switch, indicating the likely presence of structures that do not contain the 
expected core residues; these non-canonical structures are likely the cause for at least some of 
the additional entries in Table 41. We will discuss these unexpected structures in more detail 
later.
We can imagine applying the additional scoring heuristics to the entries of Table 42. For 
example, entries 2 and 3 would be expected to have a facile cleavage at the penultimate N, 
losing only the reducing-end n and yielding a fragment with composition H3FN2-(ene), m/z 
1313.64. However, no such peak is apparent in Spectrum A-18 (page 217), effectively ruling out 
these structures.
Entries 1 and 4, by contrast, would lose both the terminal n and the attached F w ith this
cleavage, leaving an expected fragment of H3N2-(ene), m/z 1139.56. This is the base peak of
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the spectrum, giving greater weight to these structures. However, structure l 's  score is so much 
higher than 4's that it would rightly be considered the best solution.
9.2.3. IgG m/z 1636.84
9.2.3.1 IDA
Table 43 summarized the spectra collected for IgG ion m/z 1636.84. We again see a 
MajorGlyco pathway extended (entries 1 through 5). Entry 6 collects a fragment w ith only a 
reducing-end scar, and entry 7 extends that spectrum w ith a single MajorGlyco spectrum. These 
spectra are presented as Spectrum A-19 through Spectrum A-25 beginning on page 218.
Table 43: Spectra suggested by IDA fo r IgG m /z  1636.84.
p1 1636.84 N/A 1636.84 H3N3h
1636.84 H4N2n
Initial
2 1636.84_1173.49 100.0 1173.60 H2N2h-(oh)
1173.60 H3Nn-(oh)
M ajor(l)













6 1636.84_1343.50 14.3 1343.66 H4N2-(ene)' REScar(l)
7 1636.84_1343.50_880.40 100.0 880.42 H3N-(ene)(oh)' Major(6)
9.2.3.2 IsoSolve
Using the spectra from Table 43, IsoSolve returns 2 structures from 23 total pathways (Table
44).
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Table 44: IsoSolve results for the spectra shown in Table 43.
1 95.65 NHH'fH'jH'N’n1 22/23 95.65% (22/23)
2 40.00 NH'IH’jH'N’tHjn' 6/15 100.00% (23/23)
9.2.3.3 Discussion
In this instance, IsoSolve failed to produce the expected structure, HNH'(IT)ITN'n'. This 
surprising result stems from an equally surprising fact: The major glycosidic disassembly 
pathway, m/z 1636.84 1173.65 914.45 -» 710.36 506.20 (Table 43, entries 1 through 5),
is not consistent w ith any glycan containing the /V-linked core! A look at the possible 
compositions o f these ions reveals why. First, we must disregard compositions containing h, a 
reduced hexose, if we expect to  find an A/-linked core. Now we see that the composition 
sequence, including the major peak o f m/z 316.2 from the final spectrum, must be as shown in 
Table 45.
Table 45: Putative composition pathway for the non-AMinked structure 
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As one example, the H3n-(oh)2 composition for m/z  914.46 cannot possible come from an N- 
linked glycan because there is no intervening N between the H3 and the reducing-end n. The 
incompatibility of this pathway w ith the expected /V-linked core is confirmed by OSCAR. 
Executing the input script shown in Listing 23 produces no candidate structures.
-NLinkedBranching
AddPathway NoCrossRing 1636.84_1173.65_914.45_710.36_506.20_316.2 
Summarize
Listing 23: Input that yields no candidate /V-linked structures.
Interpreting this pathway as containing a reduced hexose (h) fails to yield a composition 
assignment at every ion: m/z 1636.84 = H3N3h, m/z 1173.60 = H2N2h-(oh), m/z 914.46 = H2Nh- 
(oh)2, and m/z 710.36 = HNh-(oh)2, but m/z 506.26 and m/z 316.17 have no possible glycosidic 
compositions.
Clearly, something unexpected has been found here. This provides an opportunity to show 
how an analyst might use GlySpy to  manually assign a novel structure.
Executing the input of Listing 24 produced a list o f only five possible structures (Table 46).
-ReducingEndResidue n
AddPathway NoCrossRing 1636.84_1173.65_914.45_710.36_506.20_316.2 
Summarize
Listing 24: Input that reveals only five possible structures for 
the pathway 1636.84_1173.65_914.45_710.36_506.20_316.2.
None of these structures contain the expected /V-linked core.
174
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.






At this point the analyst decides to collect more data for analysis. By manually adding 
several interesting spectra, the SuggestPeaks Auto command is then repeated until, in this 
case, eleven additional spectra have been acquired. This enhanced data set is then subjected to 
IsoSolve analysis both w ith (Table 47) and without (Table 48) the -NLinkedBranching option.
Table 47: IsoSolve results for the additional m /z  1636 spectra. 
The -NLinkedBranching switch was specified for this analysis.
j
B
i 93.55 NHH'fH’jH'N'n' 29/31 80.56% (29/36)
2 87.10 HNH'fH'JH'N'n' 27/31 83.33% (30/36)
3 54.55 NH'fH'jH'N'fHJn' 12/22 100.00% (36/36)
Table 47 shows two high-scoring A/-linked candidates. Entries 1 and 3 are repeated from 
entries 1 and 2 of Table 44, but we notice a new entry, HNH'fH'jH'N'n', which matches the 
expected structure.
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Table 48 shows the structures produced by IsoSolve w ithout the -NLinkedBranching flag. 
The two highest-scoring topologies, HNH(NH)Hn and NHH(HN)Hn, are repeated from Table 46, 
lending them further credence. The 15 highest-scoring structures in Table 48 all share the same 
very unusual reducing-end m otif of Hn. GlySpy has produced, with very little direction from the 
analyst, a short list o f structures worthy o f further investigation.
It should be noted that none o f these structures would have been considered if GlySpy had 
implemented (presumed) biosynthetic constraints. This is both the strength and weakness o f de 
novo analysis: structures are not incorrectly ruled out, but the generated list is necessarily 
longer.
Further complicating the analysis is the interaction of the structures w ith and w ithout the 
expected A/-linked core. For example, the expected A/-glycan HNH'fH'JH'N'n' would be expected 
to  have a facile loss of the terminal HN and reducing-end n, yielding a composition o f H3N- 
(oh)(ene)', m/z 880.4. This ion is in fact present in Spectrum A-19, lending support to this 
structure. The highest-ranking /V-glycan from Table 47, NHH'tH'JH’N'n’, would be expected to 
lose a terminal N and reducing-end n, giving a composition o f H4N-(ene)(oh)', m/z 1084.5. 
However, this ion is absent from Spectrum A-19, perhaps signifying that this structure is an 
artifact caused by combining pathways taken from two or more structural isomers.
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Table 48: IsoSolve results for the additional m /z  1636 spectra. 
The -NLinkedBranching switch was not specified for this analysis.
1 87.88 HNH(NH)Hn 58/66 81.69% (58/71)
2 87.10 NHH(HN)Hn 54/62 83.10% (59/71)
3 81.97 HN(NH)HHn 50/61 90.14% (64/71)
4 80.65 HNH(N)(H)Hn 50/62 90.14% (64/71)
5 79.03 NHH(N)(H)Hn 49/62 91.55% (65/71)
6 77.78 NHH(NH)Hn 49/63 91.55% (65/71)
7 77.61 HNH(N)HHn 52/67 91.55% (65/71)
8 75.56 NHN(H)HHn 34/45 98.59% (70/71)
9 69.05 HNN(H)HHn 29/42 98.59% (70/71)
10 68.75 NHH(N)HHn 44/64 98.59% (70/71)
11 68.75 NNH(H)HHn 22/32 100.00% (71/71)
12 66.67 NH(H)HNHn 30/45 100.00% (71/71)
13 62.79 HNH(H)HNn 27/43 100.00% (71/71)
14 56.25 N(N)H(H)HHn 18/32 100.00% (71/71)
15 51.11 NHHHNHn 23/45 100.00% (71/71)
16 47.37 HN(N)HH(H)n 18/38 100.00% (71/71)
17 39.39 NHHNH(H)n 13/33 100.00% (71/71)
The analysis can be taken further, but several important points have been made. To wit:
1) IDA can be assisted by a human by providing "seed" pathways to be automatically 
extended.
2) Complicated isomeric mixtures are more common in biologically-derived samples than is 
generally appreciated and can greatly complicate structural analysis. In these cases,
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chromatographic separation might be considered to reduce the complexity o f the 
mixture.
3) Even under these adverse circumstances, GlySpy is able to  quickly point the analyst 
toward novel structures, including those that would have been excluded by the 
application o f biosynthetic constraints.
9.2.4. IgG m/z 1677.87
9.2.4.1 IDA
The spectra collected for IgG m/z 1677.87 are shown in Table 49. Again we see the typical 
MajorGlyco pathway extended in steps 1-6, with additional non-reducing-end scar fragments 
selected in steps 7, 9, and 11. Each o f these in turn generates a single MajorGlyco spectrum 
(entries 8,10 and 12, respectively) before pruning halts the data collection. A total o f 12 spectra 
are collected for a structure containing seven residues.
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Table 49: Spectra suggested by IDA for IgG m /z  1677.87.
R elative Putative T erm inal Ion Reason  
# Spectrum  Added In tensity Com positions Added




2 ' 1677.87_1384.53 C  ’ 100.0 1384.68 H3N3-(ene)' M ajor(l)
3 1677.87_1384.64_1125.43 100.0 1125.54 H3N2-(ene)(oh)' Major(2)
4 1677.87_1384.64_1125.54_866.33 100.0 866.40 H3N-(ene)(oh)2' Major(3)
5 1677.87_1384.64_1125.54_866.40_ 
662.22 ' :
100.0 662.30 H2N-(ene)(oh)2' Major(4)
6 1677.87_1384.64_1125.54_866.40_
662.36_458.13
100.0 458.20 HN-(ene)(oh)2' Major(5)
7 1677.87_1418.57 96.3 1418.73 H2N3h-(oh)
1418.73 H3N2n-(oh)
NREScar(l)
8 1677.87_1418.60_1125.38 100.0 1125.54 H3N2-(ene)(oh)' Major(7)
9 1677.87_1418.60_1159.44 54.7 1159.58 H2N2h-(oh)2
1159.58 H3Nn-(oh)2
NREScar(7)
10 1677.87_1418.60_1159.50_866.31 100,0 866.40 H3N-(ene)(oh)2' Major(9)







M a jo r( ll)
9.2.4.2 IsoSolve
Given those spectra, IsoSolve returns tw o  structures fro m  47 to ta l pathways. See Table 50. 
The expected structure, asterisked, is ranked as th e  higher-scoring o f th e  tw o .
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Table 50: IsoSolve results for the spectra shown in Table 49.
1* 97.87 NH'fNH'JH'N’n’ 46/47 97.87% (4 6 / 47)
2 91.30 NH’fN K H 'jH W 100.00% (47/47)
9.2.4.3 Discussion
As Table 50 shows, the expected structure is compatible w ith 46 o f 47 total pathways. The 
single available pathway with which it is not compatible is m /z  1677.87 1384.64 -> 1125.54
866.40 -> 662.36 444.11. The terminal m/z  444.11 ion has composition HN-(ene)(oh)3'
and is invariably found in structures which contain a bisecting HexNAc. (In structures w ithout a 
bisecting HexNAc, the central core would yield ion m/z 458.20 with composition HN-(ene)(oh)2'.)
Structure 2 is exactly the structure that would be expected if a bisecting HexNAc were 
present. A very strong case can be made that IsoSolve, with no human guidance whatsoever, 
has successfully identified a structural isomer not reported in (Butler 13). This feat is 
considerably more impressive when one considers Spectrum A-26. Here, m/z 444.1 has a 
relative intensity of only 2%, so small as to be unlabeled in the spectrum. Clearly the bisecting 
HexNAc isomer is of much lower abundance than the reported structure. The spectrum for the 
pathway 1677.87 -» 1384.64 1125.54 -» 866.40 -» 662.36 444.11 was collected
(Spectrum A-27) to  prove the presumed bisecting profile. Although the spectrum has a very low 
normalization level (3.80E-2) and only one ion was measured (m/z 268.1), that ion was 
consistent w ith composition N-(ene)(oh)', which in turn is consistent with, but not diagnostic of, 
a bisecting HexNAc.
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9.2.5. IgG m/z 1810.93
9.2.5.1 IDA
The spectra collected for IgG m/z 1810.93 are shown in Table 51. This sample yields a deep 
MS" pathway, 1810.93_1551.79_1125.58_866.44_662.34_458.14, as shown in the first 6 entries 
o f the table. Entry 7, 1810.93_1384.52, is selected because its composition has a scar on its 
reducing end only, and entry 8 follows as the MajorGlyco pathway from 7.
Table 51: Spectra suggested by IDA for IgG m /z  1810.93.

































7 1810.93_1384.52 71.6 1384.68 H3N3-(ene)' REScar(l)
8 1810.93_1384.60_1125.40 100.0 1125.54 H3N2-(ene)(oh)’ Major(7)
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9.2.5.2 IsoSolve
Given these spectra and the -NLinkedBranching switch, IsoSolve returns 11 structures 
from 28 total pathways. See Table 52.
Table 52: IsoSolve results for the spectra shown in Table 51.
1 7407 NH’(H,)H’(H)N,(F)n’ 20/27 71.43% (20/28)
2 74.07 NH’fHH’JH’N'fFjn’ 20/27 75.00% (21/28)
3 67.86 NHH^H'JH’N’fF h ’ 19/28 78.57% (22/28)
4 64.29 N H H '^H 'tFJN 'n ’ 18/28 89.29% (25/28)
5 62.96 NH'(HI)H'(FH)N,n1 17/27 89.29% (25/28)
6 59.26 N(F)H'(HH')H,N,n' 16/27 96.43% (27/28)
7 59.26 NH'JH'JH'N’tFjfHjn' 16/27 100.00% (28/28)
8 59.26 NH'fH’JH'N’fFHJn' 16/27 100.00% (28/28)
9 55.56 NH'fHH'jH'fFJN'n' 15/27 100.00% (28/28)
10 44.44 12/27 100.00% (28/28)
11 40.74 H'fH'JH'N'fNHFK 11/27 100.00% (28/28)
9.2.5.3 Discussion
The expected structure—HNH'(H')H'N'(F)n—was not generated. After some investigation, it 
is discovered that the major pathway 1810.93_1551.79_1125.58_866.44_662.34_458.14_268.1 
(which includes ion m/z  268.1 from spectrum entry 6 on Table 51) is not compatible w ith the N- 
linked core m otif of H(H)HNn (see Figure 5 on page 10). This pathway, when provided as input 
to OSCAR, produces zero structures if the -NLinkedBranching switch is given.
Next we use the LabelPathway command to investigate possible compositions o f the 
pathway's ions. Given the input of Listing 25 and the corresponding output in Listing 26, we see
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that the only valid composition for the initial ion m/z 1810.93 is that it contains a reducing-end 




Listing 25: OSCAR input to investigate the curious pathway 
1810.93_1551.79_1125.58_866.44_662.34_458.14_268.1. 
The pathway came from an /V-linked glycan, but is 
not consistent w ith a reducing-end n residue.
1810.93 H3FN3h 






Listing 26: Composition mapping for the ions from Listing 25. 
The initial ion of this pathway must contain a reduced hexose (h) 
instead of the expected reduced HexNAc (n).
Executing IsoSolve again on the input spectra, but this time specifying 
-ReducingEndResidue h but not -NLinkedBranching to  better reflect what we know 
about this sample, we find 16 structures generated from 54 input pathways. At the top o f the 
ranked list is the structure NH(NH)HN(F)h, w ith a score o f 90.74%. This unusual structure is 
shown in Figure 47.
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Figure 47: An /V-linked glycan that does not contain the usual /V-linked core motif H(H)HNn.
Instead, this glycan from IgG m /z  1810.9 has a reducing-end reduced hexose (h).
This striking glycan does not contain the expected /V-linked core m otif and has apparently 
not been reported previously. Coincidentally, this same structure was recently identified in IgG 
m/z 1810 by committee member Dr. David Ashline, and is featured in a manuscript that is 
currently in preparation (Ashline 9). We should stress that this unreported and highly unusual 
glycan was identified by GlySpy w ith almost no direction from the analyst. In fact, the only 
decision made by the analyst was to change the options given to IsoSolve. The data collection 
and analysis was otherwise fully automated.
This stands as a strong example of why de novo analysis is central to GlySpy's philosophy. 
This structure would not have been discovered if GlySpy relied on databases o f previously- 
reported glycans or on presumed biosynthetic constraints.
Recall also that the MSn pathway that first hinted at this structure 
(1810.93_1551.79_1125.58_866.44_662.34_458.14_268.1) was the major glycosidic pathway, 
the series of most abundant ions on each successive spectrum. The glycan is not a low- 
abundance isomer hiding near the spectrum baselines. If anything, it may be the most abundant 
glycan at m/z 1810, and yet it has escaped detection by other methods.
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9.2.6. IgG m/z 1851.96
9.2.6.1 IDA
Table 53 lists the spectra collected by IDA for IgG m/z 1851.96. As with previous structures, 
we see the MajorGlyco backbone formed in steps 1-6, followed by spectra selected because of 
the precursor scar pattern (step 7) or complementary nature (9). Step 8 is the MajorGlyco 
extension o f step 7.
Table 53: Spectra suggested by IDA for IgG m /z  1851.96.
I




2 1851.96_1384.54 100.0 1384.68 H3N3-(ene)’ M ajor(l)





100.0 866.40 H3N-(ene)(oh)2' Major(3)
5 1851.96_1384.68_1125.55_
866.40_662.23
100.0 662.30 H2N-(ene)(oh)2' Major(4)
6 1851.96_1384.68_1125.55_  
866.40_662.30_458.13
100.0 458.20 HN-(ene)(oh)2’ Major(5)
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9.2.6.2 IsoSolve
Given the spectra from Table 53, IsoSolve returns exactly one structure, the expected one, 
from 41 pathways. See Table 54.
Table 54: IsoSolve results for the spectra shown in Table 53.
I 1* | 100.0 | NH'tNH'JH'N’fF K | 41/41 | 100.00% (41/41) |
9.2.6.3 Discussion
This result is surprising for its simplicity. As we have seen, many biologically-derived N- 
glycan samples appear to  contain structural isomers, which have unexpected topologies. In this 
case, however, all 41 pathways are compatible with the single proposed topology.
9.2.7. Ovalbumin m/z 1187.61
9.2.7.1 IDA
The spectra collected by IDA for ovalbumin m/z 1187.6 are shown in Table 55 and 
reproduced as Spectrum A-37 through Spectrum A-45 beginning on page 228. Entry 6 (m/z 
928.3) is notable and w ill be discussed below.
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Table 55: Spectra suggested by IDA for Ovalbumin m /z  1187.61.
B
i 1187.61 N/A 1187.61 H2N2h
1187.61 H3Nn
Initial
2 1187.61_894.32 100.0 894.43 H3N-(ene)p M ajor(l)
3 1187.61_894.45_676.23 100.0 676.32 H2N-(ene}(oh)' Major(2)
4 1187.61_894.45_676.36_431.10 100.0 431.19 H2-(ene)(oh)’ Major(3)
5 1187.61_894.45_667.24 21.0 667.32 H3-(oh)' REScar(2)
6 1187.61_928.34 2.2 928.47 H2Nh-(oh)
928.47 H3n-(oh)
NREScar(2)
7 1187.61_928.34_724.28 100.0 724.37 HNh-(oh)
724.37 H2n-(oh)
Major(6)
8 1187.61_894.45_667.24_449.12 100.0 449.20 H2-(oh)2' Major(5)




Given the spectra of Table 55, IsoSolve returns 10 structures from 49 total pathways. (See 
Table 56.) IsoSolve in this instance was executed without the -NLinkedBranching switch, and so 
its output is not limited to the usual /V-linked core structure. The reducing-end residues were 
allowed to be either h or n.
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Table 56: IsoSolve results for the spectra shown in Table 55.
f l
i * 89.29 H(H)HNn 25/28 51.02% (25/49)
2 59.46 NH(H)Hn 22/37 83.67% (41/49)
3 57.14 HHHNn 16/28 87.76% (43/49)
4 43.48 NH(N)Hh 10/23 97.96% (48/49)
5 41.67 NH(N)(H)h 10/24 97.96% (48/49)
6 41.67 NH(H)Nh 10/ 24 97.96% (48/49)
7 41.38 N(H)(H)Hn 12/29 97.96% (48/49)
8 33.33 NH(HH)n 8 /24 100.00% (49/49)
9 30.43 NHH(N)h 7 / 23 100.00% (49/49)
10 30.43 NHHNh 7/23 100.00% (49/49)
9.2.7.3 Discussion
The /V-glycan isolated from ovalbumin m/z 1187.6 is widely assumed to  be the usual five- 
residue core H3Nn. Even without the -NLinkedBranching switch, IsoSolve reported this as, by 
far, the highest-scoring structure. The structure is well-covered by spectrum entries 1-5 and 8. 
However, it is interesting that this structure was not compatible with all o f the pathways 
gathered. Might a structural isomer be lurking even here?
A glance at IsoSolve's output reveals that the 1187.61_928.34 pathway o f Table 55 is not 
compatible with the expected core structure. Spectrum A-45 is the final spectrum in this 
MajorGlyco pathway, and reveals only one glycosidic fragment, m/z 316.2. Executing the 
command LabelPathway NoCrossRing 1187.61_928.34_724.28_506.27_316.18 
reveals the unambiguous composition pathway o f Table 57.
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Table 57: The composition of the anomalous pathway from Table 56.






This pathway, when provide to  OSCAR via the AddPathway command, produces a single 
possible structure: NH(H)Hn. This is the second highest-scoring structure o f Table 56. Again it 
appears that GlySpy has discovered an unexpected isomeric glycan w ithout human intervention 
and, again, biosynthetic rules would certainly have disallowed this structural assignment.
An important point here is the low abundance o f this isomer. As entry 6 in Table 55 shows, 
the m/z  928 product has a relative intensity of only 2.2%. Clearly the analysis o f this isomer 
benefits from MSn's ability to  isolate low-abundance structures by selecting ions that cannot be 
generated by the higher-abundance glycans. This analytical specificity is unique to MS".
Lastly, the isomer proposed here, NH(H)Hn, bears obvious similarities to the unusual 
isomers proposed in Section 9.2.3.3, in particular the reducing end m otif Hn. It is possible that 
these structures are exemplars o f a new class of/V-linked core structures.
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9.2.8. Ovalbumin m/z 1636.84 
9.2.8.1 IDA
Table 58: Spectra suggested by IDA for Ovalbumin m /z  1636.84.
f i 1636.80 N/A 1636.84 H3N3h
1636.84 H4N2n
Initial
■ 2 .’v 1636.80_1343.51 100.0 1343.66 H4N2-(ene}' M ajor(l)
3 1636.80 1343.60 1084.40 100.0 1084.52 H4N-(ene)(oh)' Major(2)
4 1636.80_1343.60_1084.50_
866.32
100.0 866.40 H3N-(ene)(oh)2' Major(3)
5 1636.80_1343.60_1084.50_
866.40_621.21
88.6 621.27 H3-(ene)(oh)2' Major(4)
6 1636.80_1343.60_1084.50_
866.40_463.12
39.4 463.22 H2-(oh)' REScar(5)
7 1636.80_1377.57 35.9 1377.70 H3N2h-(oh)
1377.70 H4Nn-(oh)
NREScar(l)
8 1636.80_1343.60_1084.50_463.20 4.3 463.22 H2-(oh)' REScar(3)
9 1636.80_1343.60_1116.44 4.2 1116.54 H4N-(oh)' REScar(2)
10 1636.84 1377.57 1084.39 100.0 1084.52 H4N-(ene)(oh)' Major(7)
11 1636.84_1377.57_1118.45 10.6 1118.56 H3Nh-(oh)2
1118.56 H4n-(oh)2
NREScar(7)
Surprisingly, spectrum 5 in this table is the major pathway from its precursor, yet it has a 
relative intensity of only 88.6% instead o f the expected 100%. This is because the major peak on 
that spectrum is m/z 709.36, which represents a cross-ring cleavage o f the exposed reducing- 
end HexNAc. This is an example where naive, intensity-driven data collection might select the 
less desirable m/z 709.36 instead of m/z 621.21 as was done here.
Also, pathway 1636.80 -> 1343.60 1084.50 -> 866.40 -> 621.27 463.36 was suggested
by IDA for spectrum 6. However, we were unable to  acquire the spectrum due to instrument 
sensitivity limitations, and so we used the DoNotSuggestPathway command to prevent it
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from being suggested again. Interestingly, the next pathway suggested (number 6 in the table) 
was the same terminal ion, but w ithout the intermediate ion m/z 621.27.
9.2.8.2 IsoSolve
IsoSolve returned 12 structures from 67 total pathways.
Table 59: IsoSolve results for the spectra shown in Table 58.
’! 77.61 HH^NKH^H'N’n' 77.61% (52/67) 52/67
2 73.44 NHH'fH’JH’N’n’ 94.03% (63/67) 47/64
3 71.88 NH'fH^H’JH'N'n' 94.03% (63/67) 46/64
4 71.88 NHfH'KH’JH'N'n' 94.03% (63/67) 46/64
5 70.31 NfHjH'fH'JH'N'n' 95.52% (64/67) 45/64
6* 68.18 NH'fHH'JH'N'n’ 95.52% (64/67) 45/66
7 54.39 NH'fH’JH'fHJN'n' 97.01% (65/67) 31/57
8 53.33 HH^H'JH'fNJN'n' 97.01% (65/67) 32/60
9 53,33 H'fH'HHJH'N'fNJn' 100.00% (67/67) 8/15
10 53.33 H'fH'JH'fHJN'fNJn1 100.00% (67/67) 8/15
11 53.33 HH'fH’jH'N'fNjn' 100.00% (67/67) 8/15
12 50.88 H'fH’JH'fNHJN’n' 100.00% (67/67) 29/57
9.2.8.3 Discussion
The expected structure appears as entry 6 o f Table 59, but the other suggested structures 
have merit as well. For example, entry 1, HH'fNHH'JH'N'n' contains a bisecting HexNAc while the 
expected structure does not. Evidence for both structures is present. In Spectrum A-46, and in 
the detail shown in Spectrum A-47, we see that the core structure generates both m/z 444 and 
m/z 458 fragments. (See page 233.) As we have seen before (Section 9.2.4.3J, these ions are
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diagnostic of structures with and w ithout a bisecting HexNAc, respectively. Again GlySpy has 
apparently discovered a structural isomer that was unreported in (Harvey 37), and has done so 
with no human intervention. Future improvements to GlySpy could add improved facile- 
cleavage scoring to further narrow the candidates o f Table 59, but even today the software has 
produced a candidate list that can be easily managed by an analyst.
9.2.9. Ovalbumin m/z 1677.87
9.2.9.1 IDA with spectrum pruning disabled and enabled
Table 60 shows the spectra collected for ovalbumin m/z 1677.8 with spectrum pruning 
disabled. Table 61 shows the spectra collected spectrum pruning enabled.
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Table 60: Spectra suggested by IDA for ovalbumin m /z  1677.87 with pruning disabled.




2 1677.70_1384.50 29.2 1384.68 H3N3-(ene)' M ajo r(l)
3 1677.70_1384.60_1125.38 100.0 1125.54 H3N2-(ene)(oh)' Major(2)
4 1677.70_1384.60_1125.50_866.45 100.0 866.40 H3N-{ene)(oh)2' Major(3)
5 1677.70_1384.60_1125.50_866.50_
662.41
100.0 662.30 H2N-(ene)(oh)2' Major(4)
6 1677.87_1384.60_1125.50_866.40_  
662.40 458.11
100.0 458.20 HN-(ene)(oh)2' Major(5)
7 1677.70_1418.54 18.7 1418.73 H2N3h-(oh)
1418.73 H3N2n-(oh)
NREScar(l)
8 1677.87_1418.54_1125.39 100.0 1125.54 H3N2-(ene)(oh)' Major(7)
9 1677.87_1418.54_1125.39_866.30 100.0 866.40 H3N-(ene)(oh)2' Major(8)
10 1677.87_1418.54_1125.39_866.30_
662.22
100.0 662.30 H2N-(ene)(oh)2’ Major(9)
11 1677.87_1418.54_1125.39_866.30_  
662.22 458.15
100.0 458.20 HN-(ene)(oh)2’ Major(lO)
12 1677.87_1418.54_1159.45 20.7 1159.58 H2N2h-(oh)2
1159.58 H3Nn-(oh)2
NREScar(7)
13 1677.87_1418.54_1159.45_866.30 100.0 866.40 H3N-(ene)(oh)2’ Major(12)
14 1677.87_1418.54_1159.45_866.30_
662.24
100.0 662.30 H2N-(ene)(oh)2' Major(13)
15 1677.87_1418.54_1159.45_866.30_ 
662.24 458.11
100.0 458.20 HN-(ene)(oh)2' Major(14)
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Table 61: Spectra suggested by IDA for ovalbumin m /z  1677.87 with pruning enabled.




2 1677.70 1384.50 29.2 1384.68 H3N3-(ene)V M ajor(l)
3 1677.70_1384.60_1125.38 100.0 1125.54 H3N2-(ene)(oh)' Major(2)
4 1677.70_1384.60_1125.50_866.45 100.0 866.40 H3N-(ene)(oh)2' Major(3)
5 1677.70_1384.60_1125.50_866.50_
662.41
100.0 662.30 H2N-(ene)(oh)2’ Major(4)
6 1677.87_1384.60_1125.50_866.40_
662.40_458.11
100.0 458.20 HN-(ene)(oh)2' Major(5)
7 1677.70_1418.54 :: 18.7 1418.73 H2N3h-(oh)
1418.73 H3N2n-(oh)
NREScar(l)
8 1677.87_1418.54_1125.39 100.0 1125.54 H3N2-(ene)(oh)' Major(7)
9 1677.87_1418.54_1159.45 20.7 1159.58 H2N2h-(oh)2
1159.58 H3Nn-(oh)2
NREScar(7)
10 1677.87_1418.54_1159.45_866.30 100.0 866.40 H3N-(ene)(oh)2' Major(9)







M a jo r(ll)
The obvious difference between these tables is the number of spectra collected: 17 w ith 
pruning disabled versus 12 w ith it enabled. As you can see, entries 9-11 and 14-15 of Table 60 
show the re-elaboration o f the m/z 866.3 662.2 458.1 MajorGlyco pathways. These
additional spectra add little or no useful information. See Spectrum A-48, Spectrum A-49, and 
Spectrum A-50 beginning on page 234 to see the obvious similarities between the m/z  662.2 
spectra (table entries 5, 10, and 14, respectively). Pruning in this case succeeds in rejecting 
structurally uninformative spectra, reducing data collection time.
The following analysis continues using the data from Table 61 (pruning enabled).
Notice that entry 2 this table lists 1677.70_1384.50 as the MajorGlyco pathway, and yet it
only has a relative intensity of 29.2%. A close examination of Spectrum A-51 begins to  reveal
the problem. The major peak is labeled 1417.5, and apparently represents the loss of a terminal
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HexNAc, yielding a composition o f H3N2n-(oh). However, that composition has a theoretical m/z 
o f 1418.73, which is 1.23 mass units and away from the observed value, outside the default 
mass error window of ±0.5 Da. This is an error o f 867 ppm, which is quite large fo r the LTQ. The 
logical conclusion is that these data were collected when the mass spectrometer was in a poorly 
calibrated state.
The ion m/z 1384.50 (entry 2) is also incorrect by a similar amount. The exact composition is 
H3N3-(ene)', m/z 1384.68, but Spectrum A-51 shows the measured m/z as 1383.5, an error of 
1.18 mass units or 852 ppm. So where did the ion m/z 1384.50 come from, if the observed 
value is 1383.5? It is the +1 peak of the isotopic envelope. Spectrum A-52 presents a magnified 
view of the spectrum and clearly shows the m/z  1384.5 (+1) peak that is selected by IDA. Notice 
also that the m/z 1418.6 (+1) peak is present, but at a lower abundance than m/z 1384.5. Since 
IDA chooses only the most intense glycosidic peak, m/z 1384.5 is selected.
Ions subsequently selected and fragmented from this +1 peak are remarkably close to their 
theoretical values, as the extra +1 mass unit in the precursor roughly offsets the -1 amu 
calibration error.
This leads to  several conclusions about automated data collection and mass accuracy:
1) The current method is naive about measurement error and should be improved. Future 
work could include automatically calibrating the spectrum or reporting unusually large 
suspected errors.
2) However, in this case, the data collected are still usable and, as we will see, lead to 
appropriate analytical conclusions.
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3) In this case, though, the major pathway should have begun w ith m/z 1418.73, which is 
far more intense than the +1 ion m/z 1384.5 that was actually selected. This clearly 
limits the maximum depth o f the MS" experiment.
9.2.9.2 IsoSolve
When given the spectra from Table 61, IsoSolve returns five structures from 61 total 
pathways. See Table 62.
Table 62: IsoSolve results for the spectra shown in Table 61.
1 88.52 NH’tNH'jH'N’n' 54/ 61 88.52% (54/61)
2* 88.14 NH'fNHH'jH’N'n' 52/59 96.72% (59/61)
3 78.85 N(N)H,(H,)H,N,n‘ 41/ 52 98.36% (60/61)
4 57.63 NH'tH’jH ’fNjN'n' 34/59 98.36% (60/61)
5 34.62 H,(H’)H’(N)(N)N,nV 18/52 100.00% (61/61)
9.2.9.3 Discussion
The expected structure ranks second in the output list, narrowly behind the top candidate. 
The topological difference between these structures is quite simple: structure 1 has terminal 
HexNAcs on each antenna, whereas structure 2 moves one of these Ns to become a bisecting 
HexNAc. The evidence strongly suggests that both structures are present. Spectrum A-49 
shows the expected fragments for structures with and without a bisecting HexNAc: m/z 444.1 
(not labeled, composition HN-(ene)(oh)3’) and m/z 458.3 (composition HN-(ene)(oh)2'). We 
conclude that GlySpy has again identified a structural isomer that was invisible to other 
analytical techniques.
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9.2.10. Ovalbumin m/z 1922.99 
9.2.10.1 IDA
Table 63 shows the spectra collected by IDA for ovalbumin m/z 1922.99. Again we see the 
MajorGlyco pathway extended (steps 1-7), reducing-end and non-reducing-end scar fragments 
selected (and 8, 9, 12, and 14), and those scar fragments themselves being extended by their 
major ions (steps 10, 11, and 13). A tota l o f 14 spectra were collected fo r a glycan containing 
eight residues.
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Table 63: Spectra suggested by IDA for ovalbumin m /z  1922.99.








3 1923.00_1663.70_1370.46 100.0 1370.67 H3N3-(ene)(oh)‘ Major(2)
4 1923.00_1663.70_1370.44_
1111.40
100.0 1111.53 H3N2-(ene)(oh)2' Major(3)
5 1923.00_1663.70_1370.44_
1111.40_852.28
100.0 852.38 H3N-(ene)(oh)3’ Major(4)
6 1922.99_1663.59_1370.46_
1111.40_852.28_662.33
100.0 662.30 H2N-(ene)(oh)2' Major(5)
7 1922.99_1663.59_1370.46_
1111.40_852.28_634.26
100.0 634.27 H2N-(ene)(oh)4' Major(5)
8 1923.00_1663.70_1404.48 91.0 1404.71 H2N3h-(oh)2
1404.71 H3N2n-(oh)2
NREScar(2)
9 1923.00_1629.54 44.5 1629.81 H3N4-(ene)' REScar(l)
10 1923.00_1663.70_1404.60_
1111.37
100.0 1111.53 H3N2-(ene)(oh)2' Major(8)














Note that entries 6 and 7 are both MajorGlyco extensions o f entry 5. As seen before, 
spectrum 5 contained two different scans; on one, m/z 662.33 was the base peak, and on the 
other, m/z 634.26 was.
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9.2.10.2 IsoSolve
Given the spectra o f Table 63, IsoSolve returns five structures from 74 total pathways.
Table 64: IsoSolve results for the spectra shown in Table 63.
1* 90.54 NfNJH'tNJfH'JH'N'n' 67/74 90.54% (67/74)
2 87.67 NH’tNKNHH'JH'N'n’ 64/73 98.65% (73/74)
3 76.71 N(N){N)H'(H’)H'N’n' 56/73 100.00% (74/74)
4 76.71 NMH'fNH'JH'N’n' 56/73 100.00% (74/74)
5* 73.61 NH'tNH'MNJH’N'n' 53/72 100.00% (74/74)
9.2.10.3 Discussion
There are two expected structures at this mass, and they appear in Table 64 and Figure 48 
as structures number 1 and 5.
Structures 2 and 3 are likely to  be the most controversial; 2 proposes a rare double-bisecting 
HexNAc and 3 presents a triply-substituted hexose. What is the quality o f evidence for these 
structures? To begin, we turn our attention to Spectrum A-53 (pathway 
1922.99_1663.59_1370.46_1111.40_852.28_634.26; see page 237), which matches entry 7 of 
Table 63. The precursor ion m/z 634.3 has composition H2N-(ene)(oh)4', indicating that some 
subtree of two hexoses and one HexNAc had a total of four non-reducing-end scars and one 
reducing-end scar. Structures 4 and 5 cannot generate this fragment and so are excluded from 
this analysis. Table 65 shows the compositions of the product ions found on that spectrum, and 
maps those compositions to specific residues within each structure. If no mapping is possible, 
the table entry is left blank.
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Figure 48: Structures 1-5 from Table 64.
Table 65: Putative compositions for observed ions on the ovalbumin 
spectrum m /z  1922.99_1663.59_1370.46_1111.40_852.28_634.26 
and their mapping to structures 1, 2, and 3 of Table 64.
634.3 634.27 H2N-(ene)(oh)4' H°H2N6 H°H2N6 h°h2n6
213.0 213.07 H-(ene)(oh)2' H°
231.1 231.08 H-(oh)3' H°
268.0 268.12 N-(ene)(oh)' N6 Ns N6
389.2 389.14 H2-(ene)(oh)4’ H°H2 H°H2 H°H2
407.2 407.15 H2-(oh)5' H°H2 H°H2 H°H2
430.2 430.17 HN-(ene)(oh)4' H2N6
444.3 444.18 HN-(ene)(oh)3' H2N6
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Table 65 reveals that the only ion that exclusively supports structure 2 is m/z 430.2; all other 
ions also support structure 1 and/or 3. Unfortunately, the spectrum acquired for m/z 430.2 falls 
well below an acceptable normalization level and we are therefore left w ith insufficient 
evidence to conclude that structure 2 is correct.
Structure 3 is interesting because OSCAR requires only a single pathway to generate it: m/z 
1923.00_1663.70_1404.60_1145.45_969.38. Because multiple pathways are not used, the 
possibility o f mixing pathways from multiple isomers is excluded. GlySpy's LabelPathway 
command gives composition assignments to these ions as shown in Table 66.
Table 66: Putative ion compositions for the 






As you can see, ion m/z 969.5 requires that a subtree of composition H2Nn-(oh) can be 
isolated w ith a single non-reducing-end cleavage. In other words, one H and three Ns can be 
lost with a single cleavage. Of the structures in Table 64, only structure 3 can satisfy this, using 
the residues H°H2N6n7. Again, however, attempts to acquire a reliable spectrum from the 
pathway 1923.00_1663.70_1404.60_1145.45_969.5 failed due to instrument sensitivity limits.
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CHAPTER 10: 
SUMMARY AND CONTRIBUTIONS
This work has presented GlySpy, a suite o f tools used to assign glycan structures from 
sequential mass spectral data. The document introduced the background material required to 
place GlySpy in context and reviewed a number of tools, techniques, and databases in the 
growing field o f glycomics. It described the four main components of GlySpy, detailing the 
algorithms, providing experimental data, and presenting results. To summarize, these tools are:
•  OSCAR (the Oligosaccharide Subtree Constraint Algorithm), which accepts MS" 
disassembly pathways and produces a set o f plausible glycan structures;
• IsoDetect, which reports the MS" disassembly pathways that are inconsistent w ith a 
set o f expected structures, and which therefore may indicate the presence of 
alternative isomeric structures;
• IsoSolve, which assigns the branching structures o f multiple isomeric glycans found 
in a complex mixture; and
• Intelligent Data Acquisition (IDA), which provides automated guidance to the mass 
spectrometer operator, selecting glycan fragments for further MS" disassembly.
GlySpy's contributions to the fields of glycomics and computer science include:
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1) De novo analysis. GlySpy does not use presumed biosynthetic rules or previously- 
reported glycans to  guide its analysis. Because of this de novo approach, GlySpy has 
assigned novel structures. For example, this document has presented evidence for 
/V-glycans that do not contain the expected H3Nn core, structures that have been 
overlooked by previous research. Unexpected structures such as these will lead to a 
deeper understanding o f glycan synthesis and function. As glycan biosynthesis is 
perturbed by a variety of disease processes, similar unorthodox structures may 
someday be identified as important biomarkers.
2) Performance. Careful software engineering was applied to many portions of GlySpy 
to  avoid the combinatorial problems commonly associated w ith glycan analysis. 
Examples include:
a. OSCAR's fork data structure allows it to  eliminate candidate structures 
w ithout first constructing them.
b. OSCAR optimizes composition pathways based on precursor/product 
relationships, greatly reducing the number o f interpretations to be 
analyzed.
c. OSCAR discards inconsistent and isomorphic forks, focusing its efforts on 
those forks whose interpretations can lead to unique assignments.
d. Although GlySpy's analysis is de novo, a few important options are provided 
to  allow analysts to restrict the search space, for example, the AddPathway 
command's NoCrossRing option, which eliminates cross-ring compositions 
from consideration. Also important are the -NLinked and
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-NLinkedBranching options, which restrict analysis to  structures that 
embed the H3Nn core.
e. IsoSolve applies innovative techniques to guide the search for isomeric 
structures, despite the daunting size o f the search space.
3) Interpretation of higher-order MS" data. Many existing tools rely primarily or even 
exclusively on MS2 spectra. As we have demonstrated, structural isomers may be 
hidden at this level of analysis, and higher-order analysis is required to  find them. 
Additionally, although previous tools such as STAT have recognized that glycan 
fragments can be represented as subtrees, GlySpy extends this analysis to arbitrary 
levels o f glycan disassembly, and also takes advantage of the precursor/product 
relationship at each level to reduce the number of candidate structures generated.
4) Automation. GlySpy's Intelligent Data Acquisition module presents one plausible 
model for automated data acquisition. When coupled w ith methods for directly 
controlling the mass spectrometer, GlySpy will offer fully automated data 
acquisition, greatly increasing instrument throughput. When this capability, in turn, 
is combined with IsoSolve, analytical throughput will be dramatically improved.
5) General solution. Nearly all o f OSCAR's inference rules operate on the tree 
abstraction of glycans and encode no chemistry knowledge whatsoever. The 
remaining rules are based on cross-ring cleavages, which are perhaps specific to this 
domain. If a problem space were discovered that had similar characteristics— 
especially the notion o f disassembling a tree structure in a way that leaves visible 
scars—then OSCAR's techniques may applicable. Further, depending upon the 
details of this new problem space, algorithms such as IsoDetect, IsoSolve, and
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Intelligent Data Acquisition may also be appropriate. APPENDIX B: SAMPLE OSCAR 
INFERENCE RULES provides details of many o f these rules and indicates how they 
may be applicable to a wider range o f tree-based problems.
6) Research aid. GlySpy's demonstrated high performance and progress toward 
automated glycan analysis position it as the computational engine of a future high- 
throughput glycomics platform. Such a platform could be o f value to  many 
biological and medical researchers.
Although much work remains to be done in the field of glycomics, it is hoped that GlySpy 
has made a contribution to the fascinating problem of glycan structural analysis.
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A.1. Fetuin Spectra
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Spectrum A -l: Fetuin m/z  1820.9
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Spectrum A-2: Detail o f m/z 874.4 reveals the charge state as +1.
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FET_1820x2 #1-2 RT: 0.00-0.09 AV: 2 N L 4 .61E 1  
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Spectrum A-3: Detail o f ions m/z 1258.1 and m/z 1262.0 reveals both charge states as +2.
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Spectrum A-4: Detail o f presumptive electronic noise in the high m/z range.
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FET_1820x2_1409x2 #1-2 RT: 0.00-0.15 AV: 2  NL: 7.12E1
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Spectrum A-5: Fetuin m/z 1820.92+ 1408.52+
FET_1822x2_1409x2_997x2 #1 -5 RT: 0.00-0.52 AV: 5 NL: 8.63E-1
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Spectrum A-6: Fetuin m/z 1820.92+ -¥ 1408.52+ -» 996.52
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FET_1822x2_847 #1 -5 RT: 0.00-0.10 AV: 5 NL: 5.33E1
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Spectrum A-7: Fetuin m/z 1820.92+ 847.4
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Spectrum A-8: Fetuin m/z 1820.92+ -> 1408.52+ 847.4
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A.2. GM1a/GM1b Spectra
GM1ab_1877_1273 #1-10 RT: 0.00-2.08 AV: 10 NL: 3.43E2
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Spectrum A-10: G M la /G M lb  m/z 1273.4
GM1 ab_1877_1273_898 #1 -9 RT: 0.00-2.09 AV: 9 NL: 1.07E2
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Spectrum A - l l :  G M la /G M lb  m/z 1273.4 -> 898.3
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Spectrum A-13: G M la /G M lb  m/z 1273.4 -> 847.3
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GM1ab_1877_1273_898_435 #1-11 RT: 0.00-1.60 AV: 11 NL: 3.12E1
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Spectrum A-14: G M la /G M lb  m/z 1273.5 -> 898.3 -> 435.1
GM1 ab_1877_1273_847_472 #1 -6 RT: 0.00-1.46 AV: 6 NL: 5.23
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Spectrum A-15: G M la /G M lb  m/z 1273.4 -» 847.3 -> 472.2
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GM1ab_1877_1273_898_449 #1-12 RT: 0.00-1.77 AV: 12 NL: 1.87E1
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Spectrum A-16: G M la /G M lb  m/z 1273.5 -> 898.3 449.2
GM1 ab_1877_1273_898_472 #1-13 RT: 0.00-1.93 AV: 13 NL: 1.48E1
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Spectrum A-17: G M la /G M lb  m/z 1273.5 -> 898.3 -> 472.2
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A.3. laG m/z 1606.8 Spectrum
IGG_1606 #1-2 RT: 0.00-0.08 AV: 2  NL: 1.18E4 
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Spectrum A-18: IgG m/z 1606.8
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A.4. IqG m/z 1636.8 Spectra
IG G_1636#1-2 RT: 0.00-0.12 AV: 2 NL: 3.02E3 
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Spectrum A-19: IgG m /z  1636.8
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Spectrum A-20: IgG m/z 1636.8 -» 1173.6
218
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
IGG_1636_1173_914#1-2 RT: 0.00-0.11 AV: 2 NL: 7.22E2
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Spectrum A-21: IgG m/z 1636.8 -» 1173.6 -> 914.4
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Spectrum A-22: IgG m/z 1636.8 -> 1173.6 914.4 710.3
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IGG_1636_1173_914_710_506 #1-2 RT: 0.00-0.14 AV: 2 NL: 8.24E1
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Spectrum A-23: IgG m/z 1636.8 -> 1173.6 ^  914.4 -> 710.3 ^  506.2
IGG 1636 1343 #1-2 RT: 0.00-0.12 AV: 2 NL: 1.08E1
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Spectrum A-24: IgG m/z 1636.8 1343.5
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IGG 1636_1343_880 #1-3 RT: 0.00-0.26 AV: 3 NL: 2.77
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Spectrum A-25: IgG m /z 1636.8 -> 1343.5 880.4
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A.5. IgG m/z 1677.8 Spectra
IGG_1677_1384_1125_866_662 #1 -2 RT: 0.00-0.14 AV: 2 NL: 8.47E1
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Spectrum A-26: IgG m/z 1677.8 -> 1384.6 -> 1125.5 -> 662.4
IGG_1677 1384 1125_866_662_441 #1 -20 RT: 0.00-0.92 AV: 20 NL: 3.80E-2
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Spectrum A-27: IgG m/z 1677.8 -> 1384.6 -> 1125.5 -» 662.4 ->441.1
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A.6. IgG m/z 1851.9 Spectra
IGG_1851 #1-2 RT: 0.00-0.07 AV: 2 NL: 7.59E4 
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Spectrum A-28: IgG m/z 1851.9
IGG_1851_1384 #1 -2 RT: 0.00-0.09 AV: 2 NL: 2.99E4
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Spectrum A-29: IgG m/z 1851.9 -> 1384.6
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IGG 1851_1384_1125 #1 -2 RT: 0.00-0.10 AV: 2 NL: 1.52E4
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Spectrum A-30: IgG m/z 1851.9 1384.6 1125.5
IGG_1851 1384_1125_866 #1-2 RT: 0.00-0.12 AV: 2 NL: 5.65E3
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Spectrum A-31: IgG m/z 1851.9 1384.6 1125.5 866.4
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IGG_1851_1384J125_866_662#1-2 RT: 0.00-0.13 AV: 2 NL: 1.19E3
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Spectrum A-32: IgG m/z 1851.9 1384.6 1125.5 -» 866.4 662.3
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Spectrum A-33: IgG m/z 1851.9 1384.6 -» 1125.5 866.4 -> 662.3 458.2
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IGG_1851_1592 #1 -2 RT: 0.00-0.09 AV: 2 NL: 3.61E3
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Spectrum A-35: IgG m/z  1851.9 -> 1592.7 ^  1125.4
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IGG 1851 1592_490 #1 -2 RT: 0.00-0.09 AV: 2 NL: 4.92E1
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Spectrum A-36: IgG m/z 1851.9 -» 1592.7 490.1
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A.7. Ovalbumin m/z 1187.6 Spectra
OVA_1187 #1 -2 RT: 0.00-0.06 AV: 2 NL: 1.22E5 
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Spectrum A-37: Ovalbumin m/z 1187.6
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Spectrum A-38: Ovalbumin m/z 1187.6 -> 898.4
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OVA_1187_894_676 #1-2 RT: 0.00-0.10 AV: 2 NL: 2.73E3
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Spectrum A-39: Ovalbumin m/z 1187.6 -> 898.4 -> 676.4
0V A _1187_894_676_431 #1-3 RT: 0.00-0.23 AV: 3 NL: 1.90E2
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Spectrum A-40: Ovalbumin m/z 1187.6 898.4 676.4 -> 431.2
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OVA_1187_894_667 #1-3 RT: 0.00-0.25 AV: 3 NL: 2.97E1
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Spectrum A-41: Ovalbumin m/z 1187.6 -> 898.4 667.24
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Spectrum A-42: Ovalbumin m/z 1187.6 -> 928.3
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0VA_1187_928_724 #1-2 RT: 0.00-0.11 AV: 2 NL: 1.26E1
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Spectrum A-43: Ovalbumin m/z 1187.6 -> 928.3 -> 724.3
0 VA_1187_894_667_449 #1 -3 RT: 0.00-0.12 AV: 3 NL: 3.95E1
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A.8. Ovalbumin m/z 1636.8 Spectra
OVA_1636_1343_1084_866 #1-3 RT: 0.00-0.25 AV: 3 NL: 6.68E1
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Spectrum A-46: Ovalbumin m/z 1636.8 -> 1343.6 1084.5 866.4
OVA_1636_1343_1084_866 #1-3 RT: 0.00-0.25 AV: 3 NL: 1.53E1
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Spectrum A-47: Detail from ovalbumin m/z 1636.8 1343.6 -> 1084.5 866.4 showing the
characteristic ions m/z 444 and m/z 458 indicating isomers with and w ithout bisecting HexNAcs.
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A.9. Ovalbumin m/z 1677.8 Spectra
OVA_1677_1384_1125_866_662 #1-3 RT: 0.00-0.27 AV: 3 NL: 3.07E2
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Spectrum A-48: Ovalbumin m/z 1677,8 -> 1384.6 -> 1125.5 866.4 -> 662.4
OVA_1677_1418_1125_866_662 #1 -3 RT: 0.00-0.30 AV: 3 NL: 3.19E1
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Spectrum A-51: Ovalbumin m/z 1677.7
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Spectrum A-52: Ovalbumin m/z 1677.7 (detail)
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A.10. Ovalbumin m/z 1923.0 Spectrum
OVA_1923_1663_1370_1111 _852_634 #1-2 RT: 0.00-0.20 AV: 2 NL: 2.21
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APPENDIX B: 
SAMPLE OSCAR INFERENCE RULES
This section describes several of OSCAR's inference rules. The names o f the rules are taken 
directly from the implementing C++ method. The parenthesized phrase following the rule's 
name identifies the rule's parameter, and indicates whether the rule accepts a mono or a box as 
its primary argument. The data structure fields used are described in Section 5.3 beginning on 
page 53.
Note that these rules are described as operating on glycans, boxes, monos, and scars. 
However, these rules could easily be applied to any domain that includes trees, subtrees, nodes, 
and dangling edges, respectively. As such, the rules should be considered potentially applicable 
to  a variety o f domains. The rare exceptions are the rules that deal w ith cross-ring cleavages, 
which are unlikely to map cleanly to other problem spaces.
B.1. InferNumChildrenForSinaleton (Box B)
If box B has N child scars and contains a single mono M, then we know that all of those N 
child scars belong to mono M. We therefore know that M must have exactly N children. We 
update M's NumChildrenPossible field to contain only the value N.
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B.2. RootPlusOnlvLeaves (Box B)
If a box B contains N monos and N -l o f those monos are known to be leaves, then the Nth 
mono must be the parent o f the N -l monos. (Since N -l of the monos cannot have children, only 
the remaining Nth mono can have children. Furthermore, since all o f the monos in the box must 
form a connected substructure, that Nth mono must have all o f the other monos as children.) 
We update the fork by restricting the ParentPossible field for each o f the N -l monos to 
contain only the Nth mono.
B.3. ApplvBoxLinkaqe (Box B)
Suppose that the composition of box B represents a cross-ring fragment that includes only 
the 6 position of B's parent mono. Clearly, the fragment must have been linked to position 6 of 
its parent mono and so the only monos that could be the root of box B are those that might be 
6-linked to their parent. Therefore, we remove from the box's RootPossible field any mono 
which does not have 6 in its LinkageMonoToParentPossible field.
B.4. RestrictParentPossibleGivenCrossRinqBox (Box B)
Given a box B that has a cross-ring cleavage composition and RootDefinite RD, we can 
restrict RD's possible parents to those that have enough possible children to account for the 
child scars on the cross-ring fragment.
For example, suppose box B has a 3,5A cross-ring cleavage that contains one glycosidic bond 
and one (oh) scar. RD's parent must therefore have at least two children: linkage positions 4 
and 6 are both known to be occupied. Any possible parent of RD has less than two children 
(NumChildrenPossible), or that does not have both position 4 and 6 available to attach 
children (LinkageMonoToChildrenPossible), is eliminated from box B's RootParent- 
Possible field.
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B.5. ApplvLeaf (Mono M)
If we know that the mono M is a leaf (because NumChildrenPossible = { 0 }), then the 
inference rule performs the following updates:
1) Clear mono M's ChildrenPossible to  empty (because the mono has no children).
2) Remove mono M from the ParentPossible field o f all other monos (because 
mono M cannot be the parent o f any mono).
3) Remove mono M from the RootParentPossible field o f all boxes in the enclosing 
fork (because no fragment can attach to  this mono).
4) Remove mono M from the RootPossible field of all boxes which contain more 
than one mono (since some other mono in those boxes must be the roots).
B.6. NoPossibleParentslmpliesMSRoot (Mono M)
If the mono M has no possible parents (ParentPossible is empty), then the mono must 
be the root of the glycan. The containing fork is annotated appropriately.
B.7. ApplvMSRootToAnnMono (Mono M)
If mono M is known to be the root of the glycan (for example, as the result o f the previous 
inference rule, NoPossibleParentslmpliesMSRoot), this inference rule:
1) Clears M's ParentPossible field (because the root cannot have a parent) and
2) Removes M from the ChildrenPossible field of all monos in the fork (because 
the root cannot be a child).
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B.8. ApplvMSRootToAnnBox (Box B)
If box B contains mono M, where M is known to  be the root of the glycan, then M must also 
be the root of the box. Restrict box B's RootPossible field by excluding all monos except M.
B.9. AIIChildrenAccountedFor (Mono M)
Suppose mono M has exactly N children (NumChildrenPossible = { N }) and those 
children are all known (childrenDefinite contains exactly N monos). We therefore know 
that all children o f mono M have been found, and update the enclosing fork by removing M 
from the ParentPossible field o f all monos other than M's definite children.
B.10. AssiqnChildLinkaqe (Mono M)
If parent mono M has a definite child mono C (that is, M.ChildrenDefinite contains C) 
and C has a definite linkage L to  its parent mono ( c .Linkage contains the single value L), then 
we know that linkage position L on parent mono M is occupied by child C. Obviously, no other 
child o f M can share this linkage position, and so the inference rule updates all other definite 
children of M by removing L from their Linkage field.
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B.11. InferNumChildrenFromCrossRinqCleavaqe (Box B)
Referring to the following illustration, assume that OSCAR has deduced that the cross-ring 
fragment in (C) must have come from the mono H1. Because the cross-ring fragment contains 
two linkage positions (4 and 6), and one is unscarred (in this case, position 6), we can infer that 
H1 has at most three children. (H1 could have four children only if positions 2, 3, 4, and 6 were 
all occupied, but we know that 6 is not scarred.) The inference rule updates the H1 mono by 
removing 4 from its NumChildrenPossible field. This is an example o f a rule that requires 
chemical knowledge—specifically, the structure of cross-ring fragments—in order to  derive 
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